
<html lang="en"     class="pb-page"  data-request-id="5bd05317-7ae8-4794-8bdb-6cf7875ac278"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2012.55.issue-20;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm300912k"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthesis, Evaluation, and Radiolabeling of New Potent Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2 as Potential Tracers for Positron Emission Tomography Imaging" /></meta><meta name="dc.Creator" content="José-Ignacio  Andrés" /></meta><meta name="dc.Creator" content="Jesús  Alcázar" /></meta><meta name="dc.Creator" content="José María  Cid" /></meta><meta name="dc.Creator" content="Meri  De Angelis" /></meta><meta name="dc.Creator" content="Laura  Iturrino" /></meta><meta name="dc.Creator" content="Xavier  Langlois" /></meta><meta name="dc.Creator" content="Hilde  Lavreysen" /></meta><meta name="dc.Creator" content="Andrés A.  Trabanco" /></meta><meta name="dc.Creator" content="Sofie  Celen" /></meta><meta name="dc.Creator" content="Guy  Bormans" /></meta><meta name="dc.Description" content="The synthesis and in vitro and in vivo evaluation of a new series of 7-(phenylpiperidinyl)-1,2,4-triazolo[4,3-a]pyridines, which were conveniently radiolabeled with carbon-11, as potential positron..." /></meta><meta name="Description" content="The synthesis and in vitro and in vivo evaluation of a new series of 7-(phenylpiperidinyl)-1,2,4-triazolo[4,3-a]pyridines, which were conveniently radiolabeled with carbon-11, as potential positron..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 11, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm300912k" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm300912k" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm300912k" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm300912k" /></link>
        
    
    

<title>Synthesis, Evaluation, and Radiolabeling of New Potent Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2 as Potential Tracers for Positron Emission Tomography Imaging | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm300912k" /></meta><meta property="og:title" content="Synthesis, Evaluation, and Radiolabeling of New Potent Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2 as Potential Tracers for Positron Emission Tomography Imaging" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0012.jpeg" /></meta><meta property="og:description" content="The synthesis and in vitro and in vivo evaluation of a new series of 7-(phenylpiperidinyl)-1,2,4-triazolo[4,3-a]pyridines, which were conveniently radiolabeled with carbon-11, as potential positron emission tomography (PET) radiotracers for in vivo imaging of the allosteric binding site of the metabotropic glutamate (mGlu) receptor subtype 2 are described. The synthesized compounds proved to be potent and selective positive allosteric modulators (PAMs) of the mGlu receptor 2 (mGluR2) in a [35S]GTPγS binding assay and were able to displace an mGluR2 PAM radioligand, which we had previously developed, with IC50 values in the low nanomolar range. The most promising candidates were radiolabeled and subjected to biodistribution studies and radiometabolite analysis in rats. Preliminary small-animal PET (μPET) studies in rats indicated that [11C]20f binds specifically and reversibly to an mGluR2 allosteric site, strongly suggesting that it is a promising candidate for PET imaging of mGluR2 in the brain." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm300912k"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm300912k">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm300912k&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm300912k&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm300912k&amp;href=/doi/10.1021/jm300912k" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 8685-8699</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm3008773" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm3009184" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis, Evaluation, and Radiolabeling of New Potent Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2 as Potential Tracers for Positron Emission Tomography Imaging</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jos%C3%A9-Ignacio++Andr%C3%A9s">José-Ignacio Andrés</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jes%C3%BAs++Alc%C3%A1zar">Jesús Alcázar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jos%C3%A9+Mar%C3%ADa++Cid">José María Cid</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Meri++De+Angelis">Meri De Angelis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laura++Iturrino">Laura Iturrino</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xavier++Langlois">Xavier Langlois</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hilde++Lavreysen">Hilde Lavreysen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andr%C3%A9s+A.++Trabanco">Andrés A. Trabanco</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sofie++Celen">Sofie Celen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guy++Bormans">Guy Bormans</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Medicinal Chemistry, Janssen Research & Development, Janssen-Cilag S.A., C/Jarama 75, 45007 Toledo, Spain</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Neuroscience, Janssen Research & Development, Janssen Pharmaceutica N.V., Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Laboratory for Radiopharmacy and IMIR, Faculty of Pharmaceutical Sciences, K.U. Leuven, Herestraat 49, B-3000 Leuven, Belgium</span></div><div class="corresp-info"><strong>*</strong>Tel.: + 34 925 245 780. Fax: + 34 925 245 771. E-mail: <a href="/cdn-cgi/l/email-protection#7118101f15031402311805025f1b1f1b5f121e1c"><span class="__cf_email__" data-cfemail="5e373f303a2c3b2d1e372a2d70343034703d3133">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm300912k&amp;href=/doi/10.1021%2Fjm300912k" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 8685–8699</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 20, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>28 June 2012</li><li><span class="item_label"><b>Published</b> online</span>11 October 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 October 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm300912k" title="DOI URL">https://doi.org/10.1021/jm300912k</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8685%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJos%25C3%25A9-Ignacio%2BAndr%25C3%25A9s%252C%2BJes%25C3%25BAs%2BAlc%25C3%25A1zar%252C%2BJos%25C3%25A9%2BMar%25C3%25ADa%2BCid%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D20%26contentID%3Djm300912k%26title%3DSynthesis%252C%2BEvaluation%252C%2Band%2BRadiolabeling%2Bof%2BNew%2BPotent%2BPositive%2BAllosteric%2BModulators%2Bof%2Bthe%2BMetabotropic%2BGlutamate%2BReceptor%2B2%2Bas%2BPotential%2BTracers%2Bfor%2BPositron%2BEmission%2BTomography%2BImaging%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8699%26publicationDate%3DOctober%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm300912k"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1690</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">39</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm300912k" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis, Evaluation, and Radiolabeling of New Potent Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2 as Potential Tracers for Positron Emission Tomography Imaging&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;José-Ignacio&quot;,&quot;last_name&quot;:&quot;Andrés&quot;},{&quot;first_name&quot;:&quot;Jesús&quot;,&quot;last_name&quot;:&quot;Alcázar&quot;},{&quot;first_name&quot;:&quot;José&quot;,&quot;last_name&quot;:&quot;María Cid&quot;},{&quot;first_name&quot;:&quot;Meri&quot;,&quot;last_name&quot;:&quot;De Angelis&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;Iturrino&quot;},{&quot;first_name&quot;:&quot;Xavier&quot;,&quot;last_name&quot;:&quot;Langlois&quot;},{&quot;first_name&quot;:&quot;Hilde&quot;,&quot;last_name&quot;:&quot;Lavreysen&quot;},{&quot;first_name&quot;:&quot;Andrés&quot;,&quot;last_name&quot;:&quot;A. Trabanco&quot;},{&quot;first_name&quot;:&quot;Sofie&quot;,&quot;last_name&quot;:&quot;Celen&quot;},{&quot;first_name&quot;:&quot;Guy&quot;,&quot;last_name&quot;:&quot;Bormans&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;11&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;8685-8699&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm300912k&quot;},&quot;abstract&quot;:&quot;The synthesis and in vitro and in vivo evaluation of a new series of 7-(phenylpiperidinyl)-1,2,4-triazolo[4,3-a]pyridines, which were conveniently radiolabeled with carbon-11, as potential positron emission tomography (PET) radiotracers for in vivo imaging of the allosteric binding site of the metabotropic glutamate (mGlu) receptor subtype 2 are described. The synthesized compounds proved to be potent and selective positive allosteric modulators (PAMs) of the mGlu receptor 2 (mGluR2) in a [35S]GTPγS binding assay and were able to displace an mGluR2 PAM radioligand, which we had previously developed, with IC50 values in the low nanomolar range. The most promising candidates were radiolabeled and subjected to biodistribution studies and radiometabolite analysis in rats. Preliminary small-animal PET (μPET) studies in rats indicated that [11C]20f binds specifically and reversibly to an mGluR2 allosteric site, strongly suggesting that it is a promising candidate for PET imaging of mGluR2 in the brain.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300912k&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300912k" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300912k&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300912k" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300912k&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300912k" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm300912k&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300912k&amp;href=/doi/10.1021/jm300912k" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm300912k" /></input><a href="/doi/pdf/10.1021/jm300912k" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm300912k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm300912k%26sid%3Dliteratum%253Aachs%26pmid%3D22992024%26genre%3Darticle%26aulast%3DAndr%25C3%25A9s%26date%3D2012%26atitle%3DSynthesis%252C%2BEvaluation%252C%2Band%2BRadiolabeling%2Bof%2BNew%2BPotent%2BPositive%2BAllosteric%2BModulators%2Bof%2Bthe%2BMetabotropic%2BGlutamate%2BReceptor%2B2%2Bas%2BPotential%2BTracers%2Bfor%2BPositron%2BEmission%2BTomography%2BImaging%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D20%26spage%3D8685%26epage%3D8699%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291713" title="Polyacrylamide">Polyacrylamide</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jmcmar.2012.55.issue-20/production/jmcmar.2012.55.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/medium/jm-2012-00912k_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300912k&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The synthesis and in vitro and in vivo evaluation of a new series of 7-(phenylpiperidinyl)-1,2,4-triazolo[4,3-<i>a</i>]pyridines, which were conveniently radiolabeled with carbon-11, as potential positron emission tomography (PET) radiotracers for in vivo imaging of the allosteric binding site of the metabotropic glutamate (mGlu) receptor subtype 2 are described. The synthesized compounds proved to be potent and selective positive allosteric modulators (PAMs) of the mGlu receptor 2 (mGluR2) in a [<sup>35</sup>S]GTPγS binding assay and were able to displace an mGluR2 PAM radioligand, which we had previously developed, with IC<sub>50</sub> values in the low nanomolar range. The most promising candidates were radiolabeled and subjected to biodistribution studies and radiometabolite analysis in rats. Preliminary small-animal PET (μPET) studies in rats indicated that [<sup>11</sup>C]<b>20f</b> binds specifically and reversibly to an mGluR2 allosteric site, strongly suggesting that it is a promising candidate for PET imaging of mGluR2 in the brain.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26057" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26057" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system (CNS) and plays a major role in numerous physiological and behavioral processes via two different receptor classes, the ionotropic (iGlu) and the G-protein coupled metabotropic glutamate (mGlu) receptors.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> There are eight known mGlu receptor subtypes, of which subtype 2 (mGluR2), which belongs to the group II mGlu receptors, is an attractive potential therapeutic target in neuropharmacology. Preferentially expressed on presynaptic nerve terminals, mGluR2 negatively modulates glutamate and GABA release.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Thus, it may be hypothesized that schizophrenia-like symptoms arising from increased glutamate transmission in the forebrain could be treated by stimulating mGluR2, thereby reducing synaptic glutamate levels.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Based on this mechanism, normalizing glutamate levels by mixed mGluR2/3 agonists has shown comparable efficacy as conventional antipsychotic drugs for treating schizophrenia.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Indeed, clinical validation was achieved in a phase II study in schizophrenic patients with LY2140023, the orally available prodrug of the mixed mGluR2/3 orthosteric agonist LY404039, which demonstrated improvements in both positive and negative symptoms.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> In addition, multiple preclinical studies have reported efficacy of mGluR2 activation in animal models of neurologic disorders such as schizophrenia, anxiety/stress, and depression.<a onclick="showRef(event, 'ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10">(7-10)</a> Furthermore, activating mGluR2/3 has been shown to be efficacious to treat anxiety disorders in clinical trials.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">A new avenue for developing selective agents acting at mGlu receptors is to identify compounds that act through allosteric mechanisms, modulating the receptor by binding to a site different from the highly conserved orthosteric glutamate binding site. Positive allosteric modulators (PAMs) offer several advantages over orthosteric agonists: the ligands are not based on an amino acid structure, which is generally detrimental for CNS penetration, they avoid the conserved mGluR orthosteric binding site and offer improved selectivity, they may be less liable to cause receptor desensitization, and they only act in the presence of endogenous glutamate, thereby responding to physiological fluctuations.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12-14)</a> The number of chemically diverse mGluR2 PAMs reported over the last years in both patent applications and research journals has increased dramatically.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_p">Noninvasive imaging of mGluR2 using positron emission tomography (PET) would allow quantification of the distribution, expression, and modulation of this receptor under physiological and pathological conditions. PET imaging of mGluR2 would allow better understanding of the role of this receptor under different neuropsychiatric conditions, and it would facilitate the clinical development of mGluR2 modulators as potential drug candidates by giving direct insight into the relationship between the level of receptor occupancy and the administered dose of the candidate drug.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> Several PET radiotracers have been reported for in vivo imaging of group I mGluRs (mGluR1 and mostly mGluR5).<a onclick="showRef(event, 'ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21">(18-21)</a> Very recently the first PET radioligand for imaging group II mGluRs <i>in vivo</i> has been reported ([<sup>11</sup>C]CMGDE, <b>1</b>).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> However, <b>1 </b>(Figure<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) shows high affinity for both mGluR2 and mGluR3, and since it binds to the orthosteric binding site, it cannot be used for imaging studies with novel mGluR2 PAM drug candidates. Furthermore, [<sup>11</sup>C]CMGDE is in fact a prodrug (dimethylester of an amino acid like molecule) and its brain retention may therefore also reflect esterase activity in the brain; this hypothesis is supported by the fact that blocking studies showed only 20–30% reduced brain uptake. To our knowledge, there is no PET radiotracer disclosed for imaging selectively mGluR2 so far.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/medium/jm-2012-00912k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of two mGluR2 radioligands and two 1,2,4-triazolo[4,3-<i>a</i>]pyridine mGluR2 PAMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300912k&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We started a research program to develop a PET radiotracer for in vivo imaging of mGluR2 in brain, in parallel to the Medicinal Chemistry efforts aiming at the identification of a suitable mGluR2 PAM for clinical development. We have reported several structurally diverse chemotypes of mGluR2 PAMs.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Among them, one of the most exemplified chemical series is the 1,4-disubstituted 2-pyridones.<a onclick="showRef(event, 'ref15 ref23'); return false;" href="javascript:void(0);" class="ref ref15 ref23">(15, 23)</a> Radiolabeled mGluR2 PAM [<sup>3</sup>H]JNJ-40068782 ([<sup>3</sup>H]<b>2</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) belongs to this chemotype and was recently characterized and described by us as a good tool to study allosteric mGluR2 interactions and to explore the relation between receptor binding and function.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Overall, the PAMs tested showed similar affinity and were able to displace [<sup>3</sup>H]<b>2</b> from recombinant human receptors and native rat receptors.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> These promising results prompted us to start a program aiming at the identification of a potential PET radiotracer for in vivo imaging of the mGluR2 allosteric binding site(s). In a first attempt, several analogs of the 4-(phenylpiperidinyl)-2-pyridone derivative <b>2</b>, containing different substituents that could be amenable for radiolabeling with either carbon-11 or fluorine-18, were prepared. However, none of the synthesized derivatives could be taken into consideration as a potential PET radiotracer candidate due to suboptimal potency,<a onclick="showRef(event, 'ref15 ref23'); return false;" href="javascript:void(0);" class="ref ref15 ref23">(15, 23)</a> as well as low brain uptake (unpublished results). In a second attempt, the 1,2,4-triazolo[4,3-<i>a</i>]pyridine chemical series, exemplified by compounds <b>3</b> and <b>4</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) was developed, providing compounds with increased potency.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Previous exploration on the 4-(phenylpiperidinyl)-2-pyridones showed that the introduction of a methoxy substituent on the phenyl ring in the <i>ortho</i>-position to the piperidine moiety would not only facilitate the production of the carbon-11 analog but could also increase the mGluR2 PAM potency. Furthermore, the presence of one or two fluorine atoms in different positions of the phenyl ring could impact the compound potency, as well as the metabolic stability and brain penetration.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><div class="NLM_p last">Based on these observations, a set of differently substituted 7-[4-(2-methoxyphenyl)-1-piperidinyl]-1,2,4-triazolo[4,3-<i>a</i>]pyridines as mGluR2 PAMs that could be easily radiolabeled with carbon-11 were synthesized. The synthesis and in vitro activity of this new series of mGluR2 PAMs, as well as the radiosynthesis of the most promising candidates and their preliminary in vivo evaluation in rats, are reported in this article.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58256" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58256" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry and Radiochemistry</h3><div class="NLM_p">Synthesis of key intermediates <b>7b</b>–<b>h</b> was achieved in a fast and efficient way using the appropriate synthetic technology depending on the reaction (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>), following a similar approach as that described in the literature for the synthesis of <b>7a</b>.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In the first step, commercially available boronate <b>5</b> was coupled with different 1-bromo-2-methoxyphenyl derivatives in parallel under microwave irradiation<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> to give intermediates <b>6a</b>–<b>h</b>. These bromo-methoxy-phenyl compounds were either commercially available or were synthesized according to literature precedents (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). Reduction of the double bond in compounds <b>6a</b>–<b>h</b> was effectively performed under flow conditions using an H-Cube reactor, and subsequent deprotection of the <i>tert-</i>butoxycarbonyl protecting group afforded the desired compounds <b>7a</b>–<b>h</b> in good yields. From the above intermediates, two sets of final compounds could be generated. The first set is represented by compounds containing the 3-(2,2,2-trifluoroethyl)-1,2,4-triazolo[4,3-<i>a</i>]pyridine fragment and were synthesized from intermediates <b>7b</b>,<b>d</b> as starting material (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). In a first step, derivatives <b>7b</b>,<b>d</b> were <i>N</i>-arylated with the substituted pyridines <b>8</b><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> or <b>9</b> to give derivatives <b>10d</b> and <b>11b</b>. Subsequent reaction with hydrazine under microwave conditions afforded intermediates <b>12d</b> and <b>13b</b>, which were subjected to an acylation reaction with CF<sub>3</sub>CH<sub>2</sub>COCl to introduce the 2,2,2-trifluoroethyl residue, yielding <b>14d</b> and <b>15b</b>. Finally, cyclization using microwave irradiation provided the target compounds <b>16d</b> and <b>17b</b>. The second set of compounds, containing the 3-(cyclopropylmethyl)-1,2,4-triazolo[4,3-<i>a</i>]pyridine fragment, was synthesized according to the strategy reported in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Intermediates <b>7a</b>–<b>h</b> were coupled with intermediates <b>18</b><a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> or <b>19</b><a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> under Buchwald conditions, providing the target compounds <b>20a</b>–<b>h</b> and <b>21d</b>,<b>f</b>. Demethylation of selected compounds was performed in the presence of boron tribromide, to give derivatives <b>22b</b>,<b>c</b>,<b>f–h</b> and <b>23f</b>, which were used as precursors to prepare the appropriate radiolabeled analogues. In view of the in vitro pharmacological results (see <a class="ref internalNav" href="#sec2_2" aria-label="Pharmacology">Pharmacology</a> section), derivatives <b>20b</b>,<b>c</b>,<b>f–h</b> and <b>21f</b> were selected as potential PET radioligands for imaging of mGluR2. Their radiolabeled analogues [<sup>11</sup>C]<b>20b</b>,<b>c</b>,<b>f–h</b> and [<sup>11</sup>C]<b>21f</b> were prepared by methylation of the hydroxyl precursors <b>22b</b>,<b>c</b>,<b>f–h</b> and <b>23f</b> with [<sup>11</sup>C]MeI in the presence of cesium carbonate in DMF (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). The crude radiolabeling mixtures were purified using reverse phase-HPLC (RP-HPLC), affording [<sup>11</sup>C]<b>20b</b>,<b>c</b>,<b>f–h</b> and [<sup>11</sup>C]<b>21f</b> in 35%–74% radiochemical yields (relative to starting radioactivity of [<sup>11</sup>C]MeI, nondecay corrected). The radiochemical purity of all six tracers was examined using RP-HPLC and was superior to 96%. The good radiochemical yield and purity of the employed radiochemistry procedure thus could allow easy translation to the production of clinical doses. The identity of the radiotracers was confirmed using analytical HPLC after coinjection with their nonradioactive analogues and comparison of the retention time of the observed peaks in the radiometric and UV channel, respectively.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/medium/jm-2012-00912k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Key Intermediates <b>7a</b>–<b>h</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300912k&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub> (saturated solution), 1,4-dioxane, μW, 150 °C, 10 min; (ii) H<sub>2</sub>, EtOH, Pd(OH)<sub>2</sub>/C (20%); H-CUBE, full-H<sub>2</sub>, 80 °C, 1 mL/min; (iii) HCl (7 M in <i>i</i>-PrOH), MeOH, rt, 90 min.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/medium/jm-2012-00912k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Final Products <b>16d</b> and <b>17b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300912k&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NaH, DMF, rt, 1 h; (ii) diisopropylamine, MeCN, 110 °C, overnight; (iii) NH<sub>2</sub>NH<sub>2</sub>, EtOH or THF, μW, 160 °C, 15–20 min; (iv) CF<sub>3</sub>CH<sub>2</sub>COCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h; (v) POCl<sub>3</sub>, MeCN, μW, 150–160 °C, 5–10 min.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/medium/jm-2012-00912k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Final Products <b>20a</b>–<b>h</b> and <b>21d</b>,<b>f</b> and Synthesis of the Precursors <b>22b</b>,<b>c</b>,<b>f–h</b> and <b>23f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300912k&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) <b>18</b> or <b>19</b>, Pd(AcO)<sub>2</sub>, (±)BINAP, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 125 °C, overnight; (ii) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 45 min.</p></p></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/medium/jm-2012-00912k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Radiosynthesis of the Selected PET Tracer Candidates<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300912k&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) [<sup>11</sup>C]CH<sub>3</sub>I, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, 3 min, 35–74% RCY.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Pharmacology</h3><div class="NLM_p">We evaluated the effect of all target compounds on [<sup>35</sup>S]GTPγS binding to the human mGluR2 receptor induced by an EC<sub>20</sub>-equivalent concentration of glutamate (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>) (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). All new derivatives proved to be among the most potent mGluR2 PAMs reported so far, with EC<sub>50</sub>’s ranging from 4.1 to 37 nM, and <i>E</i><sub>max</sub> values ranging from 256% to 528%. It was not obvious to identify structure–activity (SAR) trends within this series of compounds. In general, comparing the 8-chloro-3-(cyclopropylmethyl)-substituted derivatives, it seemed that the introduction of different fluorine atoms on the methoxy-substituted-phenyl ring increased functional potency, although there were some exceptions (37 nM for <b>20d</b> and 26 nM for <b>20e,</b> compared to 20 nM for the nonfluorinated derivative <b>20a</b>). On the other hand, the presence of a fluorine atom in the other position of the phenyl ring that is adjacent to the piperidinyl moiety seemed to increase potency in the [<sup>35</sup>S]GTPγS assay, as was observed for <b>20h</b> and <b>21f</b>. Lipophilicity did not seem to play a crucial role in activity either, as could be deduced from the comparison of clogP values of the target compounds (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Usually, moderate lipophilicity in the clogP range of 2.5–3.5 is considered optimal for adequate brain penetration without an excessive level of nonspecific binding.<a onclick="showRef(event, 'ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34">(32-34)</a> Hence, at first sight most of the synthesized compounds, with the exception of <b>16d</b>, might have been too lipophilic for their consideration as potential PET radiotracer candidates. However, based on previous experience searching for the identification of potential PET radiotracers for imaging PDE10A, we did not discard any compounds at this stage.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> The 8-cyano- derivative <b>16d</b> was one of the first compounds that we synthesized, and we decided to check its ability to cross the blood–brain barrier (BBB). Due to its insolubility, brain and plasma levels were studied after a 10 mg/kg oral dose in rats as a suspension, showing that brain levels were below the quantification limits at the four measured time points, 0.5, 1, 2, and 4 h after administration. Plasma levels were also very low, with the mean maximal concentration being 12.6 ng/mL after 2 h. The disappointing results of <b>16d</b> led to deprioritization of this 8-cyano-substituted subseries.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Functional Activity of the Synthesized mGluR<sub>2</sub> PAMs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/medium/jm-2012-00912k_0008.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/medium/jm-2012-00912k_0009.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">clogP values were calculated from Daylight software and Biobyte, Inc. of Claremont, CA.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Values are means of 2–4 experiments.</p></div></div><div></div></div><div class="NLM_p">The most potent compounds in the functional assay, <b>20b</b>, <b>20c</b>, <b>20f-h</b>, and <b>21f</b>, were also subjected to in vitro binding studies using radioligand [<sup>3</sup>H]<b>2</b>. These experiments showed that all compounds tested displaced the radioligand with IC<sub>50</sub> values in the low nanomolar range and that, in general, there was a nice correlation between the binding and the functional [<sup>35</sup>S]GTPγS data (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Furthermore, the binding data using the radioligand [<sup>3</sup>H]<b>2</b> suggested that the 7-(phenylpiperidinyl)-1,2,4-triazolo[4,3-<i>a</i>]pyridines and the 4-(phenylpiperidinyl)-2-pyridones may bind to the same or a mutually exclusive allosteric site of the mGluR2. These results were very promising for our goal to identify a suitable PET radiotracer from this chemical series.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In-Vitro Binding of mGluR<sub>2</sub> PAMs Derivatives <b>20b</b>, <b>20c</b>, <b>20f–h</b>, and <b>21f</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/medium/jm-2012-00912k_0010.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/medium/jm-2012-00912k_0011.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Experimental details of the in vitro binding protocol are described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Values are means of two or three experiments.</p></div></div><div></div></div><div class="NLM_p">We decided to select one of these compounds as a representative example to evaluate their potential to cross the BBB, assuming the hypothesis that the structural similarity between all derivatives would warrant comparable behavior in terms of brain penetration. We chose compound <b>20b</b> for a fast study in rats to measure brain and plasma levels after a 0.63 mg/kg intravenous (iv) dose at four different time points. This experiment showed a very quick brain uptake with maximum concentration after ∼5 min (316 ng/g) followed by a gradual decline up to 1 h (∼50 ng/g). The mean brain/plasma ratio was around 1.1 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). These results indicated that the compound showed relatively good brain penetration and some brain retention, and thus, this chemical series deserved to be further explored as potential PET tracers.</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/medium/jm-2012-00912k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Brain and plasma levels for compound <b>20b</b>. Compound was formulated in 20% HP-β-CD. Study was performed in two male Sprague–Dawley rats dosed iv at 0.63 mg/kg. Brain levels are expressed in ng/g and plasma levels in ng/mL. The graphs represent the data as geometric mean values of the two runs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300912k&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The mGluR2 selectivity of the final compounds listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> was determined using functional receptor assays. Thus, they were tested for agonist and antagonist activity in fluorescent Ca<sup>2+</sup> assays using HEK293 cells expressing human mGluR1, mGluR3, mGluR5, mGluR7, and mGluR8. Effects on the human mGluR4 and rat mGluR6, expressed in L929 or CHO cells, were assessed in [<sup>35</sup>S]-GTPγS functional assays. All compounds displayed mGluR2 selectivity >350–500 fold over the other mGluRs, with the exception of the following compounds, whose selectivity over the mGluR3 receptor was somewhat lower: <b>20b</b>, ∼40 fold; <b>20g</b>, ∼70-fold.</div><div class="NLM_p">We identified the main metabolites formed from the metabolic turnover of some derivatives after incubation with human and rat liver microsomes.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In both species two major metabolites were observed, one of them being the corresponding O-demethylated derivatives, and the others being M+O oxidative metabolites in which oxidation occurred somewhere on the 3-alkyl-1,2,4-triazolo[4,3-<i>a</i>]pyridine fragment. The nonradioactive phenolic derivative formed by O-[<sup>11</sup>C]demethylation is thus an expected metabolite for a PET tracer containing a [<sup>11</sup>C]methoxyphenyl group. As discussed later, the radiometabolite analysis of some of the radiolabeled derivatives showed that only the parent compounds were indeed responsible for brain retention. All the synthesized compounds showed very high plasma protein binding with free fractions lower than 1% in both human and rat plasma, with the exception of <b>16d</b> (free fraction 4% and 4.7% in rat and human plasma, respectively). In theory, those levels of plasma protein binding could be considered too high for a suitable PET radiotracer;<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> however, if dissociation from plasma protein occurs fast enough, high plasma protein binding will not be detrimental for adequate brain uptake. Indeed, our previous experience in the PDE10 PET program in which we identified a potential radioligand with plasma protein binding >99.5% prompted us to go ahead with the evaluation of the most promising compounds.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Also there are different reports in the literature of other successful PET tracers that have a high log <i>D</i> and high protein binding but still show good brain penetration.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Compounds <b>20b</b> and <b>20f</b> were profiled against ∼50 targets in a selectivity screen performed at CEREP.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Selectivity overall was good, with the only relevant interactions at a 10 μM concentration being dopamine-1 receptor (D1, 71% for <b>20b</b> and 76% for <b>20f</b>) and the dopamine transporter (DAT, 83% for <b>20b</b> and 52% for <b>20f</b>). However, both compounds were then tested in-house in a concentration–response curve to measure their affinity, which resulted to be negligible: D1, <i>K</i><sub>i</sub> ≥ 6200 nM for both compounds; DAT, <i>K</i><sub>i</sub> = 5005 nM for <b>20b</b> and >8500 nM for <b>20f</b>.</div><div class="NLM_p last">Based on all the results shown above, compounds <b>20b</b>, <b>20c</b>, <b>20f</b>, <b>20g</b>, <b>20h</b>, and <b>21f</b>, were selected for radiolabeling with carbon-11.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Biodistribution Studies</h3><div class="NLM_p">All six carbon-11 labeled triazolopyridines ([<sup>11</sup>C]<b>20b</b>,<b>c</b>,<b>f--h</b> and [<sup>11</sup>C]<b>21f</b>) were evaluated in vivo in male healthy Wistar rats by tissue distribution studies at 2, 30, and 60 min postinjection (pi). Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> shows the brain uptake of the six tracers at 2 min post-tracer-injection. All tracers produced a similar moderate brain uptake, average 0.71% of the injected dose (ID), with on average 0.52% ID in the cerebrum and 0.16% ID in the cerebellum. Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> shows the standardized uptake values (SUVs) of the different studied brain regions, the total brain, and the blood for [<sup>11</sup>C]<b>20f</b>. Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> presents the relative retention in the studied brain regions for the six tracers. Similar concentrations in brain and blood were observed for [<sup>11</sup>C]<b>20b</b>, [<sup>11</sup>C]<b>20c</b>, [<sup>11</sup>C]<b>20g</b>, [<sup>11</sup>C]<b>20h</b>, and [<sup>11</sup>C]<b>21f</b> (data not shown). For all studied brain regions, the radioactivity concentration increased from 2 to 30 min pi and the 2-to-30 min wash-out ratios were ≤1 for all tracers in all brain regions (except for [<sup>11</sup>C]<b>20g</b> in the hippocampus 2/30 ratio = 1.19). This accumulation of radioactivity in all studied brain regions is in accordance with the reported intracerebral distribution of mGluR2.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> For all brain regions the radioactivity concentration at 60 min pi was lower compared to the 30 min time point, indicating dissociation of the tracers from their binding site. Since radioactivity was spread throughout the brain, no reference region was available to correct for nonspecific binding in kinetic modeling using a reference tissue model, thus requiring determination of the arterial input function in order to obtain quantitative data. The complete tissue distribution study of [<sup>11</sup>C]<b>20f</b> is presented in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. At 2 min pi, 4.3% ID was present in blood, and this cleared to 2.0% by 60 min pi. The tracer was cleared mainly by the hepatobiliary system, as there was in total 35.7% of ID present in liver and intestines 60 min after injection of the radiotracer. Because of its extensive plasma protein binding, the urinary excretion of the tracer was minimal with only 2.4% ID present in the urinary system at 60 min pi. A similar clearance pattern was observed for [<sup>11</sup>C]<b>20b</b>, [<sup>11</sup>C]<b>20c</b>, [<sup>11</sup>C]<b>20g</b>, and [<sup>11</sup>C]<b>20h</b> (data not shown).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Brain Uptake of [<sup>11</sup>C]<b>20b</b>,<b>c</b>,<b>f–h</b> and [<sup>11</sup>C]<b>21f</b> in Normal Rats</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">%ID<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> at 2 min pi</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">[<sup>11</sup>C]<b>20b</b></th><th class="colsep0 rowsep0" align="center">[<sup>11</sup>C]<b>20c</b></th><th class="colsep0 rowsep0" align="center">[<sup>11</sup>C]<b>20f</b></th><th class="colsep0 rowsep0" align="center">[<sup>11</sup>C]<b>20g</b></th><th class="colsep0 rowsep0" align="center">[<sup>11</sup>C]<b>20h</b></th><th class="colsep0 rowsep0" align="center">[<sup>11</sup>C]<b>21f</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">total brain</td><td class="colsep0 rowsep0" align="center">0.58 ± 0.03</td><td class="colsep0 rowsep0" align="center">0.65 ± 0.08</td><td class="colsep0 rowsep0" align="center">0.88 ± 0.16</td><td class="colsep0 rowsep0" align="center">0.64 ± 0.13</td><td class="colsep0 rowsep0" align="center">0.75 ± 0.15</td><td class="colsep0 rowsep0" align="center">0.75 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cerebrum</td><td class="colsep0 rowsep0" align="center">0.45 ± 0.03</td><td class="colsep0 rowsep0" align="center">0.45 ± 0.07</td><td class="colsep0 rowsep0" align="center">0.69 ± 0.15</td><td class="colsep0 rowsep0" align="center">0.46 ± 0.11</td><td class="colsep0 rowsep0" align="center">0.53 ± 0.10</td><td class="colsep0 rowsep0" align="center">0.54 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cerebellum</td><td class="colsep0 rowsep0" align="center">0.10 ± 0.00</td><td class="colsep0 rowsep0" align="center">0.17 ± 0.01</td><td class="colsep0 rowsep0" align="center">0.17 ± 0.04</td><td class="colsep0 rowsep0" align="center">0.15 ± 0.05</td><td class="colsep0 rowsep0" align="center">0.18 ± 0.04</td><td class="colsep0 rowsep0" align="center">0.17 ± 0.01</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Percentage of injected dose calculated as counts per minute (cpm) in organ/total cpm recovered. Data are expressed as mean ± SD; <i>n</i> = 3 per time point.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Concentration of [<sup>11</sup>C]<b>20f</b> in Different Rat Brain Regions, Total Brain, and Blood at 2, 30, and 60 min Post-tracer-injection</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" rowspan="2" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">SUV<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">2 min</th><th class="colsep0 rowsep0" align="center" char=".">30 min</th><th class="colsep0 rowsep0" align="center" char=".">60 min</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">striatum</td><td class="colsep0 rowsep0" align="char" char=".">1.22 ± 0.24</td><td class="colsep0 rowsep0" align="char" char=".">2.14 ± 0.38</td><td class="colsep0 rowsep0" align="char" char=".">1.72 ± 0.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hippocampus</td><td class="colsep0 rowsep0" align="char" char=".">0.90 ± 0.12</td><td class="colsep0 rowsep0" align="char" char=".">1.49 ± 0.33</td><td class="colsep0 rowsep0" align="char" char=".">0.73 ± 0.61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cortex</td><td class="colsep0 rowsep0" align="char" char=".">1.46 ± 0.28</td><td class="colsep0 rowsep0" align="char" char=".">1.77 ± 0.39</td><td class="colsep0 rowsep0" align="char" char=".">1.28 ± 0.24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cerebrum</td><td class="colsep0 rowsep0" align="char" char=".">1.32 ± 0.26</td><td class="colsep0 rowsep0" align="char" char=".">1.96 ± 0.30</td><td class="colsep0 rowsep0" align="char" char=".">1.11 ± 0.60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cerebellum</td><td class="colsep0 rowsep0" align="char" char=".">1.59 ± 0.34</td><td class="colsep0 rowsep0" align="char" char=".">2.62 ± 0.42</td><td class="colsep0 rowsep0" align="char" char=".">1.75 ± 0.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">total brain</td><td class="colsep0 rowsep0" align="char" char=".">1.39 ± 0.24</td><td class="colsep0 rowsep0" align="char" char=".">2.13 ± 0.33</td><td class="colsep0 rowsep0" align="char" char=".">1.18 ± 0.55</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">blood</td><td class="colsep0 rowsep0" align="char" char=".">0.61 ± 0.09</td><td class="colsep0 rowsep0" align="char" char=".">0.39 ± 0.12</td><td class="colsep0 rowsep0" align="char" char=".">0.28 ± 0.00</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Calculated as (radioactivity in cpm in organ/weight of organ in grams)/(total cpm recovered/body weight rat in grams). Data are expressed as mean ± SD; <i>n</i> = 3 per time point.</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Wash-out from Different Rat Brain Regions Calculated as 2 min to 30 min Ratio<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> for [<sup>11</sup>C]<b>20b</b>,<b>c</b>,<b>f–h</b> and [<sup>11</sup>C]<b>21f</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">[<sup>11</sup>C]<b>20b</b></th><th class="colsep0 rowsep0" align="center" char=".">[<sup>11</sup>C]<b>20c</b></th><th class="colsep0 rowsep0" align="center" char=".">[<sup>11</sup>C]<b>20f</b></th><th class="colsep0 rowsep0" align="center" char=".">[<sup>11</sup>C]<b>20g</b></th><th class="colsep0 rowsep0" align="center" char=".">[<sup>11</sup>C]<b>20h</b></th><th class="colsep0 rowsep0" align="center" char=".">[<sup>11</sup>C]<b>21f</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">striatum</td><td class="colsep0 rowsep0" align="char" char=".">0.63</td><td class="colsep0 rowsep0" align="char" char=".">0.59</td><td class="colsep0 rowsep0" align="char" char=".">0.57</td><td class="colsep0 rowsep0" align="char" char=".">0.99</td><td class="colsep0 rowsep0" align="char" char=".">0.67</td><td class="colsep0 rowsep0" align="char" char=".">0.86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hippocampus</td><td class="colsep0 rowsep0" align="char" char=".">0.66</td><td class="colsep0 rowsep0" align="char" char=".">0.63</td><td class="colsep0 rowsep0" align="char" char=".">0.60</td><td class="colsep0 rowsep0" align="char" char=".">1.19</td><td class="colsep0 rowsep0" align="char" char=".">0.71</td><td class="colsep0 rowsep0" align="char" char=".">1.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cortex</td><td class="colsep0 rowsep0" align="char" char=".">0.88</td><td class="colsep0 rowsep0" align="char" char=".">0.71</td><td class="colsep0 rowsep0" align="char" char=".">0.82</td><td class="colsep0 rowsep0" align="char" char=".">0.84</td><td class="colsep0 rowsep0" align="char" char=".">0.66</td><td class="colsep0 rowsep0" align="char" char=".">1.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cerebrum</td><td class="colsep0 rowsep0" align="char" char=".">0.83</td><td class="colsep0 rowsep0" align="char" char=".">0.60</td><td class="colsep0 rowsep0" align="char" char=".">0.67</td><td class="colsep0 rowsep0" align="char" char=".">0.84</td><td class="colsep0 rowsep0" align="char" char=".">0.72</td><td class="colsep0 rowsep0" align="char" char=".">0.98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cerebellum</td><td class="colsep0 rowsep0" align="char" char=".">0.63</td><td class="colsep0 rowsep0" align="char" char=".">0.71</td><td class="colsep0 rowsep0" align="char" char=".">0.61</td><td class="colsep0 rowsep0" align="char" char=".">0.95</td><td class="colsep0 rowsep0" align="char" char=".">0.77</td><td class="colsep0 rowsep0" align="char" char=".">0.99</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">total brain</td><td class="colsep0 rowsep0" align="char" char=".">0.79</td><td class="colsep0 rowsep0" align="char" char=".">0.72</td><td class="colsep0 rowsep0" align="char" char=".">0.65</td><td class="colsep0 rowsep0" align="char" char=".">0.93</td><td class="colsep0 rowsep0" align="char" char=".">0.88</td><td class="colsep0 rowsep0" align="char" char=".">1.08</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Calculated from the 2 and 30 min SUV values.</p></div></div></div><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Radiometabolite Analysis in Rat Plasma and Perfused Rat Brain</h4><div class="NLM_p">In order to use these PET radioligands for accurate measurements of target density and target occupancy in drug dose occupancy studies, knowledge of radioligand metabolism is required, especially the extent to which radioactive metabolites are present in plasma and their ability to penetrate the brain and contribute to specific and/or nonspecific binding. Therefore, the metabolic stability of [<sup>11</sup>C]<b>20b</b>, [<sup>11</sup>C]<b>20f</b>, [<sup>11</sup>C]<b>20g</b>, and [<sup>11</sup>C]<b>20h</b> was studied in normal rats by determination of the relative amounts of parent tracer and radiometabolites in plasma and brain at 30 min pi of the tracers.</div><div class="NLM_p">The reconstructed radiochromatogram of a rat plasma analysis of [<sup>11</sup>C]<b>20f</b> is included as <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. From co-injection of the plasma with the authentic reference compound we could identify the peak eluting at ∼11 min as the intact tracer. The radioactivity corresponding to the more lipophilic fractions eluting after the intact tracer was negligible, indicating the absence of lipophilic radiometabolites, which, if present, could penetrate the BBB. Unidentified polar radiometabolite(s) were eluting from 3 to 6 min. Similar results were found for [<sup>11</sup>C]<b>20b</b>, [<sup>11</sup>C]<b>20g</b>, and [<sup>11</sup>C]<b>20h</b>. An overview of the results of the plasma radiometabolite analysis is presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>. Of the four <sup>11</sup>C-labeled tracers, [<sup>11</sup>C]<b>20f</b> was found to have the highest fraction (70 ± 5%) of the recovered radioactivity in plasma, present as intact tracer at 30 min post-tracer-injection. The reconstructed radiochromatograms of a perfused rat cerebrum and cerebellum analysis for [<sup>11</sup>C]<b>20f</b> are also shown in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. The peak corresponding to the intact tracer eluted at ∼12 min. An overview of the results from the perfused rat brain radiometabolite analysis for [<sup>11</sup>C]<b>20b</b>, [<sup>11</sup>C]<b>20f</b>, [<sup>11</sup>C]<b>20g</b>, and [<sup>11</sup>C]<b>20h</b> is presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>. Results were very similar for the four studied tracers. The fraction of apolar radiometabolites detected in brain was negligible. The percentage of polar radiometabolites detected in brain was very small. On average, about 92% of the recovered radioactivity was present as intact tracer in cerebrum and 95% in cerebellum. Future small-animal PET (μPET) imaging studies will reveal whether this small percentage of radiometabolites in brain needs to be taken into account for determination of quantitative parameters.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Relative Percentages of Intact Tracer and Radiometabolites in Rat Plasma at 30 min Post-injection of [<sup>11</sup>C]<b>20b</b>, [<sup>11</sup>C]<b>20f</b>, [<sup>11</sup>C]<b>20g</b>, and [<sup>11</sup>C]<b>20h</b></div><p class="last"><a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a></p></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" rowspan="2" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">mean ± SD</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">[<sup>11</sup>C]<b>20b</b></th><th class="colsep0 rowsep0" align="center" char=".">[<sup>11</sup>C]<b>20f</b></th><th class="colsep0 rowsep0" align="center" char=".">[<sup>11</sup>C]<b>20g</b></th><th class="colsep0 rowsep0" align="center" char=".">[<sup>11</sup>C]<b>20h</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">polar metabolites</td><td class="colsep0 rowsep0" align="char" char=".">59.0 ± 7.1</td><td class="colsep0 rowsep0" align="char" char=".">30.3 ± 5.1</td><td class="colsep0 rowsep0" align="char" char=".">54.5 ± 2.1</td><td class="colsep0 rowsep0" align="char" char=".">69.2 ± 7.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">intact tracer</td><td class="colsep0 rowsep0" align="char" char=".">41.0 ± 7.1</td><td class="colsep0 rowsep0" align="char" char=".">69.7 ± 5.1</td><td class="colsep0 rowsep0" align="char" char=".">45.5 ± 2.1</td><td class="colsep0 rowsep0" align="char" char=".">30.8 ± 7.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup>a</sup><p class="last">Results are presented as mean ± SD; <i>n</i> = 3 for [<sup>11</sup>C]<b>20f</b>, <i>n</i> = 2 for [<sup>11</sup>C]<b>20b</b>, [<sup>11</sup>C]<b>20g</b>, and [<sup>11</sup>C]<b>20h</b>.</p></div></div></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Relative Percentages of Intact Tracer and Radiometabolites in Perfused Rat Cerebrum and Cerebellum at 30 min Post-injection of [<sup>11</sup>C]<b>20b</b>, [<sup>11</sup>C]<b>20f</b>, [<sup>11</sup>C]<b>20g</b>, and [<sup>11</sup>C]<b>20h</b><a class="ref internalNav" href="#tbl7-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">[<sup>11</sup>C]<b>20b</b></th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">[<sup>11</sup>C]<b>20f</b></th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">[<sup>11</sup>C]<b>20g</b></th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">[<sup>11</sup>C]<b>20h</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">cbr</th><th class="colsep0 rowsep0" align="center" char=".">cbll</th><th class="colsep0 rowsep0" align="center" char=".">cbr</th><th class="colsep0 rowsep0" align="center" char=".">cbll</th><th class="colsep0 rowsep0" align="center" char=".">cbr</th><th class="colsep0 rowsep0" align="center" char=".">cbll</th><th class="colsep0 rowsep0" align="center" char=".">cbr</th><th class="colsep0 rowsep0" align="center" char=".">cbll</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">polar metabolite</td><td class="colsep0 rowsep0" align="char" char=".">7.6</td><td class="colsep0 rowsep0" align="char" char=".">7.3</td><td class="colsep0 rowsep0" align="char" char=".">9.7 ± 0.3</td><td class="colsep0 rowsep0" align="char" char=".">4.1 ± 1.5</td><td class="colsep0 rowsep0" align="char" char=".">6.9</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">intact tracer</td><td class="colsep0 rowsep0" align="char" char=".">92.4</td><td class="colsep0 rowsep0" align="char" char=".">92.7</td><td class="colsep0 rowsep0" align="char" char=".">90.3 ± 0.3</td><td class="colsep0 rowsep0" align="char" char=".">95.5 ± 1.3</td><td class="colsep0 rowsep0" align="char" char=".">93.1</td><td class="colsep0 rowsep0" align="char" char=".">96.4</td><td class="colsep0 rowsep0" align="char" char=".">92.9</td><td class="colsep0 rowsep0" align="char" char=".">95.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl7-fn1"><div class="footnote" id="tbl7-fn1"><sup>a</sup><p class="last">Results are presented as mean ± SD; <i>n</i> = 2 for [<sup>11</sup>C]<b>20f</b>, <i>n</i> = 1 for [<sup>11</sup>C]<b>20b</b>, [<sup>11</sup>C]<b>20g</b>, [<sup>11</sup>C]<b>20h</b>. cbr = cerebrum, cbll = cerebellum.</p></div></div></div></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Preliminary μPET Studies</h4><div class="NLM_p">[<sup>11</sup>C]<b>20f</b> was further evaluated in vivo in normal Wistar rats using μPET imaging (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). As was also observed in the biodistribution studies, baseline imaging (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A,B) showed tracer accumulation in all studied brain regions. The maximum radioactivity concentration (SUV 1.7) in brain was reached at 12 min pi, remained constant until 27 min, and was followed by slow wash-out. After injection of JNJ42153605, a potent PAM discovered by our Janssen R&D team with high affinity and selectivity for mGluR2,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> a clear displacement of the radioactivity in all brain regions was observed (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>C,D), demonstrating that the binding of [<sup>11</sup>C]<b>20f</b> to the mGluR2 allosteric site is reversible and specific.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/medium/jm-2012-00912k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. μPET images and TACs for [<sup>11</sup>C]<b>20f</b> in rat striatum, cerebellum, cortex, hippocampus, thalamus, and total brain. (A) Untreated baseline scan. (B) Transversal image corresponding to a baseline scan: averaged image (12–28 min after pi) of a representative rat injected with 41 MBq of [<sup>11</sup>C]<b>20f</b>. (C) Chase experiment: JNJ42153605, 1 mg/kg, was injected iv (arrow) 30 min pi. (D) Transversal images corresponding to the chase experiment: averaged image (12–28 min pi) before chase injection (left) and averaged image (68–88 min pi) after chase injection (right). max = maximum; min = minimum.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300912k&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67327" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67327" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have synthesized a series of 7-(phenylpiperidinyl)-1,2,4-triazolo[4,3-<i>a</i>]pyridines as potent and selective mGluR2 PAMs, which could be radiolabeled with carbon-11 for their evaluation as potential PET radioligands for in vivo imaging of the mGluR2 allosteric binding site. From this investigation we identified several promising candidates that were selected in view of their good potency and selectivity, as well as for their potential to cross the BBB, and they were radiolabeled with [<sup>11</sup>C]MeI. Biodistribution studies, plasma and brain radiometabolite analysis, and a preliminary μPET baseline experiment in rats showed that [<sup>11</sup>C]<b>20f</b> was the most promising PET radioligand candidate for in vivo imaging of mGluR2, due to its good brain uptake and retention and its relatively small fraction of radiometabolites in plasma and brain. The μPET displacement experiment with a potent and selective PAM discovered by our research team demonstrated that the tracer binding to mGluR2 was specific and reversible. However, due to the widespread distribution of mGluR2 in the brain, no reference region is available for quantification of kinetic parameters and estimation of receptor occupancy. Therefore, extended μPET imaging studies with [<sup>11</sup>C]<b>20f</b> are ongoing to further evaluate the kinetics of this tracer and its potential for human brain imaging, the results of which will be reported elsewhere.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83417" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83417" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Chemistry and Radiochemistry. Materials and General Methods</h3><div class="NLM_p">Unless otherwise noted, all reagents and solvents were obtained from commercial suppliers and used without further purification. Thin layer chromatography (TLC) was carried out on silica gel 60 F254 plates (Merck). Flash column chromatography was performed on silica gel, particle size 60 Å, mesh = 230–400 (Merck) under standard techniques. Microwave assisted reactions were performed in a single-mode reactor, a Biotage Initiator Sixty microwave reactor (Biotage), or in a multimode reactor, a MicroSYNTH Labstation (Milestone, Inc.). Nuclear magnetic resonance (NMR) spectra were recorded with either a Bruker DPX-400 or a Bruker AV-500 spectrometer (Bruker AG) with standard pulse sequences, operating at 400 and 500 MHz, respectively, using CDCl<sub>3</sub> and DMSO-<i>d</i><sub>6</sub> as solvents. Chemical shifts (δ) are reported in parts per million (ppm) downfield from tetramethylsilane (δ = 0). Coupling constants are reported in hertz. Splitting patterns are defined by s (singlet), d (doublet), dd (double doublet), t (triplet), q (quartet), quin (quintet), sex (sextet), sep (septet), or m (multiplet). Liquid chromatography combined with mass spectrometry (LC-MS) was performed either on a HP 1100 HPLC system (Agilent Technologies) or Advanced Chromatography Technologies, composed of a quaternary or binary pump with a degasser, an autosampler, a column oven, a diode-array detector (DAD), and a column, as specified in the respective methods. Flow from the column was split to a MS spectrometer. The MS detector was configured either with an electrospray ionization source or an ES-CI dual ionization source (electrospray combined with atmospheric pressure chemical ionization). Nitrogen was used as the nebulizer gas. Data acquisition was performed with MassLynx-Openlynx software or with Chemsation-Agilent Data Browser software. Detailed information about the different LCMS methods employed can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. Retention time (<i>t</i><sub>R</sub>) is expressed in minutes. Gas chromatography combined with mass spectrometry (GC-MS) was performed using a 6890 Series gas chromatograph (Agilent Technologies) system comprising a 7683 Series injector and autosampler, a column oven, and a J&W HP-5MS, coupled to a 5973N MSD mass selective detector (single quadrupole, Agilent Technologies). The MS detector was configured with an electronic impact ionization source/chemical ionization source (EI/CI). EI low-resolution mass spectra were acquired by scanning from 50 to 550 at a rate of 14.29 scans/s. The source temperature was maintained at 230 °C. Helium was used as the nebulizer gas. Data acquisition was performed with Chemstation-Open Action software. Melting point (mp) values are peak values, were obtained with experimental uncertainties that are commonly associated with this analytical method, and were determined in open capillary tubes on a Mettler FP62 apparatus with a temperature gradient of 10 °C/min. The maximum temperature was 300 °C. The melting point was read from a digital display.</div><div class="NLM_p">The purities of all new compounds were determined by analytical reverse phase RP-HPLC using the area percentage method on the UV trace recorded at a wavelength of 254 nm, and compounds were found to have ≥95% purity unless otherwise specified. For carbon-11 labeled compounds, HPLC analysis was performed on a LaChrom Elite HPLC system (Hitachi, Darmstadt, Germany). The HPLC eluate after passage through the UV detector was led over a shielded 3-in. NaI(Tl) scintillation detector connected to a multichannel analyzer (Gabi box, Raytest, Straubenhardt Germany). The output signal was recorded and analyzed using a GINA Star data acquisition system (Raytest, Straubenhardt, Germany).</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 4-(3,6-Difluoro-2-methoxyphenyl)-3,6-dihydro-2H-pyridine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>6f</b>)</h4><div class="NLM_p">Step 1: to a solution of 2,5-difluorophenol (2.0 g, 15.37 mmol) and isopropylamine (1.61 mL, 15.37 mmol) in dry THF (40 mL) was added NBS (3.01 g, 16.19 mmol) portionwise at −40 °C. The reaction mixture was stirred at that temperature for 30 min and then allowed to reach rt. The resulting mixture was diluted with HCl (1 N in H<sub>2</sub>O) and Et<sub>2</sub>O, the organic layer was separated and dried (Na<sub>2</sub>SO<sub>4</sub>), and the solvent was evaporated <i>in vacuo</i> to yield intermediate 2-bromo-3,6-difluorophenol (3.23 g, 51% pure) that was used as such in the next reaction step. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 5.71 (br s, 1 H), 6.69 (ddd, <i>J</i> = 9.2, 7.7, 4.2 Hz, 1 H), 7.05 (td, <i>J</i> = 9.5, 4.9 Hz, 1 H).</div><div class="NLM_p">Step 2: to a solution of 2-bromo-3,6-difluorophenol (3.23 g, 15.45 mmol) in dry MeCN (25 mL) were added K<sub>2</sub>CO<sub>3</sub> (6.4 g, 46.36 mmol) and MeI (2.88 mL, 46.36 mmol), and the resulting mixture was heated under microwave irradiation at 150 °C for 10 min. Then the mixture was diluted with DCM and filtered off, and the filtrate was evaporated <i>in vacuo</i> to yield crude 2-bromo-1,4-difluoro-3-methoxybenzene that was used without further purification in the next reaction step. C<sub>7</sub>H<sub>5</sub>BrF<sub>2</sub>O<sub>3</sub>. GCMS: Rt 6.67, <i>m</i>/<i>z</i> 223 [M]<sup>+</sup> (major product).</div><div class="NLM_p">Step 3: 2-bromo-1,4-difluoro-3-methoxybenzene obtained from the previous step (crude material) was added to a stirred mixture of 3,6-dihydro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1(2H)-pyridinecarboxylic acid, 1,1-dimethylethyl ester (<b>5</b>, 1.26 g, 4.08 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.07 g, 0.06 mmol), and a saturated aqueous solution of K<sub>2</sub>CO<sub>3</sub> (3.5 mL) in 1,4-dioxane (7 mL). The reaction mixture was heated under microwave irradiation at 150 °C for 10 min. After cooling, the mixture was diluted with water and extracted with Et<sub>2</sub>O. The organic phase was separated and dried (Na<sub>2</sub>SO<sub>4</sub>), and the solvent was evaporated <i>in vacuo</i>. The crude product was purified by column chromatography (silica gel; EtOAc in heptane 10/90 to 20/80). The desired fractions were collected and concentrated <i>in vacuo</i> to give a residue that was triturated with Et<sub>2</sub>O to yield compound <b>6f</b> as a sticky oil (0.23 g, 22%). C<sub>17</sub>H<sub>21</sub>F<sub>2</sub>NO<sub>3</sub>. LCMS: Rt 3.25, <i>m</i>/<i>z</i> 326 [(M + H)]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.50 (s, 9 H), 2.38 (br s, 2 H), 3.63 (br s, 2 H), 3.87 (d, <i>J</i> = 1.6 Hz, 3 H), 4.06 (br s, 2 H), 5.72 (br s, 1 H), 6.74 (td, <i>J</i> = 8.9, 3.9 Hz, 1 H), 6.95 (ddd, <i>J</i> = 10.6, 9.2, 5.1 Hz, 1 H).</div><div class="NLM_p last">In a similar manner, compounds <b>6b-e</b>,<b>g</b>,<b>h</b> were also synthesized, whereas <b>6a</b> is described in the literature.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> <i>tert</i>-Butyl 4-(5-Fluoro-2-methoxyphenyl)-3,6-dihydropyridine-1(2H)-carboxylate (<b>6b</b>)</h4><div class="NLM_p last">Starting from 2-bromo-4-fluoroanisole (2.28 g, 11.12 mmol) and <b>5</b> (2.86 g, 9.26 mmol), compound <b>6b</b> (3.4 g, quant yield) was obtained as colorless oil. C<sub>17</sub>H<sub>22</sub>FNO<sub>3</sub>. LCMS: Rt 3.25, <i>m</i>/<i>z</i> 308 [(M + H)]<sup>+</sup>.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> <i>tert</i>-Butyl 4-(2-Fluoro-6-methoxyphenyl)-3,6-dihydropyridine-1(2H)-carboxylate (<b>6c</b>)</h4><div class="NLM_p last">Starting from 2-bromo-3-fluoroanisole (2.2 g, 10.73 mmol) and <b>5</b> (3.01 g, 9.75 mmol), compound <b>6c</b> (2.02 g, 67%) was obtained as a colorless oil that solidified on standing. C<sub>17</sub>H<sub>22</sub>FNO<sub>3</sub>. LCMS: Rt 3.25, <i>m</i>/<i>z</i> 208 [(M – Boc) + H]<sup>+</sup>.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>tert</i>-Butyl 4-(3-Fluoro-2-methoxyphenyl)-3,6-dihydropyridine-1(2H)-carboxylate (<b>6d</b>)</h4><div class="NLM_p last">Starting from 2-bromo-6-fluoroanisole (0.974 mL, 7.31 mmol) and <b>5</b> (2.37 g, 7.68 mmol), compound <b>6d</b> (1.13 g, 50%) was obtained as a colorless oil. C<sub>17</sub>H<sub>22</sub>FNO<sub>3</sub>. LCMS: Rt 3.60, <i>m</i>/<i>z</i> 308 [(M + H)]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.49 (s, 9 H), 2.47 (br s, 2 H), 3.62 (br t, <i>J</i> = 5.7 Hz, 2 H), 3.89 (s, 3 H), 4.06 (br d, <i>J</i> = 2.5 Hz, 2 H), 5.96 (br s, 1 H), 6.92 (dd, <i>J</i> = 9.0, 8.6 Hz, 1 H), 7.04–7.16 (m, 2 H).</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>tert</i>-Butyl 4-(3,4-Difluoro-2-methoxyphenyl)-3,6-dihydropyridine-1(2H)-carboxylate (<b>6e</b>)</h4><div class="NLM_p">Step 1: to a solution of 2,3-difluorophenol (0.50 g, 3.84 mmol) and isopropylamine (0.40 mL, 3.84 mmol) in dry DCM (20 mL) was added NBS (3.01 g, 16.19 mmol) portionwise at −10 °C. The mixture was stirred at that temperature for 30 min and then allowed to reach rt. The reaction mixture was then diluted with HCl (1 N in H<sub>2</sub>O), the organic layer was separated and dried (Na<sub>2</sub>SO<sub>4</sub>), and the solvent evaporated <i>in vacuo</i>. The crude compound was purified by chromatography (silica gel, EtOAc in heptane 0:100 to 20:80). The desired fractions were collected and the solvent evaporated <i>in vacuo</i> to yield 6-bromo-2,3-difluorophenol (0.63 g, 78%). C<sub>6</sub>H<sub>3</sub>BrF<sub>2</sub>O. GCMS: Rt 6.86, <i>m</i>/<i>z</i> 209 [M]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.36 (td, <i>J</i> = 9.4, 7.6 Hz, 1 H), 6.50 (br s, 1 H), 7.12 (ddd, <i>J</i> = 8.8, 6.1, 2.4 Hz, 1 H).</div><div class="NLM_p">Step 2: 6-bromo-2,3-difluorophenol (0.63 g, 2.99 mmol), MeI (0.281 mL, 4.51 mmol), and K<sub>2</sub>CO<sub>3</sub> (0.623 g, 4.51 mmol) in MeCN 87.5 mL) were heated at 150 °C for 10 min in a microwave oven. Then DCM was added, the solid was filtered off, and the filtrate solvent was evaporated under vacuum, affording 1-bromo-3,4-difluoro-2-methoxybenzene (0.62 g, 92%) as a sticky oil that was used as such in the next reaction step. C<sub>7</sub>H<sub>35</sub>BrF<sub>2</sub>O. GCMS: Rt 6.54, <i>m</i>/<i>z</i> 222 [M]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 4.00 (d, <i>J</i> = 1.44 Hz, 3 H), 6.83 (td, <i>J</i> = 9.25, 7.51 Hz, 1 H), 7.23–7.29 (m, 1 H).</div><div class="NLM_p last">Step 3: starting from 1-bromo-3,4-difluoro-2-methoxybenzene (0.86 g, 3.83 mmol) and <b>5</b> (0.22 g, 0.19 mmol), compound <b>6e</b> was obtained (0.79 g, 63%) as a colorless oil. C<sub>17</sub>H<sub>21</sub>F<sub>2</sub>NO<sub>3</sub>. LCMS: Rt 3.31, <i>m</i>/<i>z</i> 206 [(M – Boc) + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.50 (s, 9 H), 2.45 (br s, 2 H), 3.59 (br s, 2 H), 3.90 (d, <i>J</i> = 1.4 Hz, 3 H), 4.04 (br s, 2 H), 5.76 (br s, 1 H), 6.79–6.88 (m, 2 H).</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>tert</i>-Butyl 4-(2,3-Difluoro-6-methoxyphenyl)-3,6-dihydropyridine-1(2H)-carboxylate (<b>6g</b>)</h4><div class="NLM_p last">Starting from 2-bromo-3,4-difluoroanisole (0.18 g, 0.81 mmol) and <b>5</b> (0.25 g, 0.81 mmol), compound <b>6g</b> (0.5 g, quant yield) was obtained as a colorless oil. C<sub>17</sub>H<sub>21</sub>F<sub>2</sub>NO<sub>3</sub>. LCMS: Rt 3.17, <i>m</i>/<i>z</i> 206 [(M – Boc) + H]<sup>+</sup>.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>tert</i>-Butyl 4-(2,4-Difluoro-6-methoxyphenyl)-3,6-dihydropyridine-1(2H)-carboxylate (<b>6h</b>)</h4><div class="NLM_p last">Step 1: methyl iodide (0.60 mL, 9.57 mmol) was added to a solution of 2-bromo-3,5-difluorophenol (1.0 g, 4.78 mmol) and K<sub>2</sub>CO<sub>3</sub> (1.32 g, 9.57 mmol) in DMF (10 mL). The mixture was stirred under microwave irradiation at 150 °C for 10 min, and after cooling to rt it was then treated with H<sub>2</sub>O and extracted with EtOAc. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered, and the solvent was evaporated in vacuo to give 2-bromo-1,5-difluoro-3-methoxybenzene (1.05 g, quant yield) as an oil that solidified upon standing. The compound was used as such in the next reaction step. C<sub>7</sub>H<sub>5</sub>BrF<sub>2</sub>O. GCMS: Rt 2.40, <i>m</i>/<i>z</i> 222 [M]<sup>+</sup>. Step 2: starting from 2-bromo-1,5-difluoro-3-methoxybenzene (1.05 g, 4.78 mmol) and <b>5</b> (1.5 g, 4.78 mmol), compound <b>6h</b> (1.13 g, 73%) was obtained as a colorless oil that solidified on standing. C<sub>17</sub>H<sub>21</sub>F<sub>2</sub>NO<sub>3</sub>. LCMS: Rt 3.87, <i>m</i>/<i>z</i> 311 [(M – Me) + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.50 (s, 9 H), 2.32 (br s, 2 H), 3.60 (br s, 2 H), 3.78 (s, 3 H), 4.04 (br s, 2 H), 5.63 (br s, 1 H), 6.40–6.48 (m, 2 H).</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 4-(3,6-Difluoro-2-methoxyphenyl)piperidine (<b>7f</b>)</h4><div class="NLM_p">A solution of <b>6f</b> (0.23 g, 0.71 mmol) in EtOH (15 mL) was hydrogenated in a H-Cube reactor (1 mL/min, Pd(OH)<sub>2</sub> 20% cartridge, full H<sub>2</sub> mode, 80 °C). The solvent was evaporated <i>in vacuo</i>. The crude material obtained was used in the next reaction step without further purification. C<sub>17</sub>H<sub>23</sub>F<sub>2</sub>NO<sub>3</sub>. LCMS: Rt 3.29, <i>m</i>/<i>z</i> 655 [(MM + H)]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.49 (s, 9 H), 1.61 (br d, <i>J</i> = 13.2 Hz, 2 H), 2.05 (qd, <i>J</i> = 12.6, 3.5 Hz, 2 H), 2.77 (br t, <i>J</i> = 11.3, 11.3 Hz, 2 H), 3.19 (tt, <i>J</i> = 12.4, 3.5 Hz, 1 H), 3.91 (d, <i>J</i> = 1.8 Hz, 3 H), 4.23 (br s, 2 H), 6.70 (td, <i>J</i> = 9.6, 3.9 Hz, 1 H), 6.90 (ddd, <i>J</i> = 10.8, 9.1, 4.9 Hz, 1 H). The residue was dissolved in MeOH, HCl (7 M in iPrOH, 2 mL) was added, and the mixture was stirred at rt for 1.5 h. Then, the reaction mixture was diluted with Na<sub>2</sub>CO<sub>3</sub> (aqueous saturated solution) and extracted with DCM. The organic phase was separated and dried (Na<sub>2</sub>SO<sub>4</sub>), and the solvent was evaporated <i>in vacuo</i> to yield compound <b>7f</b> (0.12 g, 85%) as a white solid. C<sub>12</sub>H<sub>15</sub>F<sub>2</sub>NO. LCMS: Rt 1.19, <i>m</i>/<i>z</i> 228 [(M + H)]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.85 (br d, <i>J</i> = 13.9 Hz, 2 H), 2.65 (qd, <i>J</i> = 13.3, 3.7 Hz, 2 H), 2.98 (td, <i>J</i> = 13.1, 2.5 Hz, 2 H), 3.27 (tt, <i>J</i> = 12.4, 3.2 Hz, 1 H), 3.63 (br d, <i>J</i> = 12.5 Hz, 2 H), 4.01 (d, <i>J</i> = 2.5 Hz, 3 H), 6.71 (td, <i>J</i> = 9.4, 3.8 Hz, 1 H), 6.94 (ddd, <i>J</i> = 11.0, 9.2, 5.2 Hz, 1 H), 7.27 (br s, 1 H).</div><div class="NLM_p last">In a similar manner, compounds <b>7b–e</b>,<b>g</b>,<b>h</b> were also synthesized.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 4-(5-Fluoro-2-methoxyphenyl)piperidine(<b>7b</b>)</h4><div class="NLM_p last">Starting from <b>6b</b> (3.4 g, 7.41 mmol) after reduction of the double bond and deprotection of the <i>N</i>-Boc protecting group, compound <b>7b</b> (0.76 g, 44% yield) was obtained as white solid. C<sub>12</sub>H<sub>16</sub>FNO. LCMS: Rt 1.85, <i>m</i>/<i>z</i> 210 [(M + H)]<sup>+</sup>.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 4-(2-Fluoro-6-methoxyphenyl)piperidine (<b>7c</b>)</h4><div class="NLM_p last">Starting from <b>6c</b> (2 g, 6.5 mmol) after reduction of the double bond and deprotection of the <i>N</i>-Boc protecting group, compound <b>7c</b> (1.0 g, 73% yield) was obtained as a white solid. C<sub>12</sub>H<sub>16</sub>FNO. LCMS: Rt 0.55, <i>m</i>/<i>z</i> 210 [(M + H)]<sup>+</sup>.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 4-(3-Fluoro-2-methoxyphenyl)piperidine Hydrochloride (<b>7d</b>)</h4><div class="NLM_p last">Starting from <b>6d</b> (1.13 g, 3.67 mmol), the double bond was reduced as previously described. The crude material was then dissolved in HCl (7 M in iPrOH, 8.5 mL), and the reaction mixture was stirred for 1.5 h. The solvent was then evaporated to give <b>7d</b> as the hydrochloride salt (0.9 g, quant yield) as a white solid. C<sub>12</sub>H<sub>16</sub>FNO. LCMS: Rt 0.74, <i>m</i>/<i>z</i> 210 [(M + H)]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.81 (qd, <i>J</i> = 12.5, 4.2 Hz, 2 H), 1.90 (br d, <i>J</i> = 11.8 Hz, 2 H), 2.79 (tt, <i>J</i> = 11.8, 3.8 Hz, 1 H), 2.87–3.02 (m, 2 H), 3.32 (br d, <i>J</i> = 12.9 Hz, 2 H), 3.81 (s, 3 H), 6.99 (dd, <i>J</i> = 8.6, 1.8 Hz, 1 H), 7.06 (dd, <i>J</i> = 12.9, 2.1 Hz, 1 H), 7.12 (t, <i>J</i> = 8.8 Hz, 1 H), 8.96 (br s, 1 H), 9.06 (br s, 1 H).</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 4-(3,4-Difluoro-2-methoxyphenyl)piperidine (<b>7e</b>)</h4><div class="NLM_p last">Starting from <b>6e</b> (0.54 g, 1.66 mmol) after reduction of the double bond and deprotection of the <i>N</i>-Boc protecting group, derivative <b>7e</b> (0.38 g, quant yield) was obtained as a white solid. C<sub>12</sub>H<sub>15</sub>F<sub>2</sub>NO. LCMS: Rt 1.35, <i>m</i>/<i>z</i> 228 [(M + H)]<sup>+</sup>.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 4-(2,3-Difluoro-6-methoxyphenyl)piperidine (<b>7g</b>)</h4><div class="NLM_p last">Starting from <b>6g</b> (0.13 g, 0.41 mmol) after reduction of the double bond and deprotection of the <i>N</i>-Boc protecting group, compound <b>7g</b> (0.09 g, quant yield) was obtained as white solid. C<sub>12</sub>H<sub>15</sub>F<sub>2</sub>NO. LCMS: Rt 0.85, <i>m</i>/<i>z</i> 228 [(M + H)]<sup>+</sup>.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 4-(2,4-Difluoro-6-methoxyphenyl)piperidine (<b>7h</b>)</h4><div class="NLM_p last">Starting from compound <b>6h</b> (0.726 g, 2.23 mmol) after reduction of the double bond and deprotection of the <i>N</i>-Boc protecting group, compound <b>7h</b> (0.525 g, quant yield) was obtained as a yellow oil. C<sub>12</sub>H<sub>15</sub>F<sub>2</sub>NO. LCMS: Rt 0.67, <i>m</i>/<i>z</i> 228 [(M + H)]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.60 (br d, <i>J</i> = 13.3 Hz, 2 H), 2.08–2.21 (m, 2 H), 2.53 (br s, 1 H), 2.71–2.80 (m, 2 H), 3.13–3.26 (m, 3 H), 3.81 (s, 3 H), 6.34–6.46 (m, 2 H).</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2-Bromo-4-[4-(3-fluoro-2-methoxyphenyl)piperidin-1-yl]pyridine-3-carbonitrile (<b>10d</b>)</h4><div class="NLM_p last">To a suspension of NaH (60% in mineral oil, 0.13 g, 3.27 mmol) in DMF (10 mL) was added <b>7d</b> at 0 °C. The reaction mixture was stirred at 0 °C for 5 min, and 2,4-dibromopyridine-3-carbonitrile (<b>8</b>,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> 0.86 g, 3.27 mmol) was added. The reaction was allowed to reach rt and stirred for 1 h. Then the reaction mixture was quenched with water and extracted with DCM. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered, and the solvent was evaporated. The solid compound obtained was then washed with diisopropyl ether to afford compound <b>10d</b> that was used as such in the next reaction step (0.943 g, 74%). C<sub>18</sub>H<sub>17</sub>BrFN<sub>3</sub>O. LCMS: Rt 3.34, <i>m</i>/<i>z</i> 390 [(M + H)]<sup>+</sup>.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2,3-Dichloro-4-[4-(5-fluoro-2-methoxyphenyl)piperidin-1-yl]pyridine (<b>11b</b>)</h4><div class="NLM_p last">To a suspension of <b>7b</b> (0.79 g, 3.78 mmol) and 2,3-dichloro-4-iodopyridine (<b>9</b>, 0.87 g, 3.15 mmol) in MeCN (8 mL) was added diisopropylethylamine (1.37 mL, 7.89 mmol). The mixture was heated at 110 °C overnight. Then the solvent was evaporated and the crude mixture was purified by column chromatography (silica gel, DCM in heptane 80/20), and the desired fractions were collected and concentrated <i>in vacuo</i>, yielding compound <b>11b</b> (0.55 g, 48.5%) as a white solid. C<sub>17</sub>H<sub>17</sub>ClFN<sub>2</sub>O. LCMS: Rt 3.30, <i>m</i>/<i>z</i> 355 [(M + H)]<sup>+</sup>.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 4-[4-(3-Fluoro-2-methoxyphenyl)piperidin-1-yl]-2-hydrazinopyridine-3-carbonitrile (<b>12d</b>)</h4><div class="NLM_p last">A mixture of <b>10d</b> (0.94 g, 2.41 mmol) and hydrazine (0.59 mL, 12.1 mmol) in THF (10 mL) was heated in a microwave oven for 15 min at 160 °C. Then the solvent was evaporated to dryness, the residue was taken up with a solution of NH<sub>3</sub> in MeOH and then treated with Na<sub>2</sub>CO<sub>3</sub> (aqueous saturated solution), and the mixture was extracted with DCM. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered, and the solvent was evaporated. The solid material obtained was then washed with Et<sub>2</sub>O, yielding compound <b>12d</b> that was used without further purification in the next reaction step (0.62 g, 75%). C<sub>20</sub>H<sub>20</sub>FN<sub>5</sub>O. LCMS: Rt 3.02, <i>m</i>/<i>z</i> 342 [(M + H)]<sup>+</sup>.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 3-Chloro-4-[4-(5-fluoro-2-methoxyphenyl)piperidin-1-yl]-2-hydrazinopyridine (<b>13b</b>)</h4><div class="NLM_p last">Compound <b>13b</b> was synthesized following a similar procedure as described for <b>12d</b>. Starting from <b>11b</b> (0.55 g, 1.53 mmol), compound <b>13b</b> was obtained (0.52 g, 92%) as a yellow oil. C<sub>17</sub>H<sub>20</sub>ClFN<sub>4</sub>O. LCMS: Rt 2.95, <i>m</i>/<i>z</i> 351 [(M + H)]<sup>+</sup>.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>′-{3-Cyano-4-[4-(3-fluoro-2-methoxyphenyl)piperidin-1-yl]pyridin-2-yl}-3,3,3-trifluoropropanehydrazide (<b>14d</b>)</h4><div class="NLM_p last">To a solution of compound <b>12d</b> (0.10 g, 0.293 mmol) and Et<sub>3</sub>N (0.061 mL, 0.44 mmol) in DCM was added 3,3,3-trifluoropropionyl chloride (0.044 mL, 0.352 mmol) portionwise at 0 °C. The reaction was stirred for 10 min at rt. Then Na<sub>2</sub>CO<sub>3</sub> (aqueous saturated solution) was added; the organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered; and the solvent was evaporated in vacuum to give compound <b>14d</b>, which was used as such in the next reaction step (0.13 g, quant yield).</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 3,3,3-Trifluoropropionic Acid <i>N</i>́-[3́-Chloro-4-(5-fluoro-2-methoxyphenyl)-3,4,5,6,tetrahydro-2H-[1,4́]bipyridinyl-2́-yl]hydrazide (<b>15b</b>)</h4><div class="NLM_p last">Compound <b>15b</b> was synthesized following a similar procedure as described for <b>14d</b>. Starting from <b>13b</b> (0.53 g, 1.51 mmol), compound <b>15b</b> was obtained (0.35 g, 54%) as a yellow oil. C<sub>20</sub>H<sub>21</sub>ClF<sub>4</sub>N<sub>4</sub>O<sub>2</sub>. LCMS: Rt 2.99, <i>m</i>/<i>z</i> 461 [(M + H)]<sup>+</sup>.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 7-[4-(3-Fluoro-2-methoxyphenyl)piperidin-1-yl]-3-(2,2,2-trifluoroethyl)[1,2,4]triazolo[4,3-<i>a</i>]pyridine-8-carbonitrile (<b>16d</b>)</h4><div class="NLM_p last">A solution of <b>14d</b> (0.133 g, 0.295 mmol) and POCl<sub>3</sub> (0.055 mL, 0.59 mmol) in MeCN was heated in a microwave oven for 5 min at 150 °C. Then Na<sub>2</sub>CO<sub>3</sub> (aqueous saturated solution) and DCM were added. The organic layer was separated and dried (Na<sub>2</sub>SO<sub>4</sub>), and the solvent was evaporated. The residue was purified by column chromatography (silica gel, EtOAc in DCM 10/90 to 80/20). The solid compound obtained was then washed with diisoproyl ether to yield compound <b>16d</b> as a sticky solid (0.073 g, 57%). C<sub>21</sub>H<sub>19</sub>ClF<sub>4</sub>N<sub>5</sub>O. LCMS: Rt 4.19, <i>m</i>/<i>z</i> 434 [(M + H)]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.80 (qd, <i>J</i> = 12.4, 3.2 Hz, 2 H), 1.87 (br d, <i>J</i> = 10.7 Hz, 2 H), 3.29 (tt, <i>J</i> = 11.8, 3.8 Hz, 1 H), 3.39–3.48 (m, 2 H), 3.87 (d, <i>J</i> = 1.2 Hz, 3 H), 4.37 (br d, <i>J</i> = 12.7 Hz, 2 H), 4.40 (q, <i>J</i> = 10.7 Hz, 2 H), 7.04–7.16 (m, 4 H), 8.52 (d, <i>J</i> = 7.8 Hz, 1 H).</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 8-Chloro-7-[4-(5-fluoro-2-methoxyphenyl)-1-piperidinyl]-3-(2,2,2-trifluoroethyl)-1,2,4-triazolo[4,3-<i>a</i>]pyridine (<b>17b</b>)</h4><div class="NLM_p last">Compound <b>17b</b> was synthesized following a similar procedure as described for <b>16d</b>. Starting from <b>15b</b> (0.35 g, 0.77 mmol), compound <b>17b</b> was obtained as a white solid (0.11 g, 33%); mp 259 °C. C<sub>20</sub>H<sub>19</sub>ClF<sub>4</sub>N<sub>4</sub>O. LCMS: Rt 3.87, <i>m</i>/<i>z</i> 443 [(M + H)]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.89 (qd, <i>J</i> = 12.4, 3.8 Hz, 2 H), 1.94–2.00 (m, 2 H), 3.08 (td, <i>J</i> = 11.8, 2.3 Hz, 2 H), 3.15 (tt, <i>J</i> = 11.9, 3.4 Hz, 1 H), 3.73–3.79 (m, 2 H), 3.83 (s, 3 H), 4.02 (q, <i>J</i> = 9.8 Hz, 2 H), 6.80 (dd, <i>J</i> = 9.0, 4.6 Hz, 1 H), 6.85 (d, <i>J</i> = 7.5 Hz, 1 H), 6.86–6.91 (m, 1 H), 6.97 (dd, <i>J</i> = 9.5, 3.2 Hz, 1 H), 7.86 (d, <i>J</i> = 7.2 Hz, 1 H).</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 8-Chloro-3-(cyclopropylmethyl)-7-[4-(3,6-difluoro-2-methoxyphenyl)-1-piperidinyl]-1,2,4-triazolo[4,3-<i>a</i>]pyridine (<b>20f</b>)</h4><div class="NLM_p last">To a mixture of 8-chloro-3-(cyclopropylmethyl)-7-iodo[1,2,4]triazolo[4,3-<i>a</i>]pyridine<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (<b>18</b>, 0.25 g, 0.75 mmol) and <b>7f</b> (0.22 g, 0.97 mmol) in toluene (2.5 mL) were added Pd(OAc)<sub>2</sub> (0.008 g, 0.04 mmol), (±)BINAP (0.046 g, 0.07 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.37 g, 1.12 mmol). The reaction mixture was heated at 125 °C overnight. Then DCM was added, the solid was filtered off, the filtrate solvent evaporated <i>in vacuo</i>, and the crude material purified by column chromatography (MeOH in DCM 0/100 to 5/95). The desired fractions were collected, the solvent was evaporated <i>in vacuo</i>, and the solid material obtained was then washed with Et<sub>2</sub>O to yield compound <b>20f</b> as an off-white solid (0.19 g, 59.2%); mp 163.2 °C. C<sub>22</sub>H<sub>23</sub>ClF<sub>2</sub>N<sub>4</sub>O. LCMS: Rt 2.43, <i>m</i>/<i>z</i> 443 [(M + H)]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.20–0.38 (m, 2 H), 0.47–0.67 (m, 2 H), 1.13–1.20 (m, 1 H), 1.78 (br d, <i>J</i> = 12.4 Hz, 2 H), 2.41 (qd, <i>J</i> = 12.5, 2.7 Hz, 2 H), 3.01 (t, <i>J</i> = 12.1 Hz, 2 H), 3.05 (d, <i>J</i> = 6.9 Hz, 2 H), 3.25 (tt, <i>J</i> = 12.5, 3.4 Hz, 1 H), 3.72 (br d, <i>J</i> = 11.8 Hz, 2 H), 3.95 (d, <i>J</i> = 1.7 Hz, 3 H), 6.74 (td, <i>J</i> = 9.2, 4.0 Hz, 1 H), 6.76 (d, <i>J</i> = 7.5 Hz, 1 H), 6.93 (ddd, <i>J</i> = 10.5, 9.2, 5.1 Hz, 1 H), 7.84 (d, <i>J</i> = 7.5 Hz, 1 H).</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 8-Chloro-3-(cyclopropylmethyl)-7-[4-(2-methoxyphenyl)-1-piperidinyl]-1,2,4-triazolo[4,3-<i>a</i>]pyridine (<b>20a</b>)</h4><div class="NLM_p last">Compound <b>20a</b> was synthesized following the same procedure as described for compound <b>20f</b>. Starting from intermediates <b>18</b> (0.15 g, 0.45 mmol) and 4-(2-methoxyphenyl)piperidine<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (<b>7a</b>, 0.1 g, 0.54 mmol), compound <b>20a</b> was obtained as a foam (0.056 g, 29.5%). C<sub>22</sub>H<sub>25</sub>ClN<sub>4</sub>O. LCMS: Rt 3.38, <i>m</i>/<i>z</i> 397 [(M + H)]<sup>+</sup><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.25–0.39 (m, 2 H), 0.54–0.67 (m, 2 H), 1.10–1.23 (m, 1 H), 1.87–2.03 (m, 4 H), 3.00–3.09 (m, 4 H), 3.11–3.21 (m, 1 H), 3.71 (br d, <i>J</i> = 12.5 Hz, 2 H), 3.86 (s, 3 H), 6.77 (d, <i>J</i> = 7.4 Hz, 1 H), 6.89 (br d, <i>J</i> = 8.1 Hz, 1 H), 6.97 (br t, <i>J</i> = 7.4, 7.4 Hz, 1 H), 7.19–7.24 (m, 1 H), 7.25–7.29 (m, 1 H), 7.84 (d, <i>J</i> = 7.6 Hz, 1 H).</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 8-Chloro-3-(cyclopropylmethyl)-7-[4-(5-fluoro-2-methoxyphenyl)-1-piperidinyl]-1,2,4-triazolo[4,3-<i>a</i>]pyridine (<b>20b</b>)</h4><div class="NLM_p last">A suspension of compounds <b>18</b> (0.10 g, 0.30 mmol), <b>7b</b> (0.13 g, 0.60 mmol), and NaHCO<sub>3</sub> (0.061 g, 0.75 mmol) in MeCN (1 mL) was heated in a pressure tube (Q-Tube) at 180 °C overnight. Then the mixture was diluted with DCM and HCl (2 N in H<sub>2</sub>O), the organic layer separated and dried (Na<sub>2</sub>SO<sub>4</sub>), and the solvent evaporated <i>in vacuo</i>. The crude material was purified by column chromatography (EtOAc in DCM 0/100 to 100/0), the desired fractions were collected, and the solvent was evaporated <i>in vacuo</i>. The solid compound obtained was then washed with diisopropyl ether to yield compound <b>20b</b> as an off-white solid (0.06 g, 49%); mp >300 °C. C<sub>22</sub>H<sub>24</sub>ClFN<sub>4</sub>O. LCMS: Rt 3.43, <i>m</i>/<i>z</i> 415 [(M + H)]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.27–0.38 (m, 2 H), 0.55–0.67 (m, 2 H), 1.13–1.20 (m, 1 H), 1.89 (qd, <i>J</i> = 12.1, 3.8 Hz, 2 H), 1.93–1.99 (m, 2 H), 3.00–3.07 (m, 2 H), 3.05 (d, <i>J</i> = 6.6 Hz, 2 H), 3.14 (tt, <i>J</i> = 11.7, 3.6 Hz, 1 H), 3.71 (br d, <i>J</i> = 11.8 Hz, 2 H), 3.83 (s, 3 H), 6.76 (d, <i>J</i> = 7.5 Hz, 1 H), 6.80 (dd, <i>J</i> = 9.0, 4.6 Hz, 1 H), 6.86–6.92 (m, 1 H), 6.97 (dd, <i>J</i> = 9.5, 3.2 Hz, 1 H), 7.84 (d, <i>J</i> = 7.5 Hz, 1 H).</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 8-Chloro-3-(cyclopropylmethyl)-7-[4-(2-fluoro-6-methoxyphenyl)-1-piperidinyl]-1,2,4-triazolo[4,3-<i>a</i>]pyridine (<b>20c</b>)</h4><div class="NLM_p last">Compound <b>20c</b> was synthesized following a similar procedure to that described for its analogue <b>20b</b>, changing the heating system from pressure tube to microwave irradiation (230 °C, 30 min). Thus, starting from intermediate <b>18</b> (0.10 g, 0.30 mmol) and intermediate <b>7c</b> (0.094 g, 0.45 mmol), the title compound <b>20c</b> was obtained as a foam (0.05 g, 38.5%). C<sub>22</sub>H<sub>24</sub>ClFN<sub>4</sub>O. LCMS: Rt 4.72, <i>m</i>/<i>z</i> 415 [(M + H)]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.28–0.38 (m, 2 H), 0.56–0.66 (m, 2 H), 1.13–1.22 (m, 1 H), 1.71–1.78 (m, 2 H), 2.45 (qd, <i>J</i> = 12.3, 3.2 Hz, 2 H), 3.01 (br t, <i>J</i> = 11.8 Hz, 2 H), 3.05 (d, <i>J</i> = 6.6 Hz, 2 H), 3.31 (tt, <i>J</i> = 12.3, 3.5 Hz, 1 H), 3.72 (br d, <i>J</i> = 11.8 Hz, 2 H), 3.85 (s, 3 H), 6.66–6.72 (m, 2 H), 6.77 (d, <i>J</i> = 7.5 Hz, 1 H), 7.15 (td, <i>J</i> = 8.3, 6.5 Hz, 1 H), 7.83 (d, <i>J</i> = 7.5 Hz, 1 H).</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 8-Chloro-3-(cyclopropylmethyl)-7-[4-(3-fluoro-2-methoxyphenyl)-1-piperidinyl]-1,2,4-triazolo[4,3-<i>a</i>]pyridine (<b>20d</b>)</h4><div class="NLM_p last">Compound <b>20d</b> was synthesized following the same procedure described for compound <b>20f</b>. Starting from intermediates <b>18</b> (0.10 g, 0.30 mmol) and <b>7d</b> (0.075 g, 0.36 mmol), the title compound <b>20d</b> was obtained as an off-white solid (0.025 g, 19.5%); mp 168.3 °C. C<sub>22</sub>H<sub>24</sub>ClFN<sub>4</sub>O. LCMS: Rt 3.40, <i>m</i>/<i>z</i> 415 [(M + H)]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.26–0.39 (m, 2 H), 0.54–0.68 (m, 2 H), 1.11–1.23 (m, 1 H), 1.86–2.04 (m, 4 H), 2.98–3.10 (m, 4 H), 3.11–3.21 (m, 1 H), 3.67–3.75 (m, 2 H), 3.95 (d, <i>J</i> = 1.8 Hz, 3 H), 6.77 (d, <i>J</i> = 7.4 Hz, 1 H), 6.94–7.09 (m, 3 H), 7.85 (d, <i>J</i> = 7.4 Hz, 1 H).</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 8-Chloro-3-(cyclopropylmethyl)-7-[4-(3,4-difluoro-2-methoxyphenyl)-1-piperidinyl]-1,2,4-triazolo[4,3-<i>a</i>]pyridine (<b>20e</b>)</h4><div class="NLM_p last">Compound <b>20e</b> was synthesized following the same approach described for compound <b>20f</b>. Starting from intermediates <b>18</b> (0.15 g, 0.45 mmol) and <b>7e</b> (0.12 g, 0.54 mmol), compound <b>20e</b> was obtained as an off-white solid (0.042 g, 21%); mp 173.5 °C. C<sub>22</sub>H<sub>23</sub>ClF<sub>2</sub>N<sub>4</sub>O. LCMS: Rt 3.56, <i>m</i>/<i>z</i> 433 [(M + H)]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.26–0.39 (m, 2 H), 0.54–0.68 (m, 2 H), 1.11–1.23 (m, 1 H), 1.85–2.00 (m, 4 H), 2.97–3.13 (m, 5 H), 3.70 (br d, <i>J</i> = 11.8 Hz, 2 H), 4.00 (d, <i>J</i> = 2.1 Hz, 3 H), 6.75 (d, <i>J</i> = 7.4 Hz, 1 H), 6.83–6.92 (m, 1 H), 6.93–6.99 (m, 1 H), 7.84 (d, <i>J</i> = 7.4 Hz, 1 H).</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 8-Chloro-3-(cyclopropylmethyl)-7-[4-(2,3-difluoro-6-methoxyphenyl)-1-piperidinyl]-1,2,4-triazolo[4,3-<i>a</i>]pyridine (<b>20g</b>)</h4><div class="NLM_p last">Compound <b>20g</b> was synthesized following the same procedure described for compound <b>20f</b>. Starting from intermediates <b>18</b> (0.10 g, 0.30 mmol) and <b>7g</b> (0.08 g, 0.36 mmol), compound <b>20g</b> was obtained as an off-white solid (0.04 g, 27.6%); mp 208.5 °C. C<sub>22</sub>H<sub>23</sub>ClF<sub>2</sub>N<sub>4</sub>O. LCMS: Rt 3.48, <i>m</i>/<i>z</i> 433 [(M + H)]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.26–0.39 (m, 2 H), 0.54–0.68 (m, 2 H), 1.11–1.22 (m, 1 H), 1.71–1.80 (m, 2 H), 2.45 (qd, <i>J</i> = 12.4, 3.4 Hz, 2 H), 3.00 (br t, <i>J</i> = 11.4, 2 H), 3.05 (d, <i>J</i> = 6.7 Hz, 2 H), 3.30 (tt, <i>J</i> = 12.4, 3.5 Hz, 1 H), 3.67–3.75 (m, 2 H), 3.83 (s, 3 H), 6.52–6.61 (m, 1 H), 6.76 (d, <i>J</i> = 7.6 Hz, 1 H), 6.98 (q, <i>J</i> = 9.2 Hz, 1 H), 7.83 (d, <i>J</i> = 7.6 Hz, 1 H).</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 8-Chloro-3-(cyclopropylmethyl)-7-[4-(2,4-difluoro-6-methoxyphenyl)-1-piperidinyl]-1,2,4-triazolo[4,3-<i>a</i>]pyridine (<b>20h</b>)</h4><div class="NLM_p last">Compound <b>20h</b> was synthesized following the same procedure described for <b>20f</b>. Starting from intermediate <b>18</b> (0.10 g, 0.30 mmol) and <b>7h</b> (0.08 g, 0.36 mmol), compound <b>20h</b> was obtained as an off-white solid (0.05 g, 38%); mp 162.2 °C. C<sub>22</sub>H<sub>23</sub>ClF<sub>2</sub>N<sub>4</sub>O. LCMS: Rt 3.6, <i>m</i>/<i>z</i> 433 [(M + H)]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.28–0.38 (m, 2 H), 0.55–0.67 (m, 2 H), 1.12–1.21 (m, 1 H), 1.68–1.76 (m, 2 H), 2.40 (qd, <i>J</i> = 12.3, 3.3 Hz, 2 H), 2.98 (br t, <i>J</i> = 11.7 Hz, 2 H), 3.05 (d, <i>J</i> = 6.6 Hz, 2 H), 3.22 (tt, <i>J</i> = 12.4, 3.6 Hz, 1 H), 3.70 (br d, <i>J</i> = 11.8 Hz, 2 H), 3.84 (s, 3 H), 6.39–6.47 (m, 2 H), 6.76 (d, <i>J</i> = 7.5 Hz, 1 H), 7.83 (d, <i>J</i> = 7.5 Hz, 1 H).</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 3-(Cyclopropylmethyl)-7-[4-(3,6-difluoro-2-methoxyphenyl)-1-piperidinyl]-8-(trifluoromethyl)-1,2,4-triazolo[4,3-<i>a</i>]pyridine (<b>21f</b>)</h4><div class="NLM_p last">A mixture of 7-chloro-3-(cyclopropylmethyl)-8-(trifluoromethyl)[1,2,4]triazolo[4,3-<i>a</i>]pyridine<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> (<b>19</b>, 0.30 g, 1.09 mmol), <b>7f</b> (0.37 g, 1.63 mmol), and diisopropylamine (0.38 mL, 2.18 mmol) in MeCN (3 mL) was heated under microwave irradiation at 190 °C for 20 min. Then the solvent was evaporated, and the crude residue was purified by column chromatography (EtOAc in DCM 0/100 to 100/0). The desired fractions were collected, and the solvent was evaporated <i>in vacuo</i>. The solid compound obtained was then washed with diisopropyl ether to yield compound <b>21f</b> as an off-white solid (0.25 g, 48.2%); mp 180.7 °C. C<sub>23</sub>H<sub>23</sub>F<sub>5</sub>N<sub>4</sub>O. LCMS: Rt 3.56, <i>m</i>/<i>z</i> 467 [(M + H)]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.28–0.38 (m, 2 H), 0.57–0.67 (m, 2 H), 1.11–1.20 (m, 1 H), 1.75 (dd, <i>J</i> = 12.1, 1.7 Hz, 2 H), 2.35 (qd, <i>J</i> = 12.4, 3.2 Hz, 2 H), 3.04 (d, <i>J</i> = 6.6 Hz, 2 H), 3.18 (br t, <i>J</i> = 12.4 Hz, 2 H), 3.27 (tt, <i>J</i> = 12.4, 3.6 Hz, 1 H), 3.62 (br d, <i>J</i> = 12.7 Hz, 2 H), 3.94 (d, <i>J</i> = 2.0 Hz, 3 H), 6.72 (ddd, <i>J</i> = 9.8, 9.3, 4.1 Hz, 1 H), 6.75 (d, <i>J</i> = 7.5 Hz, 1 H), 6.93 (ddd, <i>J</i> = 10.8, 9.2, 4.9 Hz, 1 H), 7.91 (d, <i>J</i> = 7.5 Hz, 1 H).</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 8-Chloro-3-(cyclopropylmethyl)-7-[4-(3-fluoro-2-methoxyphenyl)-1-piperidinyl]-1,2,4-triazolo[4,3-<i>a</i>]pyridine (<b>21d</b>)</h4><div class="NLM_p last">Compound <b>21d</b> was synthesized following the same procedure described for compound <b>21f</b>. Starting from intermediate <b>19</b> (0.10 g, 0.36 mmol) and <b>7d</b> (0.09 g, 0.44 mmol), compound <b>21d</b> was obtained as an off-white solid (0.045 g, 27.6%); mp 195.7 °C. C<sub>22</sub>H<sub>24</sub>F<sub>4</sub>N<sub>4</sub>O. LCMS: Rt 3.57, <i>m</i>/<i>z</i> 449 [(M + H)]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.28–0.39 (m, 2 H), 0.56–0.68 (m, 2 H), 1.08–1.20 (m, 1 H), 1.82–1.97 (m, 4 H), 3.05 (d, <i>J</i> = 6.6 Hz, 2 H), 3.10–3.18 (m, 1 H), 3.18–3.28 (m, 2 H), 3.60 (br d, <i>J</i> = 13.0 Hz, 2 H), 3.95 (d, <i>J</i> = 1.7 Hz, 3 H), 6.77 (d, <i>J</i> = 7.8 Hz, 1 H), 6.92–7.07 (m, 3 H), 7.93 (d, <i>J</i> = 7.8 Hz, 1 H).</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 2-[1-[8-Chloro-3-(cyclopropylmethyl)-1,2,4-triazolo[4,3-<i>a</i>]pyridin-7-yl]-4-piperidinyl]-3,6-difluorophenol (<b>22f</b>)</h4><div class="NLM_p last">To a solution of compound <b>20f</b> (0.05 g, 0.116) in DCM (0.5 mL) was added BBr<sub>3</sub> (0.231 mL, 0.231 mmol) dropwise at 0 °C. The reaction was stirred for 45 min at rt. The excess BBr<sub>3</sub> was quenched dropwise with MeOH (1 mL) at 0 °C, and then Na<sub>2</sub>CO<sub>3</sub> (saturated aqueous solution) was added (to pH ∼ 7). The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered, and the solvent was evaporated <i>in vacuo</i>. The residue was purified by column chromatography (silica gel, MeOH in DCM 0/100 to 6/94), the desired fractions were collected, and the solvent was evaporated <i>in vacuo</i>. The compound obtained was then treated with MeCN and then purified again by chromatography (same eluent as before) and then treated with Et<sub>2</sub>O to yield finally the title compound <b>22f</b> (0.018 g, 38%) as a white solid; mp >300 °C. C<sub>21</sub>H<sub>21</sub>ClF<sub>2</sub>N<sub>4</sub>O. LCMS: Rt 2.02, <i>m</i>/<i>z</i> 419 [(M + H)]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.21–0.35 (m, 2 H), 0.45–0.56 (m, 2 H), 1.11–1.22 (m, 1 H), 1.70 (br d, <i>J</i> = 10.7 Hz, 2 H), 2.24–2.40 (m, 2 H), 2.98 (br t, <i>J</i> = 11.8 Hz, 2 H), 3.02 (d, <i>J</i> = 6.9 Hz, 2 H), 3.24 (tt, <i>J</i> = 12.4, 3.3 Hz, 1 H), 3.61 (br d, <i>J</i> = 11.8 Hz, 2 H), 6.63 (td, <i>J</i> = 9.8, 3.9 Hz, 1 H), 6.97 (d, <i>J</i> = 7.5 Hz, 1 H), 7.07 (td, <i>J</i> = 9.7, 4.9 Hz, 1 H), 8.38 (d, <i>J</i> = 7.2 Hz, 1 H), 9.99 (br s, 1 H).</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 2-[1-[8-Chloro-3-(cyclopropylmethyl)-1,2,4-triazolo[4,3-<i>a</i>]pyridin-7-yl]-4-piperidinyl]-4-fluorophenol (<b>22b</b>)</h4><div class="NLM_p last">Compound <b>22b</b> was synthesized following the same procedure described for compound <b>22f</b>. Starting from compound <b>20b</b> (0.238 g, 0.57 mmol), the title compound <b>22b</b> was obtained as an off-white solid (0.065 g, 28.2%); mp 256 °C. C<sub>21</sub>H<sub>22</sub>ClFN<sub>4</sub>O. LCMS: Rt 3.04, <i>m</i>/<i>z</i> 401 [(M + H)]<sup>+</sup><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.21–0.33 (m, 2 H), 0.44–0.57 (m, 2 H), 1.09–1.22 (m, 1 H), 1.72–1.83 (m, 2 H), 1.81–1.96 (m, 2 H), 2.89–3.13 (m, 5 H), 3.61 (br d, <i>J</i> = 11.8 Hz, 2 H), 6.73–6.91 (m, 2 H), 6.91–6.99 (m, 1 H), 6.98 (d, <i>J</i> = 7.6 Hz, 1 H), 8.38 (d, <i>J</i> = 7.4 Hz, 1 H), 9.40 (s, 1 H).</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 2-[1-[8-Chloro-3-(cyclopropylmethyl)-1,2,4-triazolo[4,3-<i>a</i>]pyridin-7-yl]-4-piperidinyl]-3-fluorophenol (<b>22c</b>)</h4><div class="NLM_p last">Compound <b>22c</b> was synthesized following the same procedure described for compound <b>22f</b>. Starting from compound <b>20c</b> (0.124 g, 0.29 mmol), the title compound <b>22c</b> was obtained as an off-white solid (0.034 g, 28.3%); mp 242.6 °C C<sub>21</sub>H<sub>22</sub>ClFN<sub>4</sub>O. LCMS: Rt 2.76, <i>m</i>/<i>z</i> 401 [(M + H)]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.21–0.34 (m, 2 H), 0.45–0.56 (m, 2 H), 1.05–1.21 (m, 1 H), 1.67 (br d, <i>J</i> = 10.7 Hz, 2 H), 2.25–2.35 (m, 2 H), 2.97 (br t, <i>J</i> = 11.7 Hz, 2 H), 3.02 (d, <i>J</i> = 6.6 Hz, 2 H), 3.22 (tt, <i>J</i> = 12.3, 3.3 Hz, 1 H), 3.60 (br d, <i>J</i> = 11.8 Hz, 2 H), 6.56 (dd, <i>J</i> = 10.4, 8.7 Hz, 1 H), 6.67 (d, <i>J</i> = 8.1 Hz, 1 H), 6.97 (d, <i>J</i> = 7.2 Hz, 1 H), 6.99–7.07 (m, 1 H), 8.39 (d, <i>J</i> = 7.5 Hz, 1 H), 9.96 (br s, 1 H).</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 2-[1-[8-Chloro-3-(cyclopropylmethyl)-1,2,4-triazolo[4,3-<i>a</i>]pyridin-7-yl]-4-piperidinyl]-3,4-difluorophenol (<b>22g</b>)</h4><div class="NLM_p last">Compound <b>22g</b> was synthesized following the same synthetic procedure described for compound <b>22f</b>. Starting from <b>20g</b> (0.142 g, 0.33 mmol), the title compound <b>22g</b> was obtained (0.016 g, 11.6%) as an off-white solid; mp >300 °C. C<sub>21</sub>H<sub>21</sub>ClF<sub>2</sub>N<sub>4</sub>O. LCMS: Rt 2.85, <i>m</i>/<i>z</i> 419 [(M + H)]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.21–0.33 (m, 2 H), 0.44–0.56 (m, 2 H), 1.12–1.21 (m, 1 H), 1.71 (br d, <i>J</i> = 10.7 Hz, 2 H), 2.18–2.36 (m, 2 H), 2.98 (br t, <i>J</i> = 11.7 Hz, 2 H), 3.02 (d, <i>J</i> = 6.6 Hz, 2 H), 3.19–3.27 (m, 1 H), 3.61 (br d, <i>J</i> = 11.8 Hz, 2 H), 6.60 (dd, <i>J</i> = 9.0, 2.9 Hz, 1 H), 6.98 (d, <i>J</i> = 7.5 Hz, 1 H), 7.04 (q, <i>J</i> = 9.5 Hz, 1 H), 8.39 (d, <i>J</i> = 7.5 Hz, 1 H), 10.10 (br s, 1 H).</div></div><div id="sec4_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2-[1-[8-Chloro-3-(cyclopropylmethyl)-1,2,4-triazolo[4,3-<i>a</i>]pyridin-7-yl]-4-piperidinyl]-3,5-difluorophenol (<b>22h</b>)</h4><div class="NLM_p last">Compound <b>22h</b> was synthesized following the same procedure described for <b>22f</b>. Starting from <b>20h</b>, the title compound <b>22h</b> (0.129 g, 0.29 mmol) was obtained as an off-white solid (0.014 g, 11.2%); mp >300 °C. C<sub>21</sub>H<sub>21</sub>ClF<sub>2</sub>N<sub>4</sub>O. LCMS: Rt 2.97, <i>m</i>/<i>z</i> 419 [(M + H)]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.22–0.32 (m, 2 H), 0.45–0.56 (m, 2 H), 1.12–1.21 (m, 1 H), 1.66 (br d, <i>J</i> = 10.7 Hz, 2 H), 2.18–2.34 (m, 2 H), 2.96 (br t, <i>J</i> = 11.7 Hz, 2 H), 3.02 (d, <i>J</i> = 6.9 Hz, 2 H), 3.10–3.20 (m, 1 H), 3.59 (br d, <i>J</i> = 11.8 Hz, 2 H), 6.48 (br d, <i>J</i> = 10.4 Hz, 1 H), 6.51–6.61 (m, 1 H), 6.96 (d, <i>J</i> = 7.5 Hz, 1 H), 8.37 (d, <i>J</i> = 7.5 Hz, 1 H), 10.44 (br s, 1 H).</div></div><div id="sec4_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 2-[1-[3-(Cyclopropylmethyl)-8-(trifluoromethyl)-1,2,4-triazolo[4,3-<i>a</i>]pyridin-7-yl]-4-piperidinyl]-3,6-difluorophenol (<b>23f</b>)</h4><div class="NLM_p last">Compound <b>23f</b> was synthesized following the same procedure reported for <b>22f</b>. Starting from compound <b>21f</b> (0.15 g, 0.32 mmol) after deprotection with BBr<sub>3</sub>, compound <b>23f</b> was obtained (0.01 g, 8.9%) as a white solid; mp >300 °C. C<sub>22</sub>H<sub>21</sub>F<sub>5</sub>N<sub>4</sub>O. LCMS: Rt 2.92, <i>m</i>/<i>z</i> 453 [(M + H)]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.21–0.35 (m, 2 H), 0.42–0.59 (m, 2 H), 1.11–1.21 (m, 1 H), 1.67 (br d, <i>J</i> = 11.0 Hz, 2 H), 2.15–2.34 (m, 2 H), 3.00 (d, <i>J</i> = 6.9 Hz, 2 H), 3.17 (br t, <i>J</i> = 12.1 Hz, 2 H), 3.53 (br d, <i>J</i> = 12.4 Hz, 2 H), 6.60 (td, <i>J</i> = 9.5, 3.3 Hz, 1 H), 7.00 (d, <i>J</i> = 7.8 Hz, 1 H), 7.05 (td, <i>J</i> = 9.6, 5.1 Hz, 1 H), 8.47 (d, <i>J</i> = 7.5 Hz, 1 H), 9.96 (br s, 1 H).</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Radiochemistry</h3><div class="NLM_p last">Carbon-11 was produced <i>via</i> a [<sup>14</sup>N(p,α)<sup>11</sup>C] nuclear reaction. The target gas, which is a mixture of N<sub>2</sub> (95%) and H<sub>2</sub> (5%) was irradiated using 18-MeV protons at a beam current of 25 μA. The irradiation was done for about 30 min to yield [<sup>11</sup>C]methane ([<sup>11</sup>C]CH<sub>4</sub>). [<sup>11</sup>C]CH<sub>4</sub> was then reacted with vaporous I<sub>2</sub> at 650 °C to convert it to [<sup>11</sup>C]methyl iodide ([<sup>11</sup>C]MeI). The resulting volatile [<sup>11</sup>C]MeI was bubbled with a flow of helium through a solution of radiolabeling precursor <b>22b</b> (for [<sup>11</sup>C]<b>20b</b>), <b>22c</b> (for [<sup>11</sup>C]<b>20c</b>), <b>22f</b> (for [<sup>11</sup>C]<b>20f</b>), <b>22g</b> (for [<sup>11</sup>C]<b>20g</b>), <b>22h</b> (for [<sup>11</sup>C]<b>20h</b>), <b>23f</b> (for [<sup>11</sup>C]<b>21f</b>) (0.2 mg), and Cs<sub>2</sub>CO<sub>3</sub> (1–3 mg) in anhydrous DMF (0.2 mL). When the amount of radioactivity in the reaction vial had stabilized, the reaction mixture was heated at 90 °C for 3 min. After dilution with water (0.7 mL), the crude reaction mixture was injected onto an HPLC system consisting of a semipreparative XBridge column (C<sub>18</sub>, 5 μm; 4.6 mm × 150 mm; Waters, Milford, MA, USA) that was eluted with a mixture of 0.05 M sodium acetate buffer (pH 5.5) and EtOH (50:50 v/v) at a flow rate of 1 mL/min. The radiolabeled product was collected between 12 and 16 min (small difference in retention time for the different tracers). The collected peak corresponding to the desired radioligand was then diluted with saline (Mini Plasco, Braun, Melsungen, Germany) to obtain a final ethanol concentration of 10%, and the solution was sterile filtered through 0.22 μm membrane filter (Millex-GV, Millipore, Ireland). Quality control was performed on an analytical HPLC system consisting of an XBridge C<sub>18</sub> 3.5 μm column (3 mm × 100 mm; Waters) eluted with a mixture of 0.05 M NaOAc buffer (pH 5.5) and MeCN (55:45 v/v) at a flow rate of 0.8 mL/min (Rt = 4–7 min, small difference in retention time for the different tracers). UV detection was performed at 254 nm. The six carbon-11 labeled tracers were synthesized with a radiochemical yield of 35–74% (relative to starting radioactivity of [<sup>11</sup>C]MeI, nondecay corrected, <i>n</i> > 3 for each tracer). The radiochemical purity as examined using the above-described analytical HPLC system was >96%, and the average specific radioactivity was found to be in the range 54–239 GBq/μmol at end of synthesis (EOS) (<i>n</i> > 3 for each tracer).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Biology</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Membrane Preparation</h4><div class="NLM_p last">CHO cells expressing the human mGlu2 receptor were grown until 80% confluence, washed in ice-cold phosphate-buffered saline, and stored at −20 °C until membrane preparation. After thawing, cells were suspended in 50 mM Tris-HCl, pH 7.4, and collected through centrifugation for 10 min at 23,500<i>g</i> at 4 °C. Cells were lysed in 5 mM hypotonic Tris-HCl, pH 7.4, and after recentrifugation for 20 min at 30,000<i>g</i> at 4 °C, the pellet was homogenized with an Ultra Turrax homogenizer in 50 mM Tris-HCl, pH 7.4. Protein concentrations were measured by the Bio-Rad protein assay using bovine serum albumin as standard. [<sup><b>35</b></sup><b>S]GTPγS binding assay.</b> For [<sup>35</sup>S]GTPγS measurements, compound and glutamate were diluted in buffer containing 10 mM HEPES acid, 10 mM HEPES salt, pH 7.4, containing 100 mM NaCl, 3 mM MgCl<sub>2</sub>, and 10 μM GDP. Membranes were thawed on ice and diluted in the same buffer, supplemented with 14 μg/mL saponin (final assay concentration of 2 μg/mL saponin). Final assay mixtures contained 7 μg of membrane protein and were preincubated with compound alone (determination of agonist effects) or together with an EC<sub>20</sub> concentration (4 μM) of glutamate (determination of PAM effects) for 30 min at 30 °C. [<sup>35</sup>S]GTPγS was added at a final concentration of 0.1 nM and incubated for another 30 min at 30 °C. Reactions were terminated by rapid filtration through Unifilter-96 GF/B filter plates (PerkinElmer) using a Unifilter-96 Harvester (PerkinElmer). Filters were washed three times with ice-cold 10 mM NaH<sub>2</sub>PO<sub>4</sub>/10 mM Na<sub>2</sub>HPO<sub>4</sub>, pH 7.4, and filter-bound radioactivity was counted in a Topcount Microplate Scintillation and Luminescence Counter from PerkinElmer. <b>Binding Assay.</b> After thawing, membranes from hmGlu2-CHO cells were homogenized using an Ultra Turrax homogenizer and suspended in ice-cold binding buffer containing 50 mM Tris-HCl (pH 7.4), 10 mM MgCl<sub>2</sub>, and 2 mM CaCl<sub>2</sub>. Displacement studies were performed using 10 nM of radioligand [<sup>3</sup>H]<b>2</b>, JNJ-40068782. Assay mixtures were incubated for 60 min at room temperature in a volume of 0.5 mL containing 75 μg hmGlu2 CHO membrane protein. Nonspecific binding (about 30% of total binding) was estimated in the presence of 10 μM JNJ-40264796, a structurally-related molecule. Filtration was performed using Unifilter-96 GF/C filters presoaked in 0.1% PEI and a 40-well manifold or 96-well Brandell harvester 96. After the addition of scintillation liquid, radioactivity on the filters was counted in a Microplate Scintillation and Luminescence Counter or Liquid Scintillation Analyzer from Perkin-Elmer.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Biodistribution Studies and Radiometabolite Analysis</h4><div class="NLM_p last">Quantification of radioactivity measurements in samples of biodistribution studies and radiometabolite analysis was done using an automated gamma counter equipped with a 3-in. NaI(Tl) well crystal coupled to a multichannel analyzer (Wallac 1480 Wizard, Wallac, Turku, Finland). The results were corrected for background radiation, physical decay, and counter dead time. All animal experiments were conducted with the approval of the institutional ethical committee for conduct of experiments on animals. <b>Biodistribution Studies.</b> Biodistribution studies were carried out in healthy male Wistar rats (body weight 200–450 g) at 2, 30, and 60 min pi (<i>n</i> = 3/time point). Rats were injected with about 22 MBq of the tracer <i>via</i> tail vein under anesthesia (2.5% isoflurane in O<sub>2</sub> at 1 L/min flow rate) and sacrificed by decapitation at the above specified time points. Blood and major organs were collected in tared tubes and weighed. The radioactivity in blood, organs, and other body parts was measured using an automated gamma counter. For calculation of total radioactivity in blood, blood mass was assumed to be 7% of the body mass. <b>Plasma radiometabolite analysis.</b> After iv administration of about 74 MBq of the radioligand <i>via</i> tail vein under anesthesia (2.5% isoflurane in O<sub>2</sub> at 1 L/min flow rate), rats were sacrificed by decapitation at 30 min pi (<i>n</i> = 2 for [<sup>11</sup>C]<b>20b</b>, [<sup>11</sup>C]<b>20g</b>, [<sup>11</sup>C]<b>20h</b>; <i>n</i> = 3 for [<sup>11</sup>C]<b>20f</b>). Blood was collected in heparin containing tubes (4.5 mL LH PST tubes; BD vacutainer, BD, Franklin Lakes, NJ, USA) and stored on ice. Next, the blood was centrifuged for 5 min at 3000 rpm to separate the plasma. Plasma (0.5 mL) was spiked with 10 μg of the authentic nonradioactive compound. Plasma was then analyzed with HPLC (Chromolith C<sub>18</sub>, 3 mm × 100 mm, Merck) eluted with gradient mixtures of 0.05 M sodium acetate (pH 5.5) (A) and MeCN (B): 0–4 min: 0% B, flow rate 0.5 mL/min; 4–9 min: linear gradient 0% B to 90% B, flow rate 1 mL/min; 9–12 min: 90% B flow rate 1 mL/min; 12–20 min: linear gradient 90% B to 0% B, flow rate of 0.5 mL/min. After passing through an in-line UV detector (254 nm), the HPLC eluate was collected as 1 mL fractions. The radioactivity in all fractions was measured using an automated gamma counter. <b>Perfused brain radiometabolite analysis.</b> After administration of about 74 MBq of the radioligand <i>via</i> tail vein under anesthesia (2.5% isoflurane in O<sub>2</sub> at 1 L/min flow rate), rats (<i>n</i> = 1 for [<sup>11</sup>C]<b>20b</b>, [<sup>11</sup>C]<b>20g</b>, [<sup>11</sup>C]<b>20h</b>; <i>n</i> = 2 for [<sup>11</sup>C]<b>20f</b>) were sacrificed at 30 min pi by administering an overdose of Nembutal (CEVA Santé Animale, 200 mg/kg intraperitoneal). When breathing had stopped, the rats were perfused with saline (Mini Plasco, Braun, Melsungen, Germany) until the liver turned pale. Brain was isolated, and cerebrum and cerebellum were separated and homogenized in 3 and 2 mL of MeCN, respectively, for about 2 min. A volume of 1 mL of this homogenate was diluted with an equal volume of water, and a part of this homogenate was filtered through a 0.22 μm filter (Millipore, Bedford, USA). About 0.5 mL of the filtrate was diluted with 0.1 mL of water and spiked with 10 μg of authentic nonradioactive compound. The cerebrum/cerebellum homogenate extracts were then injected onto an HPLC system consisting of an analytical XBridge column (C<sub>18</sub>, 3.5 μM, 3 mm × 100 mm, Waters) eluted with a mixture of 0.05 M sodium acetate (pH 5.5) and MeCN (60:40 v/v) at a flow rate of 0.8 mL/min. The HPLC eluate was collected as 1-mL fractions after passing through the UV detector (254 nm), and the radioactivity in the fractions was measured using an automated gamma counter.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Small-Animal PET Studies</h4><div class="NLM_p last">Imaging experiments were performed on a Focus 220 microPET scanner (Concorde Microsystems, Knoxville, TN, USA) using male Wistar rats. During all scan sessions, animals were kept under gas anesthesia (2.5% isoflurane in O<sub>2</sub> at 1 L/min flow rate). Dynamic 90-min-scans were acquired in list mode. Acquisition data were Fourier rebinned in 27 time frames (4 × 15 s, 4 × 1 min, 5 × 3 min, 14 × 5 min) and reconstructed with Filtered Back Projection (FBP). The images were spatially normalized to the rat brain Paxinos coordinate system using affine transformation, allowing the use of a predefined volumes of interest (VOIs) map. Time–activity curves (TAC) were generated for striatum, cortex, cerebellum, hippocampus, thalamus, and total brain for each individual scan, using PMOD software (v 3.2, PMOD Technologies Ltd.). The radioactivity concentration in the different brain regions was expressed as standardized uptake value (SUV) as a function of time π of the radiotracer by normalization for body weight of the animal and injected dose. Rats were injected with about 40–53 MBq of high specific activity formulation of [<sup>11</sup>C]<b>20f</b><i>via</i> the tail vein under isoflurane anesthesia (2.5% in O<sub>2</sub> at 1 L/min flow rate). For the displacement experiment, a solution of JNJ42153605 in 20% (2-hydroxypropyl)-β-cyclodextrine with 2 equiv of hydrochloric acid was injected iv at a dose of 1 mg/kg 30 min after radiotracer injection.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65"><a href="/doi/suppl/10.1021/jm300912k">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52167" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52167" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The different methods used for the LCMS and GCMS characterization of the compounds described in this manuscript; the biodistribution of [<sup>11</sup>C]<b>20f</b> in normal rats at 2, 30, and 60 min post-tracer-injection; the reconstructed radiochromatogram corresponding to a rat plasma analysis at 30 min postinjection of [<sup>11</sup>C]<b>20f</b>; and reconstructed radiochromatograms corresponding to a rat perfused cerebrum and cerebellum analysis at 30 min postinjection of [<sup>11</sup>C]<b>20f</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300912k/suppl_file/jm300912k_si_001.pdf">jm300912k_si_001.pdf (400.99 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm300912k" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84078" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84078" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">José-Ignacio Andrés</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Janssen Research & Development, Janssen-Cilag S.A.,
C/Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b5dcd4dbd1c7d0c6f5dcc1c69bdfdbdf9bd6dad8"><span class="__cf_email__" data-cfemail="6009010e04120513200914134e0a0e0a4e030f0d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jesús Alcázar</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Janssen Research & Development, Janssen-Cilag S.A.,
C/Jarama 75, 45007 Toledo, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">José María Cid</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Janssen Research & Development, Janssen-Cilag S.A.,
C/Jarama 75, 45007 Toledo, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Meri De Angelis</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Janssen Research & Development, Janssen-Cilag S.A.,
C/Jarama 75, 45007 Toledo, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura Iturrino</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Janssen Research & Development, Janssen-Cilag S.A.,
C/Jarama 75, 45007 Toledo, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xavier Langlois</span> - <span class="hlFld-Affiliation affiliation">Neuroscience, Janssen
Research & Development, Janssen Pharmaceutica N.V.,
Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hilde Lavreysen</span> - <span class="hlFld-Affiliation affiliation">Neuroscience, Janssen
Research & Development, Janssen Pharmaceutica N.V.,
Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrés A. Trabanco</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Janssen Research & Development, Janssen-Cilag S.A.,
C/Jarama 75, 45007 Toledo, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sofie Celen</span> - <span class="hlFld-Affiliation affiliation">Laboratory for Radiopharmacy and
IMIR, Faculty of Pharmaceutical Sciences, K.U. Leuven, Herestraat 49, B-3000 Leuven, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guy Bormans</span> - <span class="hlFld-Affiliation affiliation">Laboratory for Radiopharmacy and
IMIR, Faculty of Pharmaceutical Sciences, K.U. Leuven, Herestraat 49, B-3000 Leuven, Belgium</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2921e5096-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i66">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65008" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65008" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank José Manuel Alonso, Luis Font, and Alberto Fontana of the Analysis & Purification department in Toledo for their skillful assistance. We also thank Ivan Sannen and Julie Cornelis of the Laboratory for Radiopharmacy, KU Leuven, for their skillful help with the biodistribution and radiometabolite studies, and Ann Van Santvoort, Peter Vermaelen, and Michel Koole of the department of Nuclear Medicine (KU Leuven) for their assistance in the small-animal PET studies. We also thank Heidi Szel, Ilse Biesmans, and Luc Peeters (Janssen R&D, Neuroscience, Beerse) for their expert assistance with the in vitro pharmacology studies. Finally, we thank ADDEX Therapeutics for their collaboration on the mGluR2 PAM discovery program.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i67" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i67"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i68" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i68"> Abbreviations Used</h2><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood-brain barrier</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">ID</td><td class="NLM_def"><p class="first last">injected dose</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">mGlu</td><td class="NLM_def"><p class="first last">metabotropic glutamate</p></td></tr><tr><td class="NLM_term">mGluR2</td><td class="NLM_def"><p class="first last">metabotropic glutamate receptor 2</p></td></tr><tr><td class="NLM_term">PAM</td><td class="NLM_def"><p class="first last">positive allosteric modulator</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">μPET</td><td class="NLM_def"><p class="first last">small-animal PET</p></td></tr><tr><td class="NLM_term">pi</td><td class="NLM_def"><p class="first last">post injection</p></td></tr><tr><td class="NLM_term">RP-HPLC</td><td class="NLM_def"><p class="first last">reversed phase-high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">SUV</td><td class="NLM_def"><p class="first last">standardized uptake value</p></td></tr><tr><td class="NLM_term">TAC</td><td class="NLM_def"><p class="first last">time activity curve</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37763" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37763" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 40 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pin, J.-P.</span><span> </span><span class="NLM_article-title">Pharmacology and functions of metabotropic glutamate receptors</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1146%2Fannurev.pharmtox.37.1.205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=9131252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADyaK2sXisl2ktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1997&pages=205-237&author=P.+J.+Connauthor=J.-P.+Pin&title=Pharmacology+and+functions+of+metabotropic+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology and functions of metabotropic glutamate receptors</span></div><div class="casAuthors">Conn, P. Jeffrey; Pin, Jean-Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">205-237</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review, with 198 refs.  In the mid to late 1980s, studies were published that provided the first evidence for the existence of glutamate receptors that are not ligand-gated cation channels but are coupled to effector systems through GTP-binding proteins.  Since those initial reports, tremendous progress has been made in characterizing these metabotropic glutamate receptors (mGluRs), including cloning and characterization of cDNA that encodes a family of eight mGluR subtypes, several of which have multiple splice variants.  Also, tremendous progress has been made in developing new highly selective mGluR agonists and antagonists and toward detg. the physiol. roles of the mGluRs in mammalian brain.  These findings have exciting implications for drug development and suggest that the mGluRs provide a novel target for development of therapeutic agents that could have a significant impact on neuropharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph1fuaHYNvC7Vg90H21EOLACvtfcHk0licpORngMlc8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXisl2ktr0%253D&md5=d9df228141c4747f80bbd9d2f0843a24</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.37.1.205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.37.1.205%26sid%3Dliteratum%253Aachs%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DPin%26aufirst%3DJ.-P.%26atitle%3DPharmacology%2520and%2520functions%2520of%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D1997%26volume%3D37%26spage%3D205%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Kew, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, J. A.</span><span> </span><span class="NLM_article-title">Ionotropic and metabotropic glutamate receptor structure and pharmacology</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1007%2Fs00213-005-2200-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=15731895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtV2itbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2005&pages=4-29&author=J.+N.+Kewauthor=J.+A.+Kemp&title=Ionotropic+and+metabotropic+glutamate+receptor+structure+and+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Ionotropic and metabotropic glutamate receptor structure and pharmacology</span></div><div class="casAuthors">Kew, James N. C.; Kemp, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-29</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Rationale: L-Glutamate is the major excitatory neurotransmitter in the central nervous system (CNS) and mediates its actions via activation of both ionotropic and metabotropic receptor families.  The development of selective ligands, including competitive agonists and antagonists and pos. and neg. allosteric modulators, has enabled investigation of the functional roles of glutamate receptor family members.  Objective: In this review we describe the subunit structure and compn. of the ionotropic and metabotropic glutamate receptors and discuss their pharmacol., particularly with respect to selective tools useful for investigation of their function in the CNS.  Results: A large no. of ligands are now available that are selective either for glutamate receptor subfamilies or for particular receptor subtypes.  Such ligands have enabled considerable advances in the elucidation of the physiol. and pathophysiol. roles of receptor family members.  Furthermore, efficacy in animal models of neurol. and psychiatric disorders has supported the progression of several glutamatergic ligands into clin. studies.  These include ionotropic glutamate receptor antagonists, which have entered clin. trials for disorders including epilepsy and ischemic stroke, α-amino-3-hydroxy-5-methyl-4-isoazolepropionic acid (AMPA) receptor pos. allosteric modulators which are under evaluation as cognitive enhancers, and metabotropic glutamate receptor 2 (mGluR2) agonists which are undergoing clin. evaluation as anxiolytics.  Furthermore, preclin. studies have illustrated therapeutic potential for ligands selective for other receptor subtypes in various disorders.  These include mGluR1 antagonists in pain, mGluR5 antagonists in anxiety, pain and drug abuse and mGluR5 pos. allosteric modulators in schizophrenia.  Conclusions: Selective pharmacol. tools have enabled the study of glutamate receptors.  However, pharmacol. coverage of the family is incomplete and considerable scope remains for the development of novel ligands, particularly those with in vivo utility, and for the their use together with existing tools for the further investigation of the roles of receptor family members in CNS function and as potentially novel therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEJ0YO_TO0PbVg90H21EOLACvtfcHk0lg291qvajOmzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtV2itbY%253D&md5=e9ac822d32082f7779cc202c59db4247</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs00213-005-2200-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-005-2200-z%26sid%3Dliteratum%253Aachs%26aulast%3DKew%26aufirst%3DJ.%2BN.%26aulast%3DKemp%26aufirst%3DJ.%2BA.%26atitle%3DIonotropic%2520and%2520metabotropic%2520glutamate%2520receptor%2520structure%2520and%2520pharmacology%26jtitle%3DPsychopharmacology%26date%3D2005%26volume%3D179%26spage%3D4%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Cartmell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Regulation of neurotransmitter release by metabotropic glutamate receptors</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">889</span><span class="NLM_x">–</span> <span class="NLM_lpage">907</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1046%2Fj.1471-4159.2000.0750889.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=10936169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtFykurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2000&pages=889-907&author=J.+Cartmellauthor=D.+D.+Schoepp&title=Regulation+of+neurotransmitter+release+by+metabotropic+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of neurotransmitter release by metabotropic glutamate receptors</span></div><div class="casAuthors">Cartmell, Jayne; Schoepp, Darryle D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">889-907</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review, with ∼145 refs.  The G protein-coupled metabotropic glutamate (mGlu) receptors are differentially localized at various synapses throughout the brain.  Depending on the receptor subtype, they appear to be localized at presynaptic and/or postsynaptic sites, including glial as well as neuronal elements.  The heterogeneous distribution of these receptors on glutamate and nonglutamate neurons/cells thus allows modulation of synaptic transmission by a no. of different mechanisms.  Electrophysiol. studies have demonstrated that the activation of mGlu receptors can modulate the activity of Ca2+ or K+ channels, or interfere with release processes downstream of Ca2+ entry, and consequently regulate neuronal synaptic activity.  Such changes evoked by mGlu receptors can ultimately regulate transmitter release at both glutamatergic and nonglutamatergic synapses.  Increasing neurochem. evidence has emerged, obtained from in vitro and in vivo studies, showing modulation of the release of a variety of transmitters by mGlu receptors.  This review addresses the neurochem. evidence for mGlu receptor-mediated regulation of neurotransmitters, such as excitatory and inhibitory amino acids, monoamines, and neuropeptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrRIHmsUn6YbVg90H21EOLACvtfcHk0lg291qvajOmzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtFykurY%253D&md5=15379bf75d0949789eeaeaf4f9485460</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2000.0750889.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2000.0750889.x%26sid%3Dliteratum%253Aachs%26aulast%3DCartmell%26aufirst%3DJ.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DRegulation%2520of%2520neurotransmitter%2520release%2520by%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DJ.%2520Neurochem.%26date%3D2000%26volume%3D75%26spage%3D889%26epage%3D907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span> </span><span class="NLM_article-title">Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1016%2Fj.tips.2008.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=19058862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktlygsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=25-31&author=P.+J.+Connauthor=C.+W.+Lindsleyauthor=C.+K.+Jones&title=Activation+of+metabotropic+glutamate+receptors+as+a+novel+approach+for+the+treatment+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia</span></div><div class="casAuthors">Conn, P. Jeffrey; Lindsley, Craig W.; Jones, Carrie K.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-31</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In recent years, the metabotropic glutamate (mGlu) receptors have emerged as potential new drug targets for treatment of a range of CNS disorders.  Some of the most compelling advances have been made in targeting specific mGlu receptor subtypes as a fundamentally new approach to the treatment of schizophrenia.  Recent animal and clin. studies provide strong evidence that agonists of group II mGlu receptors (mGluR2 and mGluR3) are effective in the treatment of the pos. symptoms of schizophrenia, and animal studies suggest that mGluR5 agonists could provide a novel approach for the treatment of all major symptom domains (pos., neg., and cognitive) of this disorder.  Although the discovery of selective agonists of these receptors is a challenge, there have been recent advances in the discovery of highly selective pos. allosteric modulators (PAMs) of mGluR2 and mGluR5.  These mGlu receptor-selective PAMs have properties needed for optimization as clin. candidates and have robust effects in animal models that predict efficacy in treatment of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_CxX6LmkZObVg90H21EOLACvtfcHk0lg291qvajOmzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktlygsg%253D%253D&md5=06ee21863b9528fb70211f87827b98ce</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2008.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2008.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DJones%26aufirst%3DC.%2BK.%26atitle%3DActivation%2520of%2520metabotropic%2520glutamate%2520receptors%2520as%2520a%2520novel%2520approach%2520for%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26spage%3D25%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Moghaddam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitt, D.</span><span> </span><span class="NLM_article-title">From Revolution to Evolution: the Glutamate Hypothesis of Schizophrenia and its Implication for Treatment</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1038%2Fnpp.2011.181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=21956446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ejs77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=4-15&author=B.+Moghaddamauthor=D.+Javitt&title=From+Revolution+to+Evolution%3A+the+Glutamate+Hypothesis+of+Schizophrenia+and+its+Implication+for+Treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment</span></div><div class="casAuthors">Moghaddam, Bita; Javitt, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-15</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Glutamate is the primary excitatory neurotransmitter in mammalian brain.  Disturbances in glutamate-mediated neurotransmission have been increasingly documented in a range of neuropsychiatric disorders including schizophrenia, substance abuse, mood disorders, Alzheimer's disease, and autism-spectrum disorders.  Glutamatergic theories of schizophrenia are based on the ability of N-methyl--aspartate receptor (NMDAR) antagonists to induce schizophrenia-like symptoms, as well as emergent literature documenting disturbances of NMDAR-related gene expression and metabolic pathways in schizophrenia.  Research over the past two decades has highlighted promising new targets for drug development based on potential pre- and postsynaptic, and glial mechanisms leading to NMDAR dysfunction.  Reduced NMDAR activity on inhibitory neurons leads to disinhibition of glutamate neurons increasing synaptic activity of glutamate, esp. in the prefrontal cortex.  Based on this mechanism, normalizing excess glutamate levels by metabotropic glutamate group 2/3 receptor agonists has led to potential identification of the first non-monoaminergic target with comparable efficacy as conventional antipsychotic drugs for treating pos. and neg. symptoms of schizophrenia.  In addn., NMDAR has intrinsic modulatory sites that are active targets for drug development, several of which show promise in preclin./early clin. trials targeting both symptoms and cognition.  To date, most studies have been done with orthosteric agonists and/or antagonists at specific sites.  However, allosteric modulators, both pos. and neg., may offer superior efficacy with less danger of downregulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeNMlez-A7MbVg90H21EOLACvtfcHk0lg291qvajOmzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ejs77N&md5=0bf82fc0e3cb5c3ad2bed91414672e6f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2011.181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2011.181%26sid%3Dliteratum%253Aachs%26aulast%3DMoghaddam%26aufirst%3DB.%26aulast%3DJavitt%26aufirst%3DD.%26atitle%3DFrom%2520Revolution%2520to%2520Evolution%253A%2520the%2520Glutamate%2520Hypothesis%2520of%2520Schizophrenia%2520and%2520its%2520Implication%2520for%2520Treatment%26jtitle%3DNeuropsychopharmacology%26date%3D2012%26volume%3D37%26spage%3D4%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Patil, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreev, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avedisova, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardenstein, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurovich, I. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morozova, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosolov, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neznanov, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reznik, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smulevich, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tochilov, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1102</span><span class="NLM_x">–</span> <span class="NLM_lpage">1107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1038%2Fnm1632" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=17767166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVSgtrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1102-1107&author=S.+T.+Patilauthor=L.+Zhangauthor=F.+Martenyiauthor=S.+L.+Loweauthor=K.+A.+Jacksonauthor=B.+V.+Andreevauthor=A.+S.+Avedisovaauthor=L.+M.+Bardensteinauthor=I.+Y.+Gurovichauthor=M.+A.+Morozovaauthor=S.+N.+Mosolovauthor=N.+G.+Neznanovauthor=A.+M.+Reznikauthor=A.+B.+Smulevichauthor=V.+A.+Tochilovauthor=B.+G.+Johnsonauthor=J.+A.+Monnauthor=D.+D.+Schoepp&title=Activation+of+mGlu2%2F3+receptors+as+a+new+approach+to+treat+schizophrenia%3A+a+randomized+Phase+2+clinical+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial</span></div><div class="casAuthors">Patil, Sandeep T.; Zhang, Lu; Martenyi, Ferenc; Lowe, Stephen L.; Jackson, Kimberley A.; Andreev, Boris V.; Avedisova, Alla S.; Bardenstein, Leonid M.; Gurovich, Issak Y.; Morozova, Margarita A.; Mosolov, Sergey N.; Neznanov, Nikolai G.; Reznik, Alexander M.; Smulevich, Anatoly B.; Tochilov, Vladimir A.; Johnson, Bryan G.; Monn, James A.; Schoepp, Darryle D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1102-1107</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Schizophrenia is a chronic, complex and heterogeneous mental disorder, with pathol. features of disrupted neuronal excitability and plasticity within limbic structures of the brain.  These pathol. features manifest behaviorally as pos. symptoms (including hallucinations, delusions and thought disorder), neg. symptoms (such as social withdrawal, apathy and emotional blunting) and other psychopathol. symptoms (such as psychomotor retardation, lack of insight, poor attention and impulse control).  Altered glutamate neurotransmission has for decades been linked to schizophrenia, but all commonly prescribed antipsychotics act on dopamine receptors.  LY404039 is a selective agonist for metabotropic glutamate 2/3 (mGlu2/3) receptors and has shown antipsychotic potential in animal studies.  With data from rodents, we provide new evidence that mGlu2/3 receptor agonists work by a distinct mechanism different from that of olanzapine.  To clin. test this mechanism, an oral prodrug of LY404039 (LY2140023) was evaluated in schizophrenic patients with olanzapine as an active control in a randomized, three-armed, double-blind, placebo-controlled study.  Treatment with LY2140023, like treatment with olanzapine, was safe and well-tolerated; treated patients showed statistically significant improvements in both pos. and neg. symptoms of schizophrenia compared to placebo (P < 0.001 at week 4).  Notably, patients treated with LY2140023 did not differ from placebo-treated patients with respect to prolactin elevation, extrapyramidal symptoms or wt. gain.  These data suggest that mGlu2/3 receptor agonists have antipsychotic properties and may provide a new alternative for the treatment of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYtB0jdSzAQrVg90H21EOLACvtfcHk0liCtmktYbWtwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVSgtrvF&md5=afab88e888cba7e72e14c4e949f894d7</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnm1632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1632%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DS.%2BT.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DJackson%26aufirst%3DK.%2BA.%26aulast%3DAndreev%26aufirst%3DB.%2BV.%26aulast%3DAvedisova%26aufirst%3DA.%2BS.%26aulast%3DBardenstein%26aufirst%3DL.%2BM.%26aulast%3DGurovich%26aufirst%3DI.%2BY.%26aulast%3DMorozova%26aufirst%3DM.%2BA.%26aulast%3DMosolov%26aufirst%3DS.%2BN.%26aulast%3DNeznanov%26aufirst%3DN.%2BG.%26aulast%3DReznik%26aufirst%3DA.%2BM.%26aulast%3DSmulevich%26aufirst%3DA.%2BB.%26aulast%3DTochilov%26aufirst%3DV.%2BA.%26aulast%3DJohnson%26aufirst%3DB.%2BG.%26aulast%3DMonn%26aufirst%3DJ.%2BA.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DActivation%2520of%2520mGlu2%252F3%2520receptors%2520as%2520a%2520new%2520approach%2520to%2520treat%2520schizophrenia%253A%2520a%2520randomized%2520Phase%25202%2520clinical%2520trial%26jtitle%3DNat.%2520Med.%26date%3D2007%26volume%3D13%26spage%3D1102%26epage%3D1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">O’Neill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, S. N.</span><span> </span><span class="NLM_article-title">Recent developments in metabotropic glutamate receptors as novel drug targets</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1358%2Fdof.2010.035.04.1487693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslajtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=307-324&author=M.+J.+O%E2%80%99Neillauthor=M.+J.+Fellauthor=K.+A.+Svenssonauthor=J.+M.+Witkinauthor=S.+N.+Mitchell&title=Recent+developments+in+metabotropic+glutamate+receptors+as+novel+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in metabotropic glutamate receptors as novel drug targets</span></div><div class="casAuthors">O'Neill, M. J.; Fell, M. J.; Svensson, K. A.; Witkin, J. M.; Mitchell, S. N.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-324</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system, activating ionotropic (iGlu) and metabotropic (mGlu) glutamate receptors.  Targeting iGlu receptors has proven difficult, as these receptors play such a crit. role in fast synaptic transmission.  In recent years, there has been a switch in the focus of the pharmaceutical industry to target mGlu receptors, as these receptors have a more modulatory role in the brain.  Eight subtypes of the C protein-coupled mGlu receptors have been cloned and classified into three groups according to their second messenger assocn., sequence homol. and agonist selectivity.  Group I (mGlu1 and mGlu5) receptors are pos. coupled to phosphatidylinositol (PI) hydrolysis, while group II (mGlu2 and mGlu3) and group III (mGlu4, mGlu6, mGlu7 and mGlu8) receptors are neg. coupled to adenylate cyclase and thought to act as presynaptic autoreceptors, regulating glutamate transmission.  There has been rapid progress in understanding the biol. of mGlu receptors and their function in the central nervous system (CNS), and the field now has highly potent and selective ligands for many of the mGlu receptor subtypes.  Pharmacol. tools include both orthosteric and allosteric agonists and antagonists.  These mols. have been explored across a range of CNS conditions, the findings of which will be discussed briefly in this review.  Recently, some of the most promising mols. have progressed into clin. trials (mGlu2/3 receptor agonists for the treatment of anxiety and schizophrenia and mGlu5 receptor antagonists for acute migraine and L-DOPA-induced dyskinesia) and achieved proof of concept.  These encouraging results suggest mGlu receptors as novel drug targets with application in a range of psychiatric and neurol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC9EtQj2lZSbVg90H21EOLACvtfcHk0liCtmktYbWtwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslajtb4%253D&md5=1b51466a1778a814d0988eab288c623e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1358%2Fdof.2010.035.04.1487693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2010.035.04.1487693%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DM.%2BJ.%26aulast%3DFell%26aufirst%3DM.%2BJ.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26aulast%3DWitkin%26aufirst%3DJ.%2BM.%26aulast%3DMitchell%26aufirst%3DS.%2BN.%26atitle%3DRecent%2520developments%2520in%2520metabotropic%2520glutamate%2520receptors%2520as%2520novel%2520drug%2520targets%26jtitle%3DDrugs%2520Future%26date%3D2010%26volume%3D35%26spage%3D307%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkerton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosford, N. D. P.</span><span> </span><span class="NLM_article-title">Recent progress in the synthesis and characterization of group II metabotropic glutamate receptor allosteric modulators</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">382</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn200008d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksFaqtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=382-393&author=D.+J.+Shefflerauthor=A.+B.+Pinkertonauthor=R.+Dahlauthor=A.+Markouauthor=N.+D.+P.+Cosford&title=Recent+progress+in+the+synthesis+and+characterization+of+group+II+metabotropic+glutamate+receptor+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Progress in the Synthesis and Characterization of Group II Metabotropic Glutamate Receptor Allosteric Modulators</span></div><div class="casAuthors">Sheffler, Douglas J.; Pinkerton, Anthony B.; Dahl, Russell; Markou, Athina; Cosford, Nicholas D. P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">382-393</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Group II metabotropic glutamate (mGlu) receptors consist of the metabotropic glutamate 2 (mGlu2) and metabotropic glutamate 3 (mGlu3) receptor subtypes which modulate glutamate transmission by second messenger activation to neg. regulate the activity of adenylyl cyclase.  Excessive accumulation of glutamate in the perisynaptic extracellular region triggers mGlu2 and mGlu3 receptors to inhibit further release of glutamate.  There is growing evidence that the modulation of glutamatergic neurotransmission by small mol. modulators of Group II mGlu receptors has significant potential for the treatment of several neuropsychiatric and neurodegenerative diseases.  This review provides an overview of recent progress on the synthesis and pharmacol. characterization of pos. and neg. allosteric modulators of the Group II mGlu receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN3kTaVydOYbVg90H21EOLACvtfcHk0li2yofuX2JH-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksFaqtbg%253D&md5=98860a15e30c38b831332dcc82425f14</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fcn200008d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200008d%26sid%3Dliteratum%253Aachs%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26aulast%3DDahl%26aufirst%3DR.%26aulast%3DMarkou%26aufirst%3DA.%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26atitle%3DRecent%2520progress%2520in%2520the%2520synthesis%2520and%2520characterization%2520of%2520group%2520II%2520metabotropic%2520glutamate%2520receptor%2520allosteric%2520modulators%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D382%26epage%3D393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Wooley, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pemberton, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bate, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. M.</span><span> </span><span class="NLM_article-title">The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">196</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2008&pages=431-440&author=M.+L.+Wooleyauthor=D.+J.+Pembertonauthor=S.+Bateauthor=C.+Cortiauthor=D.+M.+Jones&title=The+mGlu2+but+not+the+mGlu3+receptor+mediates+the+actions+of+the+mGluR2%2F3+agonist%2C+LY379268%2C+in+mouse+models+predictive+of+antipsychotic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWooley%26aufirst%3DM.%2BL.%26aulast%3DPemberton%26aufirst%3DD.%2BJ.%26aulast%3DBate%26aufirst%3DS.%26aulast%3DCorti%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DD.%2BM.%26atitle%3DThe%2520mGlu2%2520but%2520not%2520the%2520mGlu3%2520receptor%2520mediates%2520the%2520actions%2520of%2520the%2520mGluR2%252F3%2520agonist%252C%2520LY379268%252C%2520in%2520mouse%2520models%2520predictive%2520of%2520antipsychotic%2520activity%26jtitle%3DPsychopharmacology%26date%3D2008%26volume%3D196%26spage%3D431%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Fell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (−)-(1R,4S,5S,6S)-4-Amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic Acid (LY404039)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1124%2Fjpet.108.136861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=18424625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotlyltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2008&pages=209-217&author=M.+J.+Fellauthor=K.+A.+Svenssonauthor=B.+G.+Johnsonauthor=D.+D.+Schoepp&title=Evidence+for+the+role+of+metabotropic+glutamate+%28mGlu%292+not+mGlu3+receptors+in+the+preclinical+antipsychotic+pharmacology+of+the+mGlu2%2F3+receptor+agonist+%28%E2%88%92%29-%281R%2C4S%2C5S%2C6S%29-4-Amino-2-sulfonylbicyclo%5B3.1.0%5Dhexane-4%2C6-dicarboxylic+Acid+%28LY404039%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039)</span></div><div class="casAuthors">Fell, Matthew J.; Svensson, Kjell A.; Johnson, Bryan G.; Schoepp, Darryle D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">209-217</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">(-)-(1R,4S,5S,6S)-4-Amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039) is a potent and selective group II metabotropic glutamate [(mGlu)2 and mGlu3] receptor agonist for which its prodrug LY2140023 [(1R,4S,5S,6S)-2-thiabicyclo[3.1.0]-hexane-4,6-dicarboxylic acid,4-[(2S)-2-amino-4-(methylthio)-1-oxobutyl]amino-, 2,2-dioxide monohydrate] has recently been shown to have efficacy in the treatment of the pos. and neg. symptoms of schizophrenia.  In this article, we use mGlu receptor-deficient mice to investigate the relative contribution of mGlu2 and mGlu3 receptors in mediating the antipsychotic profile of LY404039 in the phencyclidine (PCP) and d-amphetamine (AMP) models of psychosis.  To further explore the mechanism of action of LY404039, we compared the drugs' ability to block PCP-induced hyperlocomotion to that of atypical antipsychotics in wild-type and mice lacking mGlu2/3 receptors.  In wild-type animals, LY404039 (3-30 mg/kg i.p.) significantly reversed AMP (5 mg/kg, i.p.)-induced increases in ambulations, distance traveled, and reduced time spent at rest.  LY404039 reversed PCP (7.5 mg/kg i.p.)-evoked behaviors at 10 mg/kg.  The antipsychotic-like effects of LY404039 (10 mg/kg i.p.) on PCP and AMP-evoked behavioral activation were absent in mGlu2 and mGlu2/3 but not in mGlu3 receptor-deficient mice, indicating that the activation of mGlu2 and not mGlu3 receptors is responsible for the antipsychotic-like effects of the mGlu2/3 receptor agonist LY404039.  In contrast, the atypical antipsychotic drugs clozapine and risperidone inhibited PCP-evoked behaviors in both wild-type and mGlu2/3 receptor-deficient mice.  These data demonstrate that the antipsychotic-like effects of the mGlu2/3 receptor agonist LY404039 in psychostimulant models of psychosis are mechanistically distinct from those of atypical antipsychotic drugs and are dependent on functional mGlu2 and not mGlu3 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQQM2jpXbmkLVg90H21EOLACvtfcHk0li2yofuX2JH-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotlyltrw%253D&md5=795527aeddef2ee2829f2ae2c6803b6e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.136861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.136861%26sid%3Dliteratum%253Aachs%26aulast%3DFell%26aufirst%3DM.%2BJ.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26aulast%3DJohnson%26aufirst%3DB.%2BG.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DEvidence%2520for%2520the%2520role%2520of%2520metabotropic%2520glutamate%2520%2528mGlu%25292%2520not%2520mGlu3%2520receptors%2520in%2520the%2520preclinical%2520antipsychotic%2520pharmacology%2520of%2520the%2520mGlu2%252F3%2520receptor%2520agonist%2520%2528%25E2%2588%2592%2529-%25281R%252C4S%252C5S%252C6S%2529-4-Amino-2-sulfonylbicyclo%255B3.1.0%255Dhexane-4%252C6-dicarboxylic%2520Acid%2520%2528LY404039%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D326%26spage%3D209%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Levine, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaydos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goddard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feighner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">The mGlu2/3 receptor agonist, LY354740, reduces panic anxiety induced by a CO<sub>2</sub> challenge in patients diagnosed with panic disorder</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=294-294&author=L.+Levineauthor=B.+Gaydosauthor=D.+Sheehanauthor=A.+Goddardauthor=J.+Feighnerauthor=W.+Potterauthor=D.+D.+Schoepp&title=The+mGlu2%2F3+receptor+agonist%2C+LY354740%2C+reduces+panic+anxiety+induced+by+a+CO2+challenge+in+patients+diagnosed+with+panic+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevine%26aufirst%3DL.%26aulast%3DGaydos%26aufirst%3DB.%26aulast%3DSheehan%26aufirst%3DD.%26aulast%3DGoddard%26aufirst%3DA.%26aulast%3DFeighner%26aufirst%3DJ.%26aulast%3DPotter%26aufirst%3DW.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DThe%2520mGlu2%252F3%2520receptor%2520agonist%252C%2520LY354740%252C%2520reduces%2520panic%2520anxiety%2520induced%2520by%2520a%2520CO2%2520challenge%2520in%2520patients%2520diagnosed%2520with%2520panic%2520disorder%26jtitle%3DNeuropharmacology%26date%3D2002%26volume%3D43%26spage%3D294%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Pin, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prezeau, L.</span><span> </span><span class="NLM_article-title">Positive allosteric modulators for γ-aminobutyric acid<sub>B</sub> receptors open new routes for the development of drugs targeting family 3 G-protein-coupled receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">884</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=881-884&author=J.-P.+Pinauthor=M.-L.+Parmentierauthor=L.+Prezeau&title=Positive+allosteric+modulators+for+%CE%B3-aminobutyric+acidB+receptors+open+new+routes+for+the+development+of+drugs+targeting+family+3+G-protein-coupled+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPin%26aufirst%3DJ.-P.%26aulast%3DParmentier%26aufirst%3DM.-L.%26aulast%3DPrezeau%26aufirst%3DL.%26atitle%3DPositive%2520allosteric%2520modulators%2520for%2520%25CE%25B3-aminobutyric%2520acidB%2520receptors%2520open%2520new%2520routes%2520for%2520the%2520development%2520of%2520drugs%2520targeting%2520family%25203%2520G-protein-coupled%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D60%26spage%3D881%26epage%3D884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Gjoni, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urwyler, S.</span><span> </span><span class="NLM_article-title">Receptor activation involving positive allosteric modulation, unlike full agonism, does not result in GABA<sub>B</sub> receptor desensitization</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1293</span><span class="NLM_x">–</span> <span class="NLM_lpage">1299</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=1293-1299&author=T.+Gjoniauthor=S.+Urwyler&title=Receptor+activation+involving+positive+allosteric+modulation%2C+unlike+full+agonism%2C+does+not+result+in+GABAB+receptor+desensitization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGjoni%26aufirst%3DT.%26aulast%3DUrwyler%26aufirst%3DS.%26atitle%3DReceptor%2520activation%2520involving%2520positive%2520allosteric%2520modulation%252C%2520unlike%2520full%2520agonism%252C%2520does%2520not%2520result%2520in%2520GABAB%2520receptor%2520desensitization%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26spage%3D1293%26epage%3D1299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Melancon, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmitte, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Allosteric modulation of seven transmembrane spanning receptors: Theory, Practice, and opportunities for Central Nervous System Drug Discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1445</span><span class="NLM_x">–</span> <span class="NLM_lpage">1464</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201139r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1SmurnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1445-1464&author=B.+J.+Melanconauthor=C.+R.+Hopkinsauthor=M.+R.+Woodauthor=K.+A.+Emmitteauthor=C.+M.+Niswenderauthor=A.+Christopoulosauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=Allosteric+modulation+of+seven+transmembrane+spanning+receptors%3A+Theory%2C+Practice%2C+and+opportunities+for+Central+Nervous+System+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug Discovery</span></div><div class="casAuthors">Melancon, Bruce J.; Hopkins, Corey R.; Wood, Michael R.; Emmitte, Kyle A.; Niswender, Colleen M.; Christopoulos, Arthur; Conn, P. Jeffrey; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1445-1464</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Allosteric modulation of Seven transmembrane spanning receptors and the opportunities for CNS drug discovery is reviewed here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlr4lj_Wp-O7Vg90H21EOLACvtfcHk0ljemnhgH99q1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1SmurnJ&md5=7c70f066f1581f1ff327c0dce37bb0e1</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm201139r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201139r%26sid%3Dliteratum%253Aachs%26aulast%3DMelancon%26aufirst%3DB.%2BJ.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DAllosteric%2520modulation%2520of%2520seven%2520transmembrane%2520spanning%2520receptors%253A%2520Theory%252C%2520Practice%252C%2520and%2520opportunities%2520for%2520Central%2520Nervous%2520System%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1445%26epage%3D1464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span> </span><span class="NLM_article-title">Progress in the development of positive allosteric modulators of the metabotropic glutamate receptor 2</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.2174%2F092986711793979706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=21110815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslahs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=47-68&author=A.+A.+Trabancoauthor=J.+M.+Cidauthor=H.+Lavreysenauthor=G.+J.+Macdonaldauthor=G.+Tresadern&title=Progress+in+the+development+of+positive+allosteric+modulators+of+the+metabotropic+glutamate+receptor+2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the development of positive allosteric modulators of the metabotropic glutamate receptor 2</span></div><div class="casAuthors">Trabanco, A. A.; Cid, J. M.; Lavreysen, H.; MacDonald, G. J.; Tresadern, G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-68</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The metabotropic glutamate type 2 (mGlu2) receptor is a G-protein coupled receptor (GPCR) expressed on presynaptic nerve terminals where it neg. modulates glutamate and GABA release.  Mixed mGlu2/mGlu3 orthosteric agonists such as LY354740 have shown activity in a range of preclin. animal models of anxiety and schizophrenia.  Clin. work with LY354740 demonstrated activity in a CO2 inhalation study suggesting application in the treatment of anxiety related disorders.  Subsequently, a related prodrug LY2140023 demonstrated improvements in pos. and neg. symptoms in patients suffering from schizophrenia.  These mols. exhibit combined mGlu2/mGlu3 activity although there is evidence from knock-out studies that preclin. anti-psychotic effects may be mediated via the mGlu2 receptor.  An alternative avenue for modulating GPCRs is to act via allosteric mechanisms, binding at a different site from the orthosteric agonist.  Since the first discovery of mGlu2 pos. allosteric modulators (PAMs) such as 2,2,2-TEMPS and BINA, multiple families of mGlu2 modulators have been reported and several have entered into clin. development.  This review focuses on recent advances in the development of novel mGlu2 PAMs by anal. of compds. disclosed in research articles and patent literature between 2007 and 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkHtOXKWJY9rVg90H21EOLACvtfcHk0ljemnhgH99q1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslahs7g%253D&md5=b4059bdfb0001b97cde8ec0e30032a48</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F092986711793979706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711793979706%26sid%3Dliteratum%253Aachs%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DTresadern%26aufirst%3DG.%26atitle%3DProgress%2520in%2520the%2520development%2520of%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25202%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D47%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Passchier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willemsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaalburg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Waarde, A.</span><span> </span><span class="NLM_article-title">Measuring drug-related receptor occupancy with positron emission tomography</span> <span class="citation_source-journal">Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=278-286&author=J.+Passchierauthor=A.+Geeauthor=A.+Willemsenauthor=W.+Vaalburgauthor=A.+van+Waarde&title=Measuring+drug-related+receptor+occupancy+with+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPasschier%26aufirst%3DJ.%26aulast%3DGee%26aufirst%3DA.%26aulast%3DWillemsen%26aufirst%3DA.%26aulast%3DVaalburg%26aufirst%3DW.%26aulast%3Dvan%2BWaarde%26aufirst%3DA.%26atitle%3DMeasuring%2520drug-related%2520receptor%2520occupancy%2520with%2520positron%2520emission%2520tomography%26jtitle%3DMethods%26date%3D2002%26volume%3D27%26spage%3D278%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tauscher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gründer, G.</span><span> </span><span class="NLM_article-title">The role of imaging in proof of concept for CNS drug discovery and development</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1038%2Fnpp.2008.166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=18843264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVyru7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=187-203&author=D.+F.+Wongauthor=J.+Tauscherauthor=G.+Gr%C3%BCnder&title=The+role+of+imaging+in+proof+of+concept+for+CNS+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The Role of Imaging in Proof of Concept for CNS Drug Discovery and Development</span></div><div class="casAuthors">Wong, Dean F.; Tauscher, Johannes; Grunder, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">187-203</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Neuroimaging, particularly that of neuroreceptor radioisotope and functional magnetic resonance imaging (fMRI), has played a fundamental role in neuropharmacol. and neurophysiol.  Because of the unique and pioneering role, esp. of the radiolabeling of central nervous system (CNS) drugs for receptor and neurotransmitter system imaging, there is an increasingly major role to aid in CNS drug development.  One component is providing evidence for proof of concept of the target for which candidate drugs are being tested for receptor occupancy mechanism of action and ultimately rational drug dosing.  There is also a role for other areas of neuroimaging, including fMRI and magnetic resonance spectroscopy in other magnetic resonance-based techniques that, together with radioisotope imaging, represent CNS mol. imaging.  ' The role of these approaches and a review of the recent advances in such neuroimaging for proof-of-concept studies is the subject for this paper.  Moreover, hypothetical examples and possible algorithms for early discovery/phase I development using neuroimaging provide specific working approaches.  In summary, this article reviews the vital biomarker approach of neuroimaging in proof of concept studies.  Neuropsychopharmacol. (2009) 34, 187-203; doi:10.1038/npp.2008.166; published online 8 Oct. 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8I0KCciAqxbVg90H21EOLACvtfcHk0lg-OYzSltJHJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVyru7rN&md5=c5c7b9b30303e57ceabf287e7eec35b6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2008.166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2008.166%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DTauscher%26aufirst%3DJ.%26aulast%3DGr%25C3%25BCnder%26aufirst%3DG.%26atitle%3DThe%2520role%2520of%2520imaging%2520in%2520proof%2520of%2520concept%2520for%2520CNS%2520drug%2520discovery%2520and%2520development%26jtitle%3DNeuropsychopharmacology%26date%3D2009%26volume%3D34%26spage%3D187%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Wang, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brownell, A.-L.</span><span> </span><span class="NLM_article-title">Development of metabotropic glutamate receptor ligands for neuroimaging</span> <span class="citation_source-journal">Curr. Med. Imaging Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.2174%2F157340507781387059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFKhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=186-205&author=J.+Q.+Wangauthor=A.-L.+Brownell&title=Development+of+metabotropic+glutamate+receptor+ligands+for+neuroimaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Development of metabotropic glutamate receptor ligands for neuroimaging</span></div><div class="casAuthors">Wang, Ji-Quan; Brownell, Anna-Liisa</div><div class="citationInfo"><span class="NLM_cas:title">Current Medical Imaging Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">186-205</span>CODEN:
                <span class="NLM_cas:coden">CMIRCV</span>;
        ISSN:<span class="NLM_cas:issn">1573-4056</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Metabotropic glutamate receptors (mGluRs) belong to a superfamily of G protein coupled receptors.  In the central nervous system (CNS), mGluRs modulate glutamatergic neurotransmission and are considered to affect also on dopaminergic and adrenergic neurotransmission.  MGluRs have various physiol. functions in CNS and are suggested to be involved in a no. of neurol. disorders.  Receptor ligands binding to mGluRs are also considered as potential therapeutic agents.  Classic competitive ligands, which are amino acid derivs., bind to the orthosteric binding site as endogenous glutamate.  It is believed that developing highly selective competitive agonists and antagonists for specific mGluR subtypes has been exceedingly difficult, because of the high conservation of the glutamate binding site across members of this receptor family and the restricted structural requirements for pharmacophores that occupy the binding pocket.  Another shortcoming of this kind of ligands is that the carboxyl and amino groups make them too polar to penetrate the blood brain barrier.  Although these ligands have had and still have important roles in elucidating physiol. and pathophysiol. properties of mGluRs, their poor selectivity within group presupposes some knowledge of complexity.  In addn., their poor CNS penetration limits their candidacy as promising radiotracers for in vivo imaging of mGluRs.  Over the last decade, a no. of non-competitive mGluR ligands, which are structurally diverse and bind to mGluRs in the allosteric binding sites located in the seven strand transmembrane domain, have been identified.  These include neg., pos. and neutral allosteric modulators.  Modulating mGlu receptor activity through an allosteric binding site is a relatively new strategy with the first example appeared in 1996.  Based on these modulators, a no. of radiotracers useful for imaging specific metabotropic glutamate receptors have been developed and their in vivo biol. properties have been characterized.  We have developed five ligands for PET imaging of metabotropic glutamate subgroup 5 receptors and investigated mGluR functions in animal models of different neurodegenerative disorders.  In this review we evaluate our data in comparison to the theor. and exptl. aspects of developing selective and sensitive imaging ligands for in vivo imaging.  Emphasis will be given to those highly potent and subtype selective allosteric modulators which are good candidates for radiolabeling with fluorine-18 and carbon-11.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroGRnZuSavsLVg90H21EOLACvtfcHk0lg-OYzSltJHJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFKhtL8%253D&md5=013394d5d92261cbb092743387a6f6a4</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F157340507781387059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157340507781387059%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%2BQ.%26aulast%3DBrownell%26aufirst%3DA.-L.%26atitle%3DDevelopment%2520of%2520metabotropic%2520glutamate%2520receptor%2520ligands%2520for%2520neuroimaging%26jtitle%3DCurr.%2520Med.%2520Imaging%2520Rev.%26date%3D2007%26volume%3D3%26spage%3D186%26epage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Yu, M.</span><span> </span><span class="NLM_article-title">Recent developments of the PET imaging agents for metabotropic glutamate receptor subtype 5</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1800</span><span class="NLM_x">–</span> <span class="NLM_lpage">1805</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.2174%2F156802607782507394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=17979788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVOrtb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1800-1805&author=M.+Yu&title=Recent+developments+of+the+PET+imaging+agents+for+metabotropic+glutamate+receptor+subtype+5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments of the PET imaging agents for metabotropic glutamate receptor subtype 5</span></div><div class="casAuthors">Yu, Meixiang</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1800-1805</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Glutamate is a major excitatory neurotransmitter in central nervous system (CNS) acting through ionotropic and G-protein coupled metabotropic glutamate receptors.  Metabotropic glutamate receptor 5 (mGluR5), a subtype in the group I mGluRs, presents in high d. in many brain regions (hippocampus, cortex and olfactory system).  Stimulation of mGluR5 leads to the release of calcium from intracellular supplies and protein kinase C activation.  Excessive activation of mGluR5 has been assocd. with psychiatric, neurol. and neurodegenerative diseases, including Parkinson's disease, anxiety, depression, schizophrenia, pain, epilepsy, focal and global ischemia diseases.  2-Methyl-6-(phenylethynyl)pyridine (MPEP) and 2-methyl-4-(pyridin-3-ylethynyl)thiazole (MTEP) are the first generation of non-competitive mGluR5 antagonists with potent, selective and systemically active properties.  They have therapeutic functions in varied diseases.  Investigation of mGluR5 physiol. functions under pathol. conditions in patients will be critically important in mGluR5 antagonist's therapy using noninvasive positron emission tomog. (PET) imaging technique.  There are eleven mGluR5 imaging PET tracers have been tested in animal studies.  This article highlights efforts on the design and development of novel PET tracers for mGluR5 in vivo imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwdizkEifPW7Vg90H21EOLACvtfcHk0lg-OYzSltJHJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVOrtb3J&md5=da0bd73681b5b7ed9fe41bb4fc4c3560</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2174%2F156802607782507394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607782507394%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DM.%26atitle%3DRecent%2520developments%2520of%2520the%2520PET%2520imaging%2520agents%2520for%2520metabotropic%2520glutamate%2520receptor%2520subtype%25205%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D1800%26epage%3D1805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Seneca, N.</span><span> </span><span class="NLM_article-title">Recent advances in positron emission tomography imaging of the brain</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">613</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1WgtrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=601-613&author=N.+Seneca&title=Recent+advances+in+positron+emission+tomography+imaging+of+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in positron emission tomography imaging of brain</span></div><div class="casAuthors">Seneca, N.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">601-613</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Positron emission tomog. (PET) has been widely used to non-invasively study various functions of the brain, the pathophysiol. of disease and aid in drug development.  PET and selective radiolabeled mols. allow imaging of certain crit. components of the functioning of healthy and diseased brain.  The shortage of available PET radioligands for studying the functioning of the brain is a major limiting factor for expanding their use in research and implementation in a clin. setting.  Thus, the development of novel PET radioligands for further understanding brain functions is a key factor for advancement in the field.  This article provides an overview of recent developments of novel PET radioligands for imaging various functions of healthy and diseased brain, highlighting the recent development of novel PET radioligands for a monoamine transporter, describing the use of pharmacol. challenges combined with PET imaging to measure neurotransmitter release and potential imaging biomarkers of disease pathol.  In summary, the article reviews recent developments in the field of PET imaging of the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqat_lYq2YPrVg90H21EOLACvtfcHk0lg-OYzSltJHJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1WgtrbJ&md5=c6763478d90ebe7e4d67661ca337c0b0</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeneca%26aufirst%3DN.%26atitle%3DRecent%2520advances%2520in%2520positron%2520emission%2520tomography%2520imaging%2520of%2520the%2520brain%26jtitle%3DDrugs%2520Future%26date%3D2011%26volume%3D36%26spage%3D601%26epage%3D613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Fujinaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asagawa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nengaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.-R.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of novel radioligands for positron emission tomography imaging of metabotropic glutamate receptor subtype 1 (mGluR1) in rodent brain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2342</span><span class="NLM_x">–</span> <span class="NLM_lpage">2352</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201590g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2342-2352&author=M.+Fujinagaauthor=T.+Yamasakiauthor=J.+Yuiauthor=A.+Hatoriauthor=L.+Xieauthor=K.+Kawamuraauthor=C.+Asagawaauthor=K.+Kumataauthor=Y.+Yoshidaauthor=M.+Ogawaauthor=N.+Nengakiauthor=T.+Fukumuraauthor=M.-R.+Zhang&title=Synthesis+and+evaluation+of+novel+radioligands+for+positron+emission+tomography+imaging+of+metabotropic+glutamate+receptor+subtype+1+%28mGluR1%29+in+rodent+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm201590g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201590g%26sid%3Dliteratum%253Aachs%26aulast%3DFujinaga%26aufirst%3DM.%26aulast%3DYamasaki%26aufirst%3DT.%26aulast%3DYui%26aufirst%3DJ.%26aulast%3DHatori%26aufirst%3DA.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DKawamura%26aufirst%3DK.%26aulast%3DAsagawa%26aufirst%3DC.%26aulast%3DKumata%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DY.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DNengaki%26aufirst%3DN.%26aulast%3DFukumura%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DM.-R.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520novel%2520radioligands%2520for%2520positron%2520emission%2520tomography%2520imaging%2520of%2520metabotropic%2520glutamate%2520receptor%2520subtype%25201%2520%2528mGluR1%2529%2520in%2520rodent%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2342%26epage%3D2352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Wang, J.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuruppu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brownell, A.-L.</span><span> </span><span class="NLM_article-title">Radiosynthesis of PET radiotracer as a prodrug for imaging group II metabotropic glutamate recepotors in vivo</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1958</span><span class="NLM_x">–</span> <span class="NLM_lpage">1962</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1958-1962&author=J.-Q.+Wangauthor=Z.+Zhangauthor=D.+Kuruppuauthor=A.-L.+Brownell&title=Radiosynthesis+of+PET+radiotracer+as+a+prodrug+for+imaging+group+II+metabotropic+glutamate+recepotors+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.-Q.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DKuruppu%26aufirst%3DD.%26aulast%3DBrownell%26aufirst%3DA.-L.%26atitle%3DRadiosynthesis%2520of%2520PET%2520radiotracer%2520as%2520a%2520prodrug%2520for%2520imaging%2520group%2520II%2520metabotropic%2520glutamate%2520recepotors%2520in%2520vivo%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1958%26epage%3D1962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nhem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furnari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluzeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lucas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himogai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlirch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahnaou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drinkenburg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">Discovery of 1,4-disubstituted 3-cyano-2-pyridones: a new class of positive allosteric modulators of the metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2388</span><span class="NLM_x">–</span> <span class="NLM_lpage">2405</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2016864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2388-2405&author=J.+M.+Cidauthor=G.+Duveyauthor=G.+Tresadernauthor=V.+Nhemauthor=R.+Furnariauthor=P.+Cluzeauauthor=J.+A.+Vegaauthor=A.+I.+De+Lucasauthor=E.+Matesanzauthor=J.+M.+Alonsoauthor=M.+L.+Linaresauthor=J.+I.+Andresauthor=S.+M.+Poliauthor=R.+Lutjensauthor=H.+Himogaiauthor=J.-P.+Rocherauthor=G.+J.+Macdonaldauthor=D.+Oehlirchauthor=H.+Lavreysenauthor=A.+Ahnaouauthor=W.+Drinkenburgauthor=C.+Mackieauthor=A.+A.+Trabanco&title=Discovery+of+1%2C4-disubstituted+3-cyano-2-pyridones%3A+a+new+class+of+positive+allosteric+modulators+of+the+metabotropic+glutamate+2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm2016864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2016864%26sid%3Dliteratum%253Aachs%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DDuvey%26aufirst%3DG.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DNhem%26aufirst%3DV.%26aulast%3DFurnari%26aufirst%3DR.%26aulast%3DCluzeau%26aufirst%3DP.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3DDe%2BLucas%26aufirst%3DA.%2BI.%26aulast%3DMatesanz%26aufirst%3DE.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DLinares%26aufirst%3DM.%2BL.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DPoli%26aufirst%3DS.%2BM.%26aulast%3DLutjens%26aufirst%3DR.%26aulast%3DHimogai%26aufirst%3DH.%26aulast%3DRocher%26aufirst%3DJ.-P.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DOehlirch%26aufirst%3DD.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DAhnaou%26aufirst%3DA.%26aulast%3DDrinkenburg%26aufirst%3DW.%26aulast%3DMackie%26aufirst%3DC.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3DDiscovery%2520of%25201%252C4-disubstituted%25203-cyano-2-pyridones%253A%2520a%2520new%2520class%2520of%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2388%26epage%3D2405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Van der Linden, I.; Peeters, L.; Biesmans, I.; Andrés, J. I.; Vliegen, M.; Te Riele, P.; Langlois, X.; Atack, J. R.; Lavreysen, H.</span><span> </span><span class="NLM_article-title">In vitro Characterization of the Binding of the mGlu2 Receptor Positive Allosteric Modulator [<sup>3</sup>H]JNJ-40068782 to Native and Recombinant mGlu2 Receptors</span>. 7th Int. Meeting on Metabotropic Glutamate Receptors<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">, </span>Taormina, Italy.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=I.+Van+der+Linden&author=L.+Peeters&author=I.+Biesmans&author=J.+I.+Andr%C3%A9s&author=M.+Vliegen&author=P.+Te+Riele&author=X.+Langlois&author=J.+R.+Atack&author=H.+Lavreysen&title=In+vitro+Characterization+of+the+Binding+of+the+mGlu2+Receptor+Positive+Allosteric+Modulator+%5B3H%5DJNJ-40068782+to+Native+and+Recombinant+mGlu2+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BLinden%26aufirst%3DI.%26atitle%3DIn%2520vitro%2520Characterization%2520of%2520the%2520Binding%2520of%2520the%2520mGlu2%2520Receptor%2520Positive%2520Allosteric%2520Modulator%2520%255B3H%255DJNJ-40068782%2520to%2520Native%2520and%2520Recombinant%2520mGlu2%2520Receptors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cid-Nuñez, J. M.; Oehlrich, D.; Trabanco-Suárez, A. A.; Tresadern, G. J.; Vega-Ramiro, J. A.; Macdonald, G. J.</span><span> </span><span class="NLM_article-title">1,2,4-Triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders</span>. PCT Int. Appl.WO2010130424, November 18,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+M.+Cid-Nu%C3%B1ez&author=D.+Oehlrich&author=A.+A.+Trabanco-Su%C3%A1rez&author=G.+J.+Tresadern&author=J.+A.+Vega-Ramiro&author=G.+J.+Macdonald&title=1%2C2%2C4-Triazolo%5B4%2C3-a%5Dpyridine+derivatives+and+their+use+for+the+treatment+or+prevention+of+neurological+and+psychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCid-Nu%25C3%25B1ez%26aufirst%3DJ.%2BM.%26atitle%3D1%252C2%252C4-Triazolo%255B4%252C3-a%255Dpyridine%2520derivatives%2520and%2520their%2520use%2520for%2520the%2520treatment%2520or%2520prevention%2520of%2520neurological%2520and%2520psychiatric%2520disorders%26jtitle%3DPCT%2520Int.%2520Appl.%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cid-Nunez, J. M.; De Lucas Olivares, A. I.; Trabanco-Suarez, A. A.; Macdonald, G. J.</span><span> </span><span class="NLM_article-title">7-Aryl-1,2,4-triazolo[4,3-a]pyridine derivatives as positive allosteric modulators of mGluR2 receptors and their preparation, pharmaceutical compositions and use in the treatment of CNS disorders</span>. PCT Int. Appl.WO2010130423, November 18,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+M.+Cid-Nunez&author=A.+I.+De+Lucas+Olivares&author=A.+A.+Trabanco-Suarez&author=G.+J.+Macdonald&title=7-Aryl-1%2C2%2C4-triazolo%5B4%2C3-a%5Dpyridine+derivatives+as+positive+allosteric+modulators+of+mGluR2+receptors+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+CNS+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCid-Nunez%26aufirst%3DJ.%2BM.%26atitle%3D7-Aryl-1%252C2%252C4-triazolo%255B4%252C3-a%255Dpyridine%2520derivatives%2520as%2520positive%2520allosteric%2520modulators%2520of%2520mGluR2%2520receptors%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520CNS%2520disorders%26jtitle%3DPCT%2520Int.%2520Appl.%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cid-Nunez, J. M.; De Lucas Olivares, A. I.; Trabanco-Suarez, A. A.; Macdonald, G. J.</span><span> </span><span class="NLM_article-title">1,2,4-Triazolo[4,3-a]pyridine derivatives as mGluR2 modulators and their preparation and use for the treatment of CNS diseases</span>. PCT Int. Appl.WO2010130422, November 18,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+M.+Cid-Nunez&author=A.+I.+De+Lucas+Olivares&author=A.+A.+Trabanco-Suarez&author=G.+J.+Macdonald&title=1%2C2%2C4-Triazolo%5B4%2C3-a%5Dpyridine+derivatives+as+mGluR2+modulators+and+their+preparation+and+use+for+the+treatment+of+CNS+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCid-Nunez%26aufirst%3DJ.%2BM.%26atitle%3D1%252C2%252C4-Triazolo%255B4%252C3-a%255Dpyridine%2520derivatives%2520as%2520mGluR2%2520modulators%2520and%2520their%2520preparation%2520and%2520use%2520for%2520the%2520treatment%2520of%2520CNS%2520diseases%26jtitle%3DPCT%2520Int.%2520Appl.%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="note"><p class="first last">Manuscripts describing further results of the Medicinal Chemistry exploration around the 1,4-disubstituted-2-pyridones and the 1,2,4-Triazolo[4,3-a]pyridines are in progress and will be reported elsewhere.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topiol, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poda, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasena, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doller, D.</span><span> </span><span class="NLM_article-title">Design and synthesis of 4-arylpiperidinyl amide and <i>N</i>-arylpiperidin-3-yl-cyclopropane carboxamide derivatives as novel melatonin receptor ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1236</span><span class="NLM_x">–</span> <span class="NLM_lpage">1242</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1236-1242&author=G.+Liauthor=H.+Zhouauthor=Y.+Jiangauthor=H.+Keimauthor=S.+W.+Topiolauthor=S.+B.+Podaauthor=Y.+Renauthor=G.+Chandrasenaauthor=D.+Doller&title=Design+and+synthesis+of+4-arylpiperidinyl+amide+and+N-arylpiperidin-3-yl-cyclopropane+carboxamide+derivatives+as+novel+melatonin+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DKeim%26aufirst%3DH.%26aulast%3DTopiol%26aufirst%3DS.%2BW.%26aulast%3DPoda%26aufirst%3DS.%2BB.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DChandrasena%26aufirst%3DG.%26aulast%3DDoller%26aufirst%3DD.%26atitle%3DDesign%2520and%2520synthesis%2520of%25204-arylpiperidinyl%2520amide%2520and%2520N-arylpiperidin-3-yl-cyclopropane%2520carboxamide%2520derivatives%2520as%2520novel%2520melatonin%2520receptor%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D1236%26epage%3D1242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Alcázar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diels, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoentjes, B.</span><span> </span><span class="NLM_article-title">Reproducibility across microwave instruments: First example of genuine parallel scale up of compounds under microwave irradiation</span> <span class="citation_source-journal">QSAR Comb. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">906</span><span class="NLM_x">–</span> <span class="NLM_lpage">910</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=906-910&author=J.+Alc%C3%A1zarauthor=G.+Dielsauthor=B.+Schoentjes&title=Reproducibility+across+microwave+instruments%3A+First+example+of+genuine+parallel+scale+up+of+compounds+under+microwave+irradiation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlc%25C3%25A1zar%26aufirst%3DJ.%26aulast%3DDiels%26aufirst%3DG.%26aulast%3DSchoentjes%26aufirst%3DB.%26atitle%3DReproducibility%2520across%2520microwave%2520instruments%253A%2520First%2520example%2520of%2520genuine%2520parallel%2520scale%2520up%2520of%2520compounds%2520under%2520microwave%2520irradiation%26jtitle%3DQSAR%2520Comb.%2520Sci.%26date%3D2004%26volume%3D23%26spage%3D906%26epage%3D910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="note"><p class="first last">See ref <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">25</a>. CA registry no. 1152617-14-5.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="note"><p class="first last">See ref <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">25</a>. CA registry no. 1254981-17-3.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="note"><p class="first last">See ref <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">25</a>. CA registry no. 1254981-30-0.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Pike, V. W.</span><span> </span><span class="NLM_article-title">PET Radiotracers: Crossing the Blood-Brain Barrier and Surviving Metabolism</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1016%2Fj.tips.2009.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=19616318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1KgsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=431-440&author=V.+W.+Pike&title=PET+Radiotracers%3A+Crossing+the+Blood-Brain+Barrier+and+Surviving+Metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">PET radiotracers: crossing the blood-brain barrier and surviving metabolism</span></div><div class="casAuthors">Pike, Victor W.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">431-440</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Radiotracers for imaging protein targets in the living human brain with positron emission tomog. (PET) are increasingly useful in clin. research and in drug development.  Such radiotracers must fulfill many criteria, among which an ability to enter brain adequately and reversibly without contamination by troublesome radiometabolites is desirable for accurate measurement of the d. of a target protein (e.g. neuroreceptor, transporter, enzyme or plaque).  Candidate radiotracers can fail as a result of poor passive brain entry, rejection from brain by efflux transporters or undesirable metab.  These issues are reviewed.  Emerging PET radiotracers for measuring efflux transporter function and new strategies for ameliorating radiotracer metab. are discussed.  A growing understanding of the mol. features affecting the brain penetration, metab. and efflux transporter sensitivity of prospective radiotracers should ultimately lead to their more rational and efficient design, and also to their greater efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6ftMCpkOSmrVg90H21EOLACvtfcHk0lgE_93UtHWsaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1KgsLg%253D&md5=97704995fecd968baf1e0892bf70324e</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2009.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2009.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DV.%2BW.%26atitle%3DPET%2520Radiotracers%253A%2520Crossing%2520the%2520Blood-Brain%2520Barrier%2520and%2520Surviving%2520Metabolism%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26spage%3D431%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Laruelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slifstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span> </span><span class="NLM_article-title">Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1016%2Fj.mibio.2003.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=14667491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A280%3ADC%252BD3sroslehtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=363-375&author=M.+Laruelleauthor=M.+Slifsteinauthor=Y.+Huang&title=Relationships+between+radiotracer+properties+and+image+quality+in+molecular+imaging+of+the+brain+with+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography</span></div><div class="casAuthors">Laruelle Marc; Slifstein Mark; Huang Yiyun</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">363-75</span>
        ISSN:<span class="NLM_cas:issn">1536-1632</span>.
    </div><div class="casAbstract">In molecular imaging of the brain, many factors affect the reliability of the quantitative information that can be derived from the imaging process.  This article discusses factors impacting on the imaging quality that are related to the radiotracer per se.  Following a brief summary of key concepts in receptor quantification, a number of these factors are discussed, including selectivity, affinity, delivery, and lipophilicity.  Concepts discussed in the theoretical section are then illustrated, by reviewing a recent comparative evaluation of four agents developed to label the serotonin transporter ([(11)C]ADAM, [(11)C]DASB, [(11)C]DAPA, and [(11)C]AFM).  Specifically, the relationship between affinity and lipophilicity, measured in vitro, and several scanning parameters are investigated.  These include peripherical metabolism, brain uptake, required scanning time, nonspecific binding, and binding potential.  It is shown that, within a given structural family, affinity and lipophilicity are associated with scan outcome in a relatively predictable manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAWgqdOQ2p8o2y4bB4mnvYfW6udTcc2eY4eycIdb3EmLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3sroslehtg%253D%253D&md5=b38c23d5032e968cc119f5b4197670d1</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.mibio.2003.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mibio.2003.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DLaruelle%26aufirst%3DM.%26aulast%3DSlifstein%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DRelationships%2520between%2520radiotracer%2520properties%2520and%2520image%2520quality%2520in%2520molecular%2520imaging%2520of%2520the%2520brain%2520with%2520positron%2520emission%2520tomography%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2003%26volume%3D5%26spage%3D363%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Waterhouse, R. N.</span><span> </span><span class="NLM_article-title">Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">376</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1016%2Fj.mibio.2003.09.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=14667492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A280%3ADC%252BD3sroslehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=376-389&author=R.+N.+Waterhouse&title=Determination+of+lipophilicity+and+its+use+as+a+predictor+of+blood-brain+barrier+penetration+of+molecular+imaging+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents</span></div><div class="casAuthors">Waterhouse Rikki N</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">376-89</span>
        ISSN:<span class="NLM_cas:issn">1536-1632</span>.
    </div><div class="casAbstract">Compound lipophilicity is a fundamental physicochemical property that plays a pivotal role in the absorption, distribution, metabolism, and elimination (ADME) of therapeutic drugs.  Lipophilicity is expressed in several different ways, including terms such as Log P, clogP, delta Log P, and Log D.  Often a parabolic relationship exists between measured lipophilicity and in vivo brain penetration of drugs, where those moderate in lipophilicity often exhibit highest uptake.  Reduced brain extraction of more lipophilic compounds is associated with increased non-specific binding to plasma proteins.  More lipophilic compounds can also be more vulnerable to P450 metabolism, leading to faster clearance.  Very polar compounds normally exhibit high water solubility, fast clearance through the kidneys, and often contain ionizable functional groups that limit blood-brain barrier (BBB) penetration.  The brain penetration and specific to non-specific binding ratios exhibited in vivo by positron emission tomography (PET) and single photon emission computed tomography (SPECT) radiotracers involves a complex interplay between many critical factors, including lipophilicity, receptor affinity, metabolism, molecular size and shape, ionization potential, and specific binding to BBB efflux pumps or binding sites on albumin or other plasma proteins.  This paper explores situations in which lipophilicity is a good predictor of BBB penetration, as well as those where this correlation is poor.  The more commonly used methods for measuring lipophilicity are presented, and the various terms often found in the literature outlined.  An attempt is made to describe how this information can be used in optimizing the development of PET and SPECT tracers that target the central nervous system (CNS).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAWgqdOQ2p8j0SWnHPWbmmfW6udTcc2ebnXjetuq6HB7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3sroslehtw%253D%253D&md5=cfff94825034cffcce30e56d703745cf</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.mibio.2003.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mibio.2003.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DWaterhouse%26aufirst%3DR.%2BN.%26atitle%3DDetermination%2520of%2520lipophilicity%2520and%2520its%2520use%2520as%2520a%2520predictor%2520of%2520blood-brain%2520barrier%2520penetration%2520of%2520molecular%2520imaging%2520agents%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2003%26volume%3D5%26spage%3D376%26epage%3D389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Celen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koole, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sannen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chitneni, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcazar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dedeurwaerdere, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbruggen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Laere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span> </span><span class="NLM_article-title">Preclinical Evaluation of <sup>18</sup>F-JNJ41510417 as a Radioligand for PET Imaging of Phosphodiesterase-10A in the Brain</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1584</span><span class="NLM_x">–</span> <span class="NLM_lpage">1591</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=1584-1591&author=S.+Celenauthor=M.+Kooleauthor=M.+De+Angelisauthor=I.+Sannenauthor=S.+K.+Chitneniauthor=J.+Alcazarauthor=S.+Dedeurwaerdereauthor=D.+Moecharsauthor=M.+Schmidtauthor=A.+Verbruggenauthor=X.+Langloisauthor=K.+Van+Laereauthor=J.+I.+Andr%C3%A9sauthor=G.+Bormans&title=Preclinical+Evaluation+of+18F-JNJ41510417+as+a+Radioligand+for+PET+Imaging+of+Phosphodiesterase-10A+in+the+Brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DKoole%26aufirst%3DM.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DSannen%26aufirst%3DI.%26aulast%3DChitneni%26aufirst%3DS.%2BK.%26aulast%3DAlcazar%26aufirst%3DJ.%26aulast%3DDedeurwaerdere%26aufirst%3DS.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DVerbruggen%26aufirst%3DA.%26aulast%3DLanglois%26aufirst%3DX.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.%2BI.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DPreclinical%2520Evaluation%2520of%252018F-JNJ41510417%2520as%2520a%2520Radioligand%2520for%2520PET%2520Imaging%2520of%2520Phosphodiesterase-10A%2520in%2520the%2520Brain%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2010%26volume%3D51%26spage%3D1584%26epage%3D1591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Andrés, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcazar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iturrino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dedeurwaerdere, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenaerts, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanhoof, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span> </span><span class="NLM_article-title">Synthesis, <i>In Vivo</i> Occupancy and Radiolabeling of Potent Phosphodiesterase Subtype-10 Inhibitors as candidates for Positron Emission Tomography Imaging</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5820</span><span class="NLM_x">–</span> <span class="NLM_lpage">5835</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200536d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5820-5835&author=J.+I.+Andr%C3%A9sauthor=M.+De+Angelisauthor=J.+Alcazarauthor=L.+Iturrinoauthor=X.+Langloisauthor=S.+Dedeurwaerdereauthor=I.+Lenaertsauthor=G.+Vanhoofauthor=S.+Celenauthor=G.+Bormans&title=Synthesis%2C+In+Vivo+Occupancy+and+Radiolabeling+of+Potent+Phosphodiesterase+Subtype-10+Inhibitors+as+candidates+for+Positron+Emission+Tomography+Imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm200536d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200536d%26sid%3Dliteratum%253Aachs%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.%2BI.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DAlcazar%26aufirst%3DJ.%26aulast%3DIturrino%26aufirst%3DL.%26aulast%3DLanglois%26aufirst%3DX.%26aulast%3DDedeurwaerdere%26aufirst%3DS.%26aulast%3DLenaerts%26aufirst%3DI.%26aulast%3DVanhoof%26aufirst%3DG.%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DSynthesis%252C%2520In%2520Vivo%2520Occupancy%2520and%2520Radiolabeling%2520of%2520Potent%2520Phosphodiesterase%2520Subtype-10%2520Inhibitors%2520as%2520candidates%2520for%2520Positron%2520Emission%2520Tomography%2520Imaging%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5820%26epage%3D5835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="note"><p class="first last">Method for identification of main metabolites: the test compounds were incubated with human and rat liver microsomes, at 0.4% final solvent concentration (0.16% DMSO and 0.24% MeCN). The study was conducted to identify the main metabolites formed after 0 min (control) and 60 min incubation time in the presence of the NADPH generating system at 37 °C. The test concentration of the compound was 5 μM. Samples were compared to the control incubations, in which compound was added at termination. Data were acquired on a Waters UPLC/QToF Premier mass spectrometer using a 10 min generic UPLC method and a generic MSe method. Complementary MS/MS experiments were performed when necessary. An Acquity UPLC C18 (2.1 mm × 100 mm, 1.8 μm) column was used. Interpretation of data was performed with Waters Metabolynx software.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="note"><p class="first last">The CEREP selectivity screen was performed on the following targets: 5HT<sub>1A</sub>, 5HT<sub>2A</sub>, 5HT<sub>3</sub>, 5HT<sub>5A</sub>, 5HT<sub>6</sub>, 5HT<sub>7</sub>, A<sub>1</sub>, A<sub>2A</sub>, A<sub>3</sub>, AT<sub>1</sub>, Beta<sub>1</sub>, BK<sub>2</sub>, CCKA, CCR<sub>1</sub>, D<sub>1</sub>, D<sub>2</sub>, DAT, ETA, GAL<sub>2</sub>, H<sub>1</sub>, H<sub>2</sub>, IL<sub>8B</sub>, CXCR<sub>2</sub>, M<sub>1</sub>, M<sub>2</sub>, M<sub>3</sub>, MC<sub>4</sub>, ML<sub>1</sub>, NET, NK<sub>2</sub>, NK<sub>3</sub>, NPY<sub>1</sub>, NPY<sub>2</sub>, NT<sub>1</sub>, OP<sub>1</sub>, OP<sub>3</sub>, ORL<sub>1</sub>, V<sub>1</sub>A, VIP, SST, 5HT<sub>1B</sub>, α<sub>1</sub>, α<sub>2</sub>, BZD, CaCH, CICH, GABA, KCH, NaCH, SKCaCH.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ohishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, N.</span><span> </span><span class="NLM_article-title">Distribution of a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat and mouse: an immunohistochemical study with a monoclonal antibody</span> <span class="citation_source-journal">Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1016%2FS0168-0102%2897%2900120-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=9572581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADyaK1cXhtVWrs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1998&pages=65-82&author=H.+Ohishiauthor=A.+Nekiauthor=N.+Mizuno&title=Distribution+of+a+metabotropic+glutamate+receptor%2C+mGluR2%2C+in+the+central+nervous+system+of+the+rat+and+mouse%3A+an+immunohistochemical+study+with+a+monoclonal+antibody"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39aR"><div class="casContent"><span class="casTitleNuber">39a</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution of a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat and mouse: an immunohistochemical study with a monoclonal antibody</span></div><div class="casAuthors">Ohishi, Hitoshi; Neki, Akio; Mizuno, Noboru</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Research (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-82</span>CODEN:
                <span class="NLM_cas:coden">NERADN</span>;
        ISSN:<span class="NLM_cas:issn">0168-0102</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">The distribution of a metabotropic glutamate receptor mGluR2 in the central nervous system was immunohistochem. examd. in the rat and mouse with a monoclonal antibody raised against an N-terminal sequence of rat mGluR2 (amino acid residues 87-134).  Neuronal cell bodies with mGluR2-like immunoreactivity (mGluR2-LI) were clearly shown in the horizontal cells of Cajal in the cerebral cortex, neurons in the triangular septal nucleus and medial mammillary nucleus, Golgi cells and the unipolar brush cells in the cerebellar cortex, and Golgi-like and unipolar brush-like cells in the cochlear nucleus.  Neuropil was intensely immunostained in the accessory olfactory bulb, bed nucleus of the accessory olfactory tract, neocortex, cingulate cortex, retrosplenial cortex, subicular and entorhinal cortices, stratum lacunosum-moleculare of CA1 and CA3, mol. layer of the dentate gyrus, periamygdaloid cortex, basolateral amygdaloid nucleus, bed nucleus of the anterior commissure, caudate-putamen, accumbens nucleus, thalamic reticular nucleus, anteroventral and paraventricular thalamic nuclei, granular layer of the cerebellar cortex, anterior and ventral tegmental nuclei, granular layer of the cochlear nucleus, and parvicellular part of the lateral reticular nucleus.  Many axons in the white matter and fiber bundles were also immunostained.  No glial cells with mGluR2-LI were found.  No particular species differences were found in the distribution pattern of mGluR2-LI between the rat and mouse.  The results indicate that mGluR2 is expressed not only in somato-dendritic domain, but also in axonal domain of excitatory and inhibitory neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoltow_VoMzdLVg90H21EOLACvtfcHk0liX5j9RwtejwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtVWrs7k%253D&md5=64d4794a23898739f08ef586d9106c69</span></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=10.1016%2FS0168-0102%2897%2900120-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0168-0102%252897%252900120-X%26sid%3Dliteratum%253Aachs%26aulast%3DOhishi%26aufirst%3DH.%26aulast%3DNeki%26aufirst%3DA.%26aulast%3DMizuno%26aufirst%3DN.%26atitle%3DDistribution%2520of%2520a%2520metabotropic%2520glutamate%2520receptor%252C%2520mGluR2%252C%2520in%2520the%2520central%2520nervous%2520system%2520of%2520the%2520rat%2520and%2520mouse%253A%2520an%2520immunohistochemical%2520study%2520with%2520a%2520monoclonal%2520antibody%26jtitle%3DNeurosci.%2520Res.%26date%3D1998%26volume%3D30%26spage%3D65%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit39b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Richards, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malherbe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brockhaus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutel, V.</span><span> </span><span class="NLM_article-title">Distribution and abundance of metabotropic glutamate receptor subtype 2 in rat brain revealed by [<sup>3</sup>H]LY354740 binding in vitro and quantitative radioautography: correlation with the sites of synthesis, expression, and agonist stimulation of [<sup>35</sup>S]GTPgammaS binding</span> <span class="citation_source-journal">J. Comp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">487</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1002%2Fcne.20538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=15861463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvVGhs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=487&publication_year=2005&pages=15-27&author=G.+Richardsauthor=J.+Messerauthor=P.+Malherbeauthor=R.+Pinkauthor=M.+Brockhausauthor=H.+Stadlerauthor=J.+Wichmannauthor=H.+Schaffhauserauthor=V.+Mutel&title=Distribution+and+abundance+of+metabotropic+glutamate+receptor+subtype+2+in+rat+brain+revealed+by+%5B3H%5DLY354740+binding+in+vitro+and+quantitative+radioautography%3A+correlation+with+the+sites+of+synthesis%2C+expression%2C+and+agonist+stimulation+of+%5B35S%5DGTPgammaS+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39bR"><div class="casContent"><span class="casTitleNuber">39b</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution and abundance of metabotropic glutamate receptor subtype 2 in rat brain revealed by [3H]LY354740 binding in vitro and quantitative radioautography: Correlation with the sites of synthesis, expression, and agonist stimulation of [35S]GTPγS binding</span></div><div class="casAuthors">Richards, Grayson; Messer, Juerg; Malherbe, Pari; Pink, Richard; Brockhaus, Manfred; Stadler, Heinz; Wichmann, Juergen; Schaffhauser, Herve; Mutel, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Comparative Neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">487</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-27</span>CODEN:
                <span class="NLM_cas:coden">JCNEAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9967</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Until recently, there was a lack of selective radioligands for the subtypes of metabotropic glutamate (mGlu) receptors.  [3H]LY 354740 ((+)-2-aminobicyclo[3,1,0]hexane-2,6-dicarboxylic acid), a selective agonist for group II receptors (mGlu2 and -3, which are neg. coupled to cAMP prodn.), has now been used to map their brain distribution and abundance by in vitro binding and quant. radioautog.  The selective cation dependence of its binding allowed the discrimination between mGlu2 and mGlu3 receptor labeling.  Thus, in the presence of Ca2+ and Mg2+ ions, the agonist bound selectively to mGlu2 receptors as evidenced by: (1) the correlative distribution and abundance of binding sites (highest in the lacunosum moleculare of the hippocampus and lowest in white matter) with mGlu2 receptor mRNA and protein revealed by in situ hybridization histochem. and immunohistochem., resp.; (2) its selective pharmacol.; and (3) the distribution of LY 354740-stimulated [35S]GTPγS binding (25-97% above basal, according to the brain region), revealing G protein-coupled receptor coupling to Gi proteins.  Nonspecific binding (in the presence of 10 μM DCG-IV, a group II-selective, mGlu2-preferring, receptor agonist) was <10% of total.  In adjacent sections, the distribution of binding sites for [3H]DCG-IV was very similar.  This extensive study paves the way for investigations of the regional expression and regulation of mGlu2 receptors in human CNS diseases, such as Alzheimer's disease, which may reveal their functional roles and identify potential therapeutic drug targets.  Indeed, it has recently been demonstrated (Higgins et al. [2004]) that pharmacol. manipulation of mGlu2 receptors influences cognitive performance in the rodent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV2ub35EbJUbVg90H21EOLACvtfcHk0lgiGbDcvwDSPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvVGhs7k%253D&md5=711b9b109da0ea76161bbe8a629b1336</span></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=10.1002%2Fcne.20538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcne.20538%26sid%3Dliteratum%253Aachs%26aulast%3DRichards%26aufirst%3DG.%26aulast%3DMesser%26aufirst%3DJ.%26aulast%3DMalherbe%26aufirst%3DP.%26aulast%3DPink%26aufirst%3DR.%26aulast%3DBrockhaus%26aufirst%3DM.%26aulast%3DStadler%26aufirst%3DH.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DSchaffhauser%26aufirst%3DH.%26aulast%3DMutel%26aufirst%3DV.%26atitle%3DDistribution%2520and%2520abundance%2520of%2520metabotropic%2520glutamate%2520receptor%2520subtype%25202%2520in%2520rat%2520brain%2520revealed%2520by%2520%255B3H%255DLY354740%2520binding%2520in%2520vitro%2520and%2520quantitative%2520radioautography%253A%2520correlation%2520with%2520the%2520sites%2520of%2520synthesis%252C%2520expression%252C%2520and%2520agonist%2520stimulation%2520of%2520%255B35S%255DGTPgammaS%2520binding%26jtitle%3DJ.%2520Comp.%2520Neurol.%26date%3D2005%26volume%3D487%26spage%3D15%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Cid, J. M.; Tresadern, G.; Vega, J. A.; De Lucas, A. I.; Matesanz, E.; Iturrino, L.; Linares, M. L.; Garcia, A.; Andrés, J. I.; Macdonald, G. J.; Oehlrich, D.; Lavreysen, H.; Megens, A.; Ahnaou, A.; Drinkenburg, W.; Mackie, C.; Pype, S.; Gallacher, D.; Trabanco, A. A.</span><span> </span><span class="NLM_article-title">Discovery of 3-Cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-a]pyridine (JNJ-42153605): A Positive Allosteric Modulator of the Metabotropic Glutamate 2 Receptor.</span> <span class="citation_source-journal">J. Med. Chem. </span>[Online early access]. DOI: http://dx.doi.org/10.1021/jm3010724</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Cid%2C+J.+M.%3B+Tresadern%2C+G.%3B+Vega%2C+J.+A.%3B+De+Lucas%2C+A.+I.%3B+Matesanz%2C+E.%3B+Iturrino%2C+L.%3B+Linares%2C+M.+L.%3B+Garcia%2C+A.%3B+Andr%C3%A9s%2C+J.+I.%3B+Macdonald%2C+G.+J.%3B+Oehlrich%2C+D.%3B+Lavreysen%2C+H.%3B+Megens%2C+A.%3B+Ahnaou%2C+A.%3B+Drinkenburg%2C+W.%3B+Mackie%2C+C.%3B+Pype%2C+S.%3B+Gallacher%2C+D.%3B+Trabanco%2C+A.+A.+Discovery+of+3-Cyclopropylmethyl-7-%284-phenylpiperidin-1-yl%29-8-trifluoromethyl%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyridine+%28JNJ-42153605%29%3A+A+Positive+Allosteric+Modulator+of+the+Metabotropic+Glutamate+2+Receptor.J.+Med.+Chem.+%5BOnline+early+access%5D.+DOI%3A+http%3A%2F%2Fdx.doi.org%2F10.1021%2Fjm3010724"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCid%26aufirst%3DJ.%2BM.%26atitle%3DDiscovery%2520of%25203-Cyclopropylmethyl-7-%25284-phenylpiperidin-1-yl%2529-8-trifluoromethyl%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyridine%2520%2528JNJ-42153605%2529%253A%2520A%2520Positive%2520Allosteric%2520Modulator%2520of%2520the%2520Metabotropic%2520Glutamate%25202%2520Receptor.%26jtitle%3DJ.%2520Med.%2520Chem.%2520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25a','cit25b','cit25c'],'ref26':[],'ref27':['cit27'],'ref28':['cit28'],'ref29':[],'ref30':[],'ref31':[],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':[],'ref38':[],'ref39':['cit39a','cit39b'],'ref40':['cit40']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 39 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Gengyang Yuan, Xiying Qu, Baohui Zheng, Ramesh Neelamegam, Sepideh Afshar, Suhasini Iyengar, Chuzhi Pan, Junfeng Wang, Hye Jin Kang, Mary Jo Ondrechen, Pekka Poutiainen, Georges El Fakhri, Zhaoda Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Anna-Liisa Brownell</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Characterization of Benzimidazole Derivatives as Positron Emission Tomography Imaging Ligands for Metabotropic Glutamate Receptor 2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 12060-12072. <a href="https://doi.org/10.1021/acs.jmedchem.0c01394" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01394</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01394%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BCharacterization%252Bof%252BBenzimidazole%252BDerivatives%252Bas%252BPositron%252BEmission%252BTomography%252BImaging%252BLigands%252Bfor%252BMetabotropic%252BGlutamate%252BReceptor%252B2%26aulast%3DYuan%26aufirst%3DGengyang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D08082020%26date%3D07102020%26date%3D28092020%26volume%3D63%26issue%3D20%26spage%3D12060%26epage%3D12072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tomoteru Yamasaki, Xiaofei Zhang, Katsushi Kumata, Yiding Zhang, Xiaoyun Deng, Masayuki Fujinaga, Zhen Chen, Wakana Mori, Kuan Hu, Hidekatsu Wakizaka, Akiko Hatori, Lin Xie, Masanao Ogawa, Nobuki Nengaki, Richard Van, Yihan Shao, Douglas J. Sheffler, Nicholas D. P. Cosford, Steven H. Liang, <span class="NLM_string-name hlFld-ContribAuthor">Ming-Rong Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Development of a New Positron Emission Tomography Ligand 4-(2-Fluoro-4-[11C]methoxyphenyl)-5-((1-methyl-1H-pyrazol-3-yl)methoxy)picolinamide for Imaging Metabotropic Glutamate Receptor Subtype 2 (mGlu2). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 11469-11483. <a href="https://doi.org/10.1021/acs.jmedchem.9b01991" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01991</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01991%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Band%252BDevelopment%252Bof%252Ba%252BNew%252BPositron%252BEmission%252BTomography%252BLigand%252B4-%2525282-Fluoro-4-%25255B11C%25255Dmethoxyphenyl%252529-5-%252528%2525281-methyl-1H-pyrazol-3-yl%252529methoxy%252529picolinamide%252Bfor%252BImaging%252BMetabotropic%252BGlutamate%252BReceptor%252BSubtype%252B2%252B%252528mGlu2%252529%26aulast%3DYamasaki%26aufirst%3DTomoteru%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D29112019%26date%3D22092020%26volume%3D63%26issue%3D20%26spage%3D11469%26epage%3D11483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christian B. M. Poulie, Na Liu, Anders A. Jensen, <span class="NLM_string-name hlFld-ContribAuthor">Lennart Bunch</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Pharmacological Characterization of Heterobivalent Ligands for the Putative 5-HT2A/mGlu2 Receptor Complex. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 9928-9949. <a href="https://doi.org/10.1021/acs.jmedchem.0c01058" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01058%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BPharmacological%252BCharacterization%252Bof%252BHeterobivalent%252BLigands%252Bfor%252Bthe%252BPutative%252B5-HT2A%25252FmGlu2%252BReceptor%252BComplex%26aulast%3DPoulie%26aufirst%3DChristian%2BB.%2BM.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D19062020%26date%3D20082020%26volume%3D63%26issue%3D17%26spage%3D9928%26epage%3D9949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaofei  Zhang</span>, <span class="hlFld-ContribAuthor ">Katsushi  Kumata</span>, <span class="hlFld-ContribAuthor ">Tomoteru  Yamasaki</span>, <span class="hlFld-ContribAuthor ">Ran  Cheng</span>, <span class="hlFld-ContribAuthor ">Akiko  Hatori</span>, <span class="hlFld-ContribAuthor ">Longle  Ma</span>, <span class="hlFld-ContribAuthor ">Yiding  Zhang</span>, <span class="hlFld-ContribAuthor ">Lin  Xie</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Hye Jin  Kang</span>, <span class="hlFld-ContribAuthor ">Douglas J.  Sheffler</span>, <span class="hlFld-ContribAuthor ">Nicholas D. P.  Cosford</span>, <span class="hlFld-ContribAuthor ">Ming-Rong  Zhang</span>, and <span class="hlFld-ContribAuthor ">Steven H.  Liang</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Preliminary Studies of a Novel Negative Allosteric Modulator, 7-((2,5-Dioxopyrrolidin-1-yl)methyl)-4-(2-fluoro-4-[11C]methoxyphenyl) quinoline-2-carboxamide, for Imaging of Metabotropic Glutamate Receptor 2. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (9)
                                     , 1937-1948. <a href="https://doi.org/10.1021/acschemneuro.7b00098" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00098%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DSynthesis%252Band%252BPreliminary%252BStudies%252Bof%252Ba%252BNovel%252BNegative%252BAllosteric%252BModulator%25252C%252B7-%252528%2525282%25252C5-Dioxopyrrolidin-1-yl%252529methyl%252529-4-%2525282-fluoro-4-%25255B11C%25255Dmethoxyphenyl%252529%252Bquinoline-2-carboxamide%25252C%252Bfor%252BImaging%252Bof%252BMetabotropic%252BGlutamate%252BReceptor%252B2%26aulast%3DZhang%26aufirst%3DXiaofei%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D13032017%26date%3D31052017%26date%3D13062017%26date%3D20092017%26date%3D31052017%26volume%3D8%26issue%3D9%26spage%3D1937%26epage%3D1948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacob C.  Timmerman</span>, <span class="hlFld-ContribAuthor ">William W.  Schmitt</span>, and <span class="hlFld-ContribAuthor ">Ross A.  Widenhoefer</span>  . </span><span class="cited-content_cbyCitation_article-title">Gold-Catalyzed Intermolecular, anti-Markovnikov Hydroarylation of Methylenecyclopropanes with Indoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2016,</strong> <em>18 </em>
                                    (19)
                                     , 4966-4969. <a href="https://doi.org/10.1021/acs.orglett.6b02431" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b02431</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b02431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b02431%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DGold-Catalyzed%252BIntermolecular%25252C%252Banti-Markovnikov%252BHydroarylation%252Bof%252BMethylenecyclopropanes%252Bwith%252BIndoles%26aulast%3DTimmerman%26aufirst%3DJacob%2BC.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D14082016%26date%3D15092016%26date%3D07102016%26volume%3D18%26issue%3D19%26spage%3D4966%26epage%3D4969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>, <span class="hlFld-ContribAuthor ">Kyle A.  Emmitte</span>, <span class="hlFld-ContribAuthor ">Corey R.  Hopkins</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Bridges</span>, <span class="hlFld-ContribAuthor ">Karen J.  Gregory</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, and <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>  . </span><span class="cited-content_cbyCitation_article-title">Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (11)
                                     , 6707-6741. <a href="https://doi.org/10.1021/acs.chemrev.5b00656" title="DOI URL">https://doi.org/10.1021/acs.chemrev.5b00656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.5b00656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.5b00656%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DPractical%252BStrategies%252Band%252BConcepts%252Bin%252BGPCR%252BAllosteric%252BModulator%252BDiscovery%25253A%252BRecent%252BAdvances%252Bwith%252BMetabotropic%252BGlutamate%252BReceptors%26aulast%3DLindsley%26aufirst%3DCraig%2BW.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D06112015%26date%3D16022016%26date%3D08062016%26volume%3D116%26issue%3D11%26spage%3D6707%26epage%3D6741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuela  Ariza</span>, <span class="hlFld-ContribAuthor ">Hartmuth C.  Kolb</span>, <span class="hlFld-ContribAuthor ">Dieder  Moechars</span>, <span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, and <span class="hlFld-ContribAuthor ">José Ignacio  Andrés</span>  . </span><span class="cited-content_cbyCitation_article-title">Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (11)
                                     , 4365-4382. <a href="https://doi.org/10.1021/jm5017544" title="DOI URL">https://doi.org/10.1021/jm5017544</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5017544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5017544%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTau%252BPositron%252BEmission%252BTomography%252B%252528PET%252529%252BImaging%25253A%252BPast%25252C%252BPresent%25252C%252Band%252BFuture%26aulast%3DAriza%26aufirst%3DManuela%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D12112014%26date%3D25022015%26date%3D11062015%26date%3D11022015%26volume%3D58%26issue%3D11%26spage%3D4365%26epage%3D4382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Corey R.  Hopkins</span>  . </span><span class="cited-content_cbyCitation_article-title">Is There a Path Forward for mGlu2 Positive Allosteric Modulators for the Treatment of Schizophrenia?. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2013,</strong> <em>4 </em>
                                    (2)
                                     , 211-213. <a href="https://doi.org/10.1021/cn400023y" title="DOI URL">https://doi.org/10.1021/cn400023y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn400023y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn400023y%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DIs%252BThere%252Ba%252BPath%252BForward%252Bfor%252BmGlu2%252BPositive%252BAllosteric%252BModulators%252Bfor%252Bthe%252BTreatment%252Bof%252BSchizophrenia%25253F%26aulast%3DHopkins%26aufirst%3DCorey%2BR.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D21012013%26date%3D21012013%26date%3D20022013%26volume%3D4%26issue%3D2%26spage%3D211%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gengyang  Yuan</span>, <span class="hlFld-ContribAuthor ">Nicolas J.  Guehl</span>, <span class="hlFld-ContribAuthor ">Baohui  Zheng</span>, <span class="hlFld-ContribAuthor ">Xiying  Qu</span>, <span class="hlFld-ContribAuthor ">Sung-Hyun  Moon</span>, <span class="hlFld-ContribAuthor ">Maeva  Dhaynaut</span>, <span class="hlFld-ContribAuthor ">Timothy M.  Shoup</span>, <span class="hlFld-ContribAuthor ">Sepideh  Afshar</span>, <span class="hlFld-ContribAuthor ">Hye Jin  Kang</span>, <span class="hlFld-ContribAuthor ">Zhaoda  Zhang</span>, <span class="hlFld-ContribAuthor ">Georges  El Fakhri</span>, <span class="hlFld-ContribAuthor ">Marc D.  Normandin</span>, <span class="hlFld-ContribAuthor ">Anna-Liisa  Brownell</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Characterization of [18F]JNJ-46356479 as the First 18F-Labeled PET Imaging Ligand for Metabotropic Glutamate Receptor 2. </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging and Biology</span><span> <strong>2021,</strong> <em>23 </em>
                                    (4)
                                     , 527-536. <a href="https://doi.org/10.1007/s11307-021-01586-0" title="DOI URL">https://doi.org/10.1007/s11307-021-01586-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11307-021-01586-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11307-021-01586-0%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%2520and%2520Biology%26atitle%3DSynthesis%252Band%252BCharacterization%252Bof%252B%25255B18F%25255DJNJ-46356479%252Bas%252Bthe%252BFirst%252B18F-Labeled%252BPET%252BImaging%252BLigand%252Bfor%252BMetabotropic%252BGlutamate%252BReceptor%252B2%26aulast%3DYuan%26aufirst%3DGengyang%26date%3D2021%26date%3D2021%26volume%3D23%26issue%3D4%26spage%3D527%26epage%3D536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaofei  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhiwei  Xiao</span>, <span class="hlFld-ContribAuthor ">Katsushi  Kumata</span>, <span class="hlFld-ContribAuthor ">Tomoteru  Yamasaki</span>, <span class="hlFld-ContribAuthor ">Lee  Josephson</span>, <span class="hlFld-ContribAuthor ">Ming-Rong  Zhang</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Steven H.  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Positron Emission Tomography (PET) Imaging of Metabotropic Glutamate Receptor Subtype 2 (mGlu2) Based on a Negative Allosteric Modulator Radioligand. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 23-37. <a href="https://doi.org/10.1007/978-1-0716-1107-4_2" title="DOI URL">https://doi.org/10.1007/978-1-0716-1107-4_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-0716-1107-4_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-0716-1107-4_2%26sid%3Dliteratum%253Aachs%26atitle%3DPositron%252BEmission%252BTomography%252B%252528PET%252529%252BImaging%252Bof%252BMetabotropic%252BGlutamate%252BReceptor%252BSubtype%252B2%252B%252528mGlu2%252529%252BBased%252Bon%252Ba%252BNegative%252BAllosteric%252BModulator%252BRadioligand%26aulast%3DZhang%26aufirst%3DXiaofei%26date%3D2021%26date%3D2021%26spage%3D23%26epage%3D37%26pub%3DSpringer%2520US%26atitle%3DMetabotropic%252BGlutamate%252BReceptor%252BTechnologies%26aulast%3DOlive%26aufirst%3DM%2BFoster%26date%3D2021%26volume%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linjing  Mu</span>, <span class="hlFld-ContribAuthor ">Simon M.  Ametamey</span>. </span><span class="cited-content_cbyCitation_article-title">Current Radioligands for the PET Imaging of Metabotropic Glutamate Receptors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 427-481. <a href="https://doi.org/10.1007/978-3-030-53176-8_13" title="DOI URL">https://doi.org/10.1007/978-3-030-53176-8_13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-53176-8_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-53176-8_13%26sid%3Dliteratum%253Aachs%26atitle%3DCurrent%252BRadioligands%252Bfor%252Bthe%252BPET%252BImaging%252Bof%252BMetabotropic%252BGlutamate%252BReceptors%26aulast%3DMu%26aufirst%3DLinjing%26date%3D2021%26date%3D2020%26spage%3D427%26epage%3D481%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DPET%252Band%252BSPECT%252Bof%252BNeurobiological%252BSystems%26aulast%3DDierckx%26aufirst%3DRudi%2BA.J.O.%26date%3D2021%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katsushi  Kumata</span>, <span class="hlFld-ContribAuthor ">Yiding  Zhang</span>, <span class="hlFld-ContribAuthor ">Masanao  Ogawa</span>, <span class="hlFld-ContribAuthor ">Yusuke  Kurihara</span>, <span class="hlFld-ContribAuthor ">Wakana  Mori</span>, <span class="hlFld-ContribAuthor ">Kuan  Hu</span>, <span class="hlFld-ContribAuthor ">Masayuki  Fujinaga</span>, <span class="hlFld-ContribAuthor ">Nobuki  Nengaki</span>, <span class="hlFld-ContribAuthor ">Ming-Rong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">3-(Cyclopropylmethyl)-7-((4-(4-[11C]methoxyphenyl)piperidin-1-yl)methyl)-8-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridine: Synthesis and preliminary evaluation for PET imaging of metabotropic glutamate receptor subtype 2. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (23)
                                     , 127555. <a href="https://doi.org/10.1016/j.bmcl.2020.127555" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127555</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127555%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D3-%252528Cyclopropylmethyl%252529-7-%252528%2525284-%2525284-%25255B11C%25255Dmethoxyphenyl%252529piperidin-1-yl%252529methyl%252529-8-%252528trifluoromethyl%252529-%25255B1%25252C2%25252C4%25255Dtriazolo%25255B4%25252C3-a%25255Dpyridine%25253A%252BSynthesis%252Band%252Bpreliminary%252Bevaluation%252Bfor%252BPET%252Bimaging%252Bof%252Bmetabotropic%252Bglutamate%252Breceptor%252Bsubtype%252B2%26aulast%3DKumata%26aufirst%3DKatsushi%26date%3D2020%26volume%3D30%26issue%3D23%26spage%3D127555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jong-Hoon  Kim</span>, <span class="hlFld-ContribAuthor ">János  Marton</span>, <span class="hlFld-ContribAuthor ">Simon Mensah  Ametamey</span>, <span class="hlFld-ContribAuthor ">Paul  Cumming</span>. </span><span class="cited-content_cbyCitation_article-title">A Review of Molecular Imaging of Glutamate Receptors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (20)
                                     , 4749. <a href="https://doi.org/10.3390/molecules25204749" title="DOI URL">https://doi.org/10.3390/molecules25204749</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25204749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25204749%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DA%252BReview%252Bof%252BMolecular%252BImaging%252Bof%252BGlutamate%252BReceptors%26aulast%3DKim%26aufirst%3DJong-Hoon%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D20%26spage%3D4749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María L.  López-Rodríguez</span>, <span class="hlFld-ContribAuthor ">Bellinda  Benhamú</span>, <span class="hlFld-ContribAuthor ">Henar  Vázquez-Villa</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric modulators targeting GPCRs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 195-241. <a href="https://doi.org/10.1016/B978-0-12-816228-6.00011-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-816228-6.00011-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816228-6.00011-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816228-6.00011-8%26sid%3Dliteratum%253Aachs%26atitle%3DAllosteric%252Bmodulators%252Btargeting%252BGPCRs%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DMar%25C3%25ADa%2BL.%26date%3D2020%26spage%3D195%26epage%3D241%26pub%3DElsevier%26atitle%3DGPCRs%26date%3D2020%26volume%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Youwen  Xu</span>, <span class="hlFld-ContribAuthor ">Zizhong  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Imaging metabotropic glutamate receptor system: Application of positron emission tomography technology in drug development. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (5)
                                     , 1892-1922. <a href="https://doi.org/10.1002/med.21566" title="DOI URL">https://doi.org/10.1002/med.21566</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21566%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DImaging%252Bmetabotropic%252Bglutamate%252Breceptor%252Bsystem%25253A%252BApplication%252Bof%252Bpositron%252Bemission%252Btomography%252Btechnology%252Bin%252Bdrug%252Bdevelopment%26aulast%3DXu%26aufirst%3DYouwen%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D5%26spage%3D1892%26epage%3D1922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katsushi  Kumata</span>, <span class="hlFld-ContribAuthor ">Akiko  Hatori</span>, <span class="hlFld-ContribAuthor ">Tomoteru  Yamasaki</span>, <span class="hlFld-ContribAuthor ">Yiding  Zhang</span>, <span class="hlFld-ContribAuthor ">Wakana  Mori</span>, <span class="hlFld-ContribAuthor ">Masayuki  Fujinaga</span>, <span class="hlFld-ContribAuthor ">Lin  Xie</span>, <span class="hlFld-ContribAuthor ">Nobuki  Nengaki</span>, <span class="hlFld-ContribAuthor ">Ming-Rong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of 4-(2-fluoro-4-[11C]methoxyphenyl)-5-((2-methylpyridin-4-yl)methoxy)picolinamide for PET imaging of the metabotropic glutamate receptor 2 in the rat brain. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (3)
                                     , 483-491. <a href="https://doi.org/10.1016/j.bmc.2018.12.025" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.12.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.12.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.12.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252B4-%2525282-fluoro-4-%25255B11C%25255Dmethoxyphenyl%252529-5-%252528%2525282-methylpyridin-4-yl%252529methoxy%252529picolinamide%252Bfor%252BPET%252Bimaging%252Bof%252Bthe%252Bmetabotropic%252Bglutamate%252Breceptor%252B2%252Bin%252Bthe%252Brat%252Bbrain%26aulast%3DKumata%26aufirst%3DKatsushi%26date%3D2019%26volume%3D27%26issue%3D3%26spage%3D483%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun-Tao  Gao</span>, <span class="hlFld-ContribAuthor ">Chloe J.  Jordan</span>, <span class="hlFld-ContribAuthor ">Guo-Hua  Bi</span>, <span class="hlFld-ContribAuthor ">Yi  He</span>, <span class="hlFld-ContribAuthor ">Hong-Ju  Yang</span>, <span class="hlFld-ContribAuthor ">Eliot L.  Gardner</span>, <span class="hlFld-ContribAuthor ">Zheng-Xiong  Xi</span>. </span><span class="cited-content_cbyCitation_article-title">Deletion of the type 2 metabotropic glutamate receptor increases heroin abuse vulnerability in transgenic rats. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2018,</strong> <em>43 </em>
                                    (13)
                                     , 2615-2626. <a href="https://doi.org/10.1038/s41386-018-0231-5" title="DOI URL">https://doi.org/10.1038/s41386-018-0231-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41386-018-0231-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41386-018-0231-5%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DDeletion%252Bof%252Bthe%252Btype%252B2%252Bmetabotropic%252Bglutamate%252Breceptor%252Bincreases%252Bheroin%252Babuse%252Bvulnerability%252Bin%252Btransgenic%252Brats%26aulast%3DGao%26aufirst%3DJun-Tao%26date%3D2018%26date%3D2018%26volume%3D43%26issue%3D13%26spage%3D2615%26epage%3D2626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irini  Abdiaj</span>, <span class="hlFld-ContribAuthor ">Alberto  Fontana</span>, <span class="hlFld-ContribAuthor ">M. Victoria  Gomez</span>, <span class="hlFld-ContribAuthor ">Antonio  de la Hoz</span>, <span class="hlFld-ContribAuthor ">Jesús  Alcázar</span>. </span><span class="cited-content_cbyCitation_article-title">Visible‐Light‐Induced Nickel‐Catalyzed Negishi Cross‐Couplings by Exogenous‐Photosensitizer‐Free Photocatalysis. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2018,</strong> <em>130 </em>
                                    (28)
                                     , 8609-8613. <a href="https://doi.org/10.1002/ange.201802656" title="DOI URL">https://doi.org/10.1002/ange.201802656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201802656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201802656%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DVisible%2525E2%252580%252590Light%2525E2%252580%252590Induced%252BNickel%2525E2%252580%252590Catalyzed%252BNegishi%252BCross%2525E2%252580%252590Couplings%252Bby%252BExogenous%2525E2%252580%252590Photosensitizer%2525E2%252580%252590Free%252BPhotocatalysis%26aulast%3DAbdiaj%26aufirst%3DIrini%26date%3D2018%26date%3D2018%26volume%3D130%26issue%3D28%26spage%3D8609%26epage%3D8613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irini  Abdiaj</span>, <span class="hlFld-ContribAuthor ">Alberto  Fontana</span>, <span class="hlFld-ContribAuthor ">M. Victoria  Gomez</span>, <span class="hlFld-ContribAuthor ">Antonio  de la Hoz</span>, <span class="hlFld-ContribAuthor ">Jesús  Alcázar</span>. </span><span class="cited-content_cbyCitation_article-title">Visible‐Light‐Induced Nickel‐Catalyzed Negishi Cross‐Couplings by Exogenous‐Photosensitizer‐Free Photocatalysis. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2018,</strong> <em>57 </em>
                                    (28)
                                     , 8473-8477. <a href="https://doi.org/10.1002/anie.201802656" title="DOI URL">https://doi.org/10.1002/anie.201802656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201802656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201802656%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DVisible%2525E2%252580%252590Light%2525E2%252580%252590Induced%252BNickel%2525E2%252580%252590Catalyzed%252BNegishi%252BCross%2525E2%252580%252590Couplings%252Bby%252BExogenous%2525E2%252580%252590Photosensitizer%2525E2%252580%252590Free%252BPhotocatalysis%26aulast%3DAbdiaj%26aufirst%3DIrini%26date%3D2018%26date%3D2018%26volume%3D57%26issue%3D28%26spage%3D8473%26epage%3D8477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel E.  O’Brien</span>, <span class="hlFld-ContribAuthor ">Douglas M.  Shaw</span>, <span class="hlFld-ContribAuthor ">Hyekyung P.  Cho</span>, <span class="hlFld-ContribAuthor ">Alan J.  Cross</span>, <span class="hlFld-ContribAuthor ">Steven S.  Wesolowski</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Felts</span>, <span class="hlFld-ContribAuthor ">Jonas  Bergare</span>, <span class="hlFld-ContribAuthor ">Charles S.  Elmore</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>. </span><span class="cited-content_cbyCitation_article-title">Differential Pharmacology and Binding of mGlu
              2
              Receptor Allosteric Modulators. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2018,</strong> <em>93 </em>
                                    (5)
                                     , 526-540. <a href="https://doi.org/10.1124/mol.117.110114" title="DOI URL">https://doi.org/10.1124/mol.117.110114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.117.110114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.117.110114%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DDifferential%252BPharmacology%252Band%252BBinding%252Bof%252BmGlu%252B2%252BReceptor%252BAllosteric%252BModulators%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DDaniel%2BE.%26date%3D2018%26date%3D2018%26volume%3D93%26issue%3D5%26spage%3D526%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Selena Milicevic  Sephton</span>. </span><span class="cited-content_cbyCitation_article-title">Positron Emission Tomography of Metabotropic Glutamate Receptors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 51-82. <a href="https://doi.org/10.1007/978-1-4939-7228-9_3" title="DOI URL">https://doi.org/10.1007/978-1-4939-7228-9_3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-7228-9_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-7228-9_3%26sid%3Dliteratum%253Aachs%26atitle%3DPositron%252BEmission%252BTomography%252Bof%252BMetabotropic%252BGlutamate%252BReceptors%26aulast%3DSephton%26aufirst%3DSelena%2BMilicevic%26date%3D2018%26date%3D2017%26spage%3D51%26epage%3D82%26pub%3DSpringer%2520New%2520York%26atitle%3DBiochemical%252BApproaches%252Bfor%252BGlutamatergic%252BNeurotransmission%26aulast%3DParrot%26aufirst%3DSandrine%26date%3D2018%26volume%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José Ignacio  Andrés</span>, <span class="hlFld-ContribAuthor ">Mark  Schmidt</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry strategies for PET tracer discovery. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today: Technologies</span><span> <strong>2017,</strong> <em>25 </em>, 11-17. <a href="https://doi.org/10.1016/j.ddtec.2017.10.002" title="DOI URL">https://doi.org/10.1016/j.ddtec.2017.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ddtec.2017.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ddtec.2017.10.002%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technologies%26atitle%3DMedicinal%252BChemistry%252Bstrategies%252Bfor%252BPET%252Btracer%252Bdiscovery%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJos%25C3%25A9%2BIgnacio%26date%3D2017%26volume%3D25%26spage%3D11%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katsushi  Kumata</span>, <span class="hlFld-ContribAuthor ">Tomoteru  Yamasaki</span>, <span class="hlFld-ContribAuthor ">Akiko  Hatori</span>, <span class="hlFld-ContribAuthor ">Yiding  Zhang</span>, <span class="hlFld-ContribAuthor ">Wakana  Mori</span>, <span class="hlFld-ContribAuthor ">Masayuki  Fujinaga</span>, <span class="hlFld-ContribAuthor ">Lin  Xie</span>, <span class="hlFld-ContribAuthor ">Takayuki  Okubo</span>, <span class="hlFld-ContribAuthor ">Nobuki  Nengaki</span>, <span class="hlFld-ContribAuthor ">Ming-Rong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and in vitro evaluation of three novel radiotracers for imaging of metabotropic glutamate receptor subtype 2 in rat brain. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (14)
                                     , 3139-3143. <a href="https://doi.org/10.1016/j.bmcl.2017.05.029" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.05.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.05.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.05.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bin%252Bvitro%252Bevaluation%252Bof%252Bthree%252Bnovel%252Bradiotracers%252Bfor%252Bimaging%252Bof%252Bmetabotropic%252Bglutamate%252Breceptor%252Bsubtype%252B2%252Bin%252Brat%252Bbrain%26aulast%3DKumata%26aufirst%3DKatsushi%26date%3D2017%26volume%3D27%26issue%3D14%26spage%3D3139%26epage%3D3143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yufei  Ma</span>, <span class="hlFld-ContribAuthor ">Katsushi  Kumata</span>, <span class="hlFld-ContribAuthor ">Joji  Yui</span>, <span class="hlFld-ContribAuthor ">Yiding  Zhang</span>, <span class="hlFld-ContribAuthor ">Tomoteru  Yamasaki</span>, <span class="hlFld-ContribAuthor ">Akiko  Hatori</span>, <span class="hlFld-ContribAuthor ">Masayuki  Fujinaga</span>, <span class="hlFld-ContribAuthor ">Nobuki  Nengaki</span>, <span class="hlFld-ContribAuthor ">Lin  Xie</span>, <span class="hlFld-ContribAuthor ">Hui  Wang</span>, <span class="hlFld-ContribAuthor ">Ming-Rong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of 1-(cyclopropylmethyl)-4-(4-[ 11 C]methoxyphenyl)-piperidin-1-yl-2-oxo-1,2-dihydropyridine-3-carbonitrile ([ 11 C]CMDC) for PET imaging of metabotropic glutamate receptor 2 in the rat brain. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (3)
                                     , 1014-1021. <a href="https://doi.org/10.1016/j.bmc.2016.12.011" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.12.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.12.011%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252B1-%252528cyclopropylmethyl%252529-4-%2525284-%25255B%252B11%252BC%25255Dmethoxyphenyl%252529-piperidin-1-yl-2-oxo-1%25252C2-dihydropyridine-3-carbonitrile%252B%252528%25255B%252B11%252BC%25255DCMDC%252529%252Bfor%252BPET%252Bimaging%252Bof%252Bmetabotropic%252Bglutamate%252Breceptor%252B2%252Bin%252Bthe%252Brat%252Bbrain%26aulast%3DMa%26aufirst%3DYufei%26date%3D2017%26volume%3D25%26issue%3D3%26spage%3D1014%26epage%3D1021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.  Mercier</span>, <span class="hlFld-ContribAuthor ">L.  Provins</span>, <span class="hlFld-ContribAuthor ">J.  Hannestad</span>. </span><span class="cited-content_cbyCitation_article-title">Progress and Challenges in the Development of PET Ligands to Aid CNS Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 20-64. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12437-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12437-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12437-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12437-0%26sid%3Dliteratum%253Aachs%26atitle%3DProgress%252Band%252BChallenges%252Bin%252Bthe%252BDevelopment%252Bof%252BPET%252BLigands%252Bto%252BAid%252BCNS%252BDrug%252BDiscovery%26aulast%3DMercier%26aufirst%3DJ.%26date%3D2017%26spage%3D20%26epage%3D64%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">László  Ürge</span>, <span class="hlFld-ContribAuthor ">Jesus  Alcazar</span>, <span class="hlFld-ContribAuthor ">Lena  Huck</span>, <span class="hlFld-ContribAuthor ">György  Dormán</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances of Microfluidics Technologies in the Field of Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 87-147. <a href="https://doi.org/10.1016/bs.armc.2017.09.001" title="DOI URL">https://doi.org/10.1016/bs.armc.2017.09.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.armc.2017.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.armc.2017.09.001%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252BAdvances%252Bof%252BMicrofluidics%252BTechnologies%252Bin%252Bthe%252BField%252Bof%252BMedicinal%252BChemistry%26aulast%3D%25C3%259Crge%26aufirst%3DL%25C3%25A1szl%25C3%25B3%26date%3D2017%26spage%3D87%26epage%3D147%26pub%3DElsevier%26atitle%3DPlatform%252BTechnologies%252Bin%252BDrug%252BDiscovery%252Band%252BValidation%26date%3D2017%26volume%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mendi A.  Higgins</span>, <span class="hlFld-ContribAuthor ">Lawrence R.  Marcin</span>, <span class="hlFld-ContribAuthor ">F.  Christopher Zusi</span>, <span class="hlFld-ContribAuthor ">Robert  Gentles</span>, <span class="hlFld-ContribAuthor ">Min  Ding</span>, <span class="hlFld-ContribAuthor ">Bradley C.  Pearce</span>, <span class="hlFld-ContribAuthor ">Amy  Easton</span>, <span class="hlFld-ContribAuthor ">Walter A.  Kostich</span>, <span class="hlFld-ContribAuthor ">Matthew A.  Seager</span>, <span class="hlFld-ContribAuthor ">Clotilde  Bourin</span>, <span class="hlFld-ContribAuthor ">Linda J.  Bristow</span>, <span class="hlFld-ContribAuthor ">Kim A.  Johnson</span>, <span class="hlFld-ContribAuthor ">Regina  Miller</span>, <span class="hlFld-ContribAuthor ">John  Hogan</span>, <span class="hlFld-ContribAuthor ">Valerie  Whiterock</span>, <span class="hlFld-ContribAuthor ">Michael  Gulianello</span>, <span class="hlFld-ContribAuthor ">Meredith  Ferrante</span>, <span class="hlFld-ContribAuthor ">Yanling  Huang</span>, <span class="hlFld-ContribAuthor ">Adam  Hendricson</span>, <span class="hlFld-ContribAuthor ">Andrew  Alt</span>, <span class="hlFld-ContribAuthor ">John E.  Macor</span>, <span class="hlFld-ContribAuthor ">Joanne J.  Bronson</span>. </span><span class="cited-content_cbyCitation_article-title">Triazolopyridine ethers as potent, orally active mGlu2 positive allosteric modulators for treating schizophrenia. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (2)
                                     , 496-513. <a href="https://doi.org/10.1016/j.bmc.2016.11.018" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.11.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.11.018%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DTriazolopyridine%252Bethers%252Bas%252Bpotent%25252C%252Borally%252Bactive%252BmGlu2%252Bpositive%252Ballosteric%252Bmodulators%252Bfor%252Btreating%252Bschizophrenia%26aulast%3DHiggins%26aufirst%3DMendi%2BA.%26date%3D2017%26volume%3D25%26issue%3D2%26spage%3D496%26epage%3D513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gil  Leurquin-Sterk</span>, <span class="hlFld-ContribAuthor ">Sofie  Celen</span>, <span class="hlFld-ContribAuthor ">Koen  Van Laere</span>, <span class="hlFld-ContribAuthor ">Michel  Koole</span>, <span class="hlFld-ContribAuthor ">Guy  Bormans</span>, <span class="hlFld-ContribAuthor ">Xavier  Langlois</span>, <span class="hlFld-ContribAuthor ">Anne  Van Hecken</span>, <span class="hlFld-ContribAuthor ">Paula  te Riele</span>, <span class="hlFld-ContribAuthor ">Jesús  Alcázar</span>, <span class="hlFld-ContribAuthor ">Alfons  Verbruggen</span>, <span class="hlFld-ContribAuthor ">Jan  de Hoon</span>, <span class="hlFld-ContribAuthor ">Jose-Ignacio  Andrés</span>, <span class="hlFld-ContribAuthor ">Mark E.  Schmidt</span>. </span><span class="cited-content_cbyCitation_article-title">What We Observe In Vivo Is Not Always What We See In Vitro: Development and Validation of
              11
              C-JNJ-42491293, A Novel Radioligand for mGluR2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2017,</strong> <em>58 </em>
                                    (1)
                                     , 110-116. <a href="https://doi.org/10.2967/jnumed.116.176628" title="DOI URL">https://doi.org/10.2967/jnumed.116.176628</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.116.176628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.116.176628%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DWhat%252BWe%252BObserve%252BIn%252BVivo%252BIs%252BNot%252BAlways%252BWhat%252BWe%252BSee%252BIn%252BVitro%25253A%252BDevelopment%252Band%252BValidation%252Bof%252B11%252BC-JNJ-42491293%25252C%252BA%252BNovel%252BRadioligand%252Bfor%252BmGluR2%26aulast%3DLeurquin-Sterk%26aufirst%3DGil%26date%3D2017%26date%3D2016%26volume%3D58%26issue%3D1%26spage%3D110%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Zeguo  Zhang</span>, <span class="hlFld-ContribAuthor ">Fan  Chen</span>, <span class="hlFld-ContribAuthor ">Yongzheng  Chen</span>, <span class="hlFld-ContribAuthor ">Ya  Lin</span>, <span class="hlFld-ContribAuthor ">Jing  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Aromatic heterocyclic esters of podophyllotoxin exert anti-MDR activity in human leukemia K562/ADR cells via ROS/MAPK signaling pathways. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>123 </em>, 226-235. <a href="https://doi.org/10.1016/j.ejmech.2016.07.050" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.07.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.07.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.07.050%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAromatic%252Bheterocyclic%252Besters%252Bof%252Bpodophyllotoxin%252Bexert%252Banti-MDR%252Bactivity%252Bin%252Bhuman%252Bleukemia%252BK562%25252FADR%252Bcells%252Bvia%252BROS%25252FMAPK%252Bsignaling%252Bpathways%26aulast%3DZhang%26aufirst%3DLei%26date%3D2016%26volume%3D123%26spage%3D226%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Idrish  Ali</span>, <span class="hlFld-ContribAuthor ">Stephanie  Boets</span>, <span class="hlFld-ContribAuthor ">Pieter  Janssens</span>, <span class="hlFld-ContribAuthor ">Annemie  Van Eetveldt</span>, <span class="hlFld-ContribAuthor ">Halima  Amhaoul</span>, <span class="hlFld-ContribAuthor ">Xavier  Langlois</span>, <span class="hlFld-ContribAuthor ">Stefanie  Dedeurwaerdere</span>. </span><span class="cited-content_cbyCitation_article-title">Metabotropic glutamate receptor 2/3 density and its relation to the hippocampal neuropathology in a model of temporal lobe epilepsy in rats. </span><span class="cited-content_cbyCitation_journal-name">Epilepsy Research</span><span> <strong>2016,</strong> <em>127 </em>, 55-59. <a href="https://doi.org/10.1016/j.eplepsyres.2016.08.010" title="DOI URL">https://doi.org/10.1016/j.eplepsyres.2016.08.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.eplepsyres.2016.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.eplepsyres.2016.08.010%26sid%3Dliteratum%253Aachs%26jtitle%3DEpilepsy%2520Research%26atitle%3DMetabotropic%252Bglutamate%252Breceptor%252B2%25252F3%252Bdensity%252Band%252Bits%252Brelation%252Bto%252Bthe%252Bhippocampal%252Bneuropathology%252Bin%252Ba%252Bmodel%252Bof%252Btemporal%252Blobe%252Bepilepsy%252Bin%252Brats%26aulast%3DAli%26aufirst%3DIdrish%26date%3D2016%26volume%3D127%26spage%3D55%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amr  Ellaithy</span>, <span class="hlFld-ContribAuthor ">Jason  Younkin</span>, <span class="hlFld-ContribAuthor ">Javier  González-Maeso</span>, <span class="hlFld-ContribAuthor ">Diomedes E.  Logothetis</span>. </span><span class="cited-content_cbyCitation_article-title">Positive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatment. </span><span class="cited-content_cbyCitation_journal-name">Trends in Neurosciences</span><span> <strong>2015,</strong> <em>38 </em>
                                    (8)
                                     , 506-516. <a href="https://doi.org/10.1016/j.tins.2015.06.002" title="DOI URL">https://doi.org/10.1016/j.tins.2015.06.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tins.2015.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tins.2015.06.002%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Neurosciences%26atitle%3DPositive%252Ballosteric%252Bmodulators%252Bof%252Bmetabotropic%252Bglutamate%252B2%252Breceptors%252Bin%252Bschizophrenia%252Btreatment%26aulast%3DEllaithy%26aufirst%3DAmr%26date%3D2015%26volume%3D38%26issue%3D8%26spage%3D506%26epage%3D516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sylvain  Celanire</span>, <span class="hlFld-ContribAuthor ">Iyassu  Sebhat</span>, <span class="hlFld-ContribAuthor ">Juergen  Wichmann</span>, <span class="hlFld-ContribAuthor ">Stanislas  Mayer</span>, <span class="hlFld-ContribAuthor ">Stephan  Schann</span>, <span class="hlFld-ContribAuthor ">Silvia  Gatti</span>. </span><span class="cited-content_cbyCitation_article-title">Novel metabotropic glutamate receptor 2/3 antagonists and their therapeutic applications: a patent review (2005 – present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2015,</strong> <em>25 </em>
                                    (1)
                                     , 69-90. <a href="https://doi.org/10.1517/13543776.2014.983899" title="DOI URL">https://doi.org/10.1517/13543776.2014.983899</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.983899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.983899%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DNovel%252Bmetabotropic%252Bglutamate%252Breceptor%252B2%25252F3%252Bantagonists%252Band%252Btheir%252Btherapeutic%252Bapplications%25253A%252Ba%252Bpatent%252Breview%252B%2525282005%252B%2525E2%252580%252593%252Bpresent%252529%26aulast%3DCelanire%26aufirst%3DSylvain%26date%3D2015%26date%3D2014%26volume%3D25%26issue%3D1%26spage%3D69%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takeshi  Fuchigami</span>, <span class="hlFld-ContribAuthor ">Morio  Nakayama</span>, <span class="hlFld-ContribAuthor ">Sakura  Yoshida</span>. </span><span class="cited-content_cbyCitation_article-title">Development of PET and SPECT Probes for Glutamate Receptors. </span><span class="cited-content_cbyCitation_journal-name">The Scientific World Journal</span><span> <strong>2015,</strong> <em>2015 </em>, 1-19. <a href="https://doi.org/10.1155/2015/716514" title="DOI URL">https://doi.org/10.1155/2015/716514</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2015/716514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2015%2F716514%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Scientific%2520World%2520Journal%26atitle%3DDevelopment%252Bof%252BPET%252Band%252BSPECT%252BProbes%252Bfor%252BGlutamate%252BReceptors%26aulast%3DFuchigami%26aufirst%3DTakeshi%26date%3D2015%26volume%3D2015%26spage%3D1%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Munenori  Inoue</span>, <span class="hlFld-ContribAuthor ">Masahiro  Shiosaki</span>, <span class="hlFld-ContribAuthor ">Hajime  Muramaru</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of ethyl 3,3,3-trifluoropropionate from 2-bromo-3,3,3-trifluoropropene. </span><span class="cited-content_cbyCitation_journal-name">Journal of Fluorine Chemistry</span><span> <strong>2014,</strong> <em>167 </em>, 135-138. <a href="https://doi.org/10.1016/j.jfluchem.2014.07.009" title="DOI URL">https://doi.org/10.1016/j.jfluchem.2014.07.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jfluchem.2014.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jfluchem.2014.07.009%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Fluorine%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bethyl%252B3%25252C3%25252C3-trifluoropropionate%252Bfrom%252B2-bromo-3%25252C3%25252C3-trifluoropropene%26aulast%3DInoue%26aufirst%3DMunenori%26date%3D2014%26volume%3D167%26spage%3D135%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jesús  Alcázar</span>, <span class="hlFld-ContribAuthor ">Yannick  Ligny</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave-assisted medicinal chemistry: examples from a pharmaceutical company. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 20-33. <a href="https://doi.org/10.4155/fseb2013.13.58" title="DOI URL">https://doi.org/10.4155/fseb2013.13.58</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fseb2013.13.58&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffseb2013.13.58%26sid%3Dliteratum%253Aachs%26atitle%3DMicrowave-assisted%252Bmedicinal%252Bchemistry%25253A%252Bexamples%252Bfrom%252Ba%252Bpharmaceutical%252Bcompany%26aulast%3DAlc%25C3%25A1zar%26aufirst%3DJes%25C3%25BAs%26date%3D2014%26date%3D2014%26spage%3D20%26epage%3D33%26pub%3DFuture%2520Science%2520Ltd%26atitle%3DMicrowaves%252Bin%252BDrug%252BDiscovery%252Band%252BDevelopment%25253A%252BRecent%252BAdvances%26aulast%3DSpencer%26aufirst%3DJohn%26date%3D2014%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cody J.  Wenthur</span>, <span class="hlFld-ContribAuthor ">Ryan D.  Morrison</span>, <span class="hlFld-ContribAuthor ">J. Scott  Daniels</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and SAR of substituted pyrazolo[1,5-a]quinazolines as dual mGlu2/mGlu3 NAMs. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (12)
                                     , 2693-2698. <a href="https://doi.org/10.1016/j.bmcl.2014.04.051" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.04.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.04.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.04.051%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BSAR%252Bof%252Bsubstituted%252Bpyrazolo%25255B1%25252C5-a%25255Dquinazolines%252Bas%252Bdual%252BmGlu2%25252FmGlu3%252BNAMs%26aulast%3DWenthur%26aufirst%3DCody%2BJ.%26date%3D2014%26volume%3D24%26issue%3D12%26spage%3D2693%26epage%3D2698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liang  Kou</span>, <span class="hlFld-ContribAuthor ">Mei-Juan  Wang</span>, <span class="hlFld-ContribAuthor ">Li-Ting  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao-Bo  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiang  Nan</span>, <span class="hlFld-ContribAuthor ">Liu  Yang</span>, <span class="hlFld-ContribAuthor ">Ying-Qian  Liu</span>, <span class="hlFld-ContribAuthor ">Susan L.  Morris-Natschke</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Toward synthesis of third-generation spin-labeled podophyllotoxin derivatives using isocyanide multicomponent reactions. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>75 </em>, 282-288. <a href="https://doi.org/10.1016/j.ejmech.2014.01.038" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.01.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.01.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.01.038%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DToward%252Bsynthesis%252Bof%252Bthird-generation%252Bspin-labeled%252Bpodophyllotoxin%252Bderivatives%252Busing%252Bisocyanide%252Bmulticomponent%252Breactions%26aulast%3DKou%26aufirst%3DLiang%26date%3D2014%26volume%3D75%26spage%3D282%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José M.  Cid</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>, <span class="hlFld-ContribAuthor ">Hilde  Lavreysen</span>. </span><span class="cited-content_cbyCitation_article-title">Metabotropic Glutamate Receptor 2 Activators. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 101-142. <a href="https://doi.org/10.1007/7355_2014_48" title="DOI URL">https://doi.org/10.1007/7355_2014_48</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2014_48&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2014_48%26sid%3Dliteratum%253Aachs%26atitle%3DMetabotropic%252BGlutamate%252BReceptor%252B2%252BActivators%26aulast%3DCid%26aufirst%3DJos%25C3%25A9%2BM.%26date%3D2014%26date%3D2014%26spage%3D101%26epage%3D142%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DSmall%252BMolecule%252BTherapeutics%252Bfor%252BSchizophrenia%26aulast%3DCelanire%26aufirst%3DSylvain%26date%3D2015%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrés A  Trabanco</span>, <span class="hlFld-ContribAuthor ">José María  Cid</span>. </span><span class="cited-content_cbyCitation_article-title">mGluR2 positive allosteric modulators: a patent review (2009 – present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2013,</strong> <em>23 </em>
                                    (5)
                                     , 629-647. <a href="https://doi.org/10.1517/13543776.2013.777043" title="DOI URL">https://doi.org/10.1517/13543776.2013.777043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2013.777043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2013.777043%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DmGluR2%252Bpositive%252Ballosteric%252Bmodulators%25253A%252Ba%252Bpatent%252Breview%252B%2525282009%252B%2525E2%252580%252593%252Bpresent%252529%26aulast%3DTrabanco%26aufirst%3DAndr%25C3%25A9s%2BA%26date%3D2013%26date%3D2013%26volume%3D23%26issue%3D5%26spage%3D629%26epage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/medium/jm-2012-00912k_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300912k&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/medium/jm-2012-00912k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of two mGluR2 radioligands and two 1,2,4-triazolo[4,3-<i>a</i>]pyridine mGluR2 PAMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300912k&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/medium/jm-2012-00912k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Key Intermediates <b>7a</b>–<b>h</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300912k&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub> (saturated solution), 1,4-dioxane, μW, 150 °C, 10 min; (ii) H<sub>2</sub>, EtOH, Pd(OH)<sub>2</sub>/C (20%); H-CUBE, full-H<sub>2</sub>, 80 °C, 1 mL/min; (iii) HCl (7 M in <i>i</i>-PrOH), MeOH, rt, 90 min.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/medium/jm-2012-00912k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Final Products <b>16d</b> and <b>17b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300912k&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NaH, DMF, rt, 1 h; (ii) diisopropylamine, MeCN, 110 °C, overnight; (iii) NH<sub>2</sub>NH<sub>2</sub>, EtOH or THF, μW, 160 °C, 15–20 min; (iv) CF<sub>3</sub>CH<sub>2</sub>COCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h; (v) POCl<sub>3</sub>, MeCN, μW, 150–160 °C, 5–10 min.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/medium/jm-2012-00912k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Final Products <b>20a</b>–<b>h</b> and <b>21d</b>,<b>f</b> and Synthesis of the Precursors <b>22b</b>,<b>c</b>,<b>f–h</b> and <b>23f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300912k&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) <b>18</b> or <b>19</b>, Pd(AcO)<sub>2</sub>, (±)BINAP, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 125 °C, overnight; (ii) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 45 min.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/medium/jm-2012-00912k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Radiosynthesis of the Selected PET Tracer Candidates<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300912k&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) [<sup>11</sup>C]CH<sub>3</sub>I, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, 3 min, 35–74% RCY.</p></p></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/medium/jm-2012-00912k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Brain and plasma levels for compound <b>20b</b>. Compound was formulated in 20% HP-β-CD. Study was performed in two male Sprague–Dawley rats dosed iv at 0.63 mg/kg. Brain levels are expressed in ng/g and plasma levels in ng/mL. The graphs represent the data as geometric mean values of the two runs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300912k&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/medium/jm-2012-00912k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. μPET images and TACs for [<sup>11</sup>C]<b>20f</b> in rat striatum, cerebellum, cortex, hippocampus, thalamus, and total brain. (A) Untreated baseline scan. (B) Transversal image corresponding to a baseline scan: averaged image (12–28 min after pi) of a representative rat injected with 41 MBq of [<sup>11</sup>C]<b>20f</b>. (C) Chase experiment: JNJ42153605, 1 mg/kg, was injected iv (arrow) 30 min pi. (D) Transversal images corresponding to the chase experiment: averaged image (12–28 min pi) before chase injection (left) and averaged image (68–88 min pi) after chase injection (right). max = maximum; min = minimum.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm300912k/production/images/large/jm-2012-00912k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300912k&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i69">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85102" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85102" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 40 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pin, J.-P.</span><span> </span><span class="NLM_article-title">Pharmacology and functions of metabotropic glutamate receptors</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1146%2Fannurev.pharmtox.37.1.205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=9131252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADyaK2sXisl2ktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1997&pages=205-237&author=P.+J.+Connauthor=J.-P.+Pin&title=Pharmacology+and+functions+of+metabotropic+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology and functions of metabotropic glutamate receptors</span></div><div class="casAuthors">Conn, P. Jeffrey; Pin, Jean-Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">205-237</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review, with 198 refs.  In the mid to late 1980s, studies were published that provided the first evidence for the existence of glutamate receptors that are not ligand-gated cation channels but are coupled to effector systems through GTP-binding proteins.  Since those initial reports, tremendous progress has been made in characterizing these metabotropic glutamate receptors (mGluRs), including cloning and characterization of cDNA that encodes a family of eight mGluR subtypes, several of which have multiple splice variants.  Also, tremendous progress has been made in developing new highly selective mGluR agonists and antagonists and toward detg. the physiol. roles of the mGluRs in mammalian brain.  These findings have exciting implications for drug development and suggest that the mGluRs provide a novel target for development of therapeutic agents that could have a significant impact on neuropharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph1fuaHYNvC7Vg90H21EOLACvtfcHk0liveQvvq8FSXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXisl2ktr0%253D&md5=d9df228141c4747f80bbd9d2f0843a24</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.37.1.205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.37.1.205%26sid%3Dliteratum%253Aachs%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DPin%26aufirst%3DJ.-P.%26atitle%3DPharmacology%2520and%2520functions%2520of%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D1997%26volume%3D37%26spage%3D205%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Kew, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, J. A.</span><span> </span><span class="NLM_article-title">Ionotropic and metabotropic glutamate receptor structure and pharmacology</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1007%2Fs00213-005-2200-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=15731895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtV2itbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2005&pages=4-29&author=J.+N.+Kewauthor=J.+A.+Kemp&title=Ionotropic+and+metabotropic+glutamate+receptor+structure+and+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Ionotropic and metabotropic glutamate receptor structure and pharmacology</span></div><div class="casAuthors">Kew, James N. C.; Kemp, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-29</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Rationale: L-Glutamate is the major excitatory neurotransmitter in the central nervous system (CNS) and mediates its actions via activation of both ionotropic and metabotropic receptor families.  The development of selective ligands, including competitive agonists and antagonists and pos. and neg. allosteric modulators, has enabled investigation of the functional roles of glutamate receptor family members.  Objective: In this review we describe the subunit structure and compn. of the ionotropic and metabotropic glutamate receptors and discuss their pharmacol., particularly with respect to selective tools useful for investigation of their function in the CNS.  Results: A large no. of ligands are now available that are selective either for glutamate receptor subfamilies or for particular receptor subtypes.  Such ligands have enabled considerable advances in the elucidation of the physiol. and pathophysiol. roles of receptor family members.  Furthermore, efficacy in animal models of neurol. and psychiatric disorders has supported the progression of several glutamatergic ligands into clin. studies.  These include ionotropic glutamate receptor antagonists, which have entered clin. trials for disorders including epilepsy and ischemic stroke, α-amino-3-hydroxy-5-methyl-4-isoazolepropionic acid (AMPA) receptor pos. allosteric modulators which are under evaluation as cognitive enhancers, and metabotropic glutamate receptor 2 (mGluR2) agonists which are undergoing clin. evaluation as anxiolytics.  Furthermore, preclin. studies have illustrated therapeutic potential for ligands selective for other receptor subtypes in various disorders.  These include mGluR1 antagonists in pain, mGluR5 antagonists in anxiety, pain and drug abuse and mGluR5 pos. allosteric modulators in schizophrenia.  Conclusions: Selective pharmacol. tools have enabled the study of glutamate receptors.  However, pharmacol. coverage of the family is incomplete and considerable scope remains for the development of novel ligands, particularly those with in vivo utility, and for the their use together with existing tools for the further investigation of the roles of receptor family members in CNS function and as potentially novel therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEJ0YO_TO0PbVg90H21EOLACvtfcHk0liveQvvq8FSXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtV2itbY%253D&md5=e9ac822d32082f7779cc202c59db4247</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs00213-005-2200-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-005-2200-z%26sid%3Dliteratum%253Aachs%26aulast%3DKew%26aufirst%3DJ.%2BN.%26aulast%3DKemp%26aufirst%3DJ.%2BA.%26atitle%3DIonotropic%2520and%2520metabotropic%2520glutamate%2520receptor%2520structure%2520and%2520pharmacology%26jtitle%3DPsychopharmacology%26date%3D2005%26volume%3D179%26spage%3D4%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Cartmell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Regulation of neurotransmitter release by metabotropic glutamate receptors</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">889</span><span class="NLM_x">–</span> <span class="NLM_lpage">907</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1046%2Fj.1471-4159.2000.0750889.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=10936169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtFykurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2000&pages=889-907&author=J.+Cartmellauthor=D.+D.+Schoepp&title=Regulation+of+neurotransmitter+release+by+metabotropic+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of neurotransmitter release by metabotropic glutamate receptors</span></div><div class="casAuthors">Cartmell, Jayne; Schoepp, Darryle D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">889-907</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review, with ∼145 refs.  The G protein-coupled metabotropic glutamate (mGlu) receptors are differentially localized at various synapses throughout the brain.  Depending on the receptor subtype, they appear to be localized at presynaptic and/or postsynaptic sites, including glial as well as neuronal elements.  The heterogeneous distribution of these receptors on glutamate and nonglutamate neurons/cells thus allows modulation of synaptic transmission by a no. of different mechanisms.  Electrophysiol. studies have demonstrated that the activation of mGlu receptors can modulate the activity of Ca2+ or K+ channels, or interfere with release processes downstream of Ca2+ entry, and consequently regulate neuronal synaptic activity.  Such changes evoked by mGlu receptors can ultimately regulate transmitter release at both glutamatergic and nonglutamatergic synapses.  Increasing neurochem. evidence has emerged, obtained from in vitro and in vivo studies, showing modulation of the release of a variety of transmitters by mGlu receptors.  This review addresses the neurochem. evidence for mGlu receptor-mediated regulation of neurotransmitters, such as excitatory and inhibitory amino acids, monoamines, and neuropeptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrRIHmsUn6YbVg90H21EOLACvtfcHk0liveQvvq8FSXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtFykurY%253D&md5=15379bf75d0949789eeaeaf4f9485460</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2000.0750889.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2000.0750889.x%26sid%3Dliteratum%253Aachs%26aulast%3DCartmell%26aufirst%3DJ.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DRegulation%2520of%2520neurotransmitter%2520release%2520by%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DJ.%2520Neurochem.%26date%3D2000%26volume%3D75%26spage%3D889%26epage%3D907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span> </span><span class="NLM_article-title">Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1016%2Fj.tips.2008.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=19058862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktlygsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=25-31&author=P.+J.+Connauthor=C.+W.+Lindsleyauthor=C.+K.+Jones&title=Activation+of+metabotropic+glutamate+receptors+as+a+novel+approach+for+the+treatment+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia</span></div><div class="casAuthors">Conn, P. Jeffrey; Lindsley, Craig W.; Jones, Carrie K.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-31</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In recent years, the metabotropic glutamate (mGlu) receptors have emerged as potential new drug targets for treatment of a range of CNS disorders.  Some of the most compelling advances have been made in targeting specific mGlu receptor subtypes as a fundamentally new approach to the treatment of schizophrenia.  Recent animal and clin. studies provide strong evidence that agonists of group II mGlu receptors (mGluR2 and mGluR3) are effective in the treatment of the pos. symptoms of schizophrenia, and animal studies suggest that mGluR5 agonists could provide a novel approach for the treatment of all major symptom domains (pos., neg., and cognitive) of this disorder.  Although the discovery of selective agonists of these receptors is a challenge, there have been recent advances in the discovery of highly selective pos. allosteric modulators (PAMs) of mGluR2 and mGluR5.  These mGlu receptor-selective PAMs have properties needed for optimization as clin. candidates and have robust effects in animal models that predict efficacy in treatment of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_CxX6LmkZObVg90H21EOLACvtfcHk0lg8a_qGlqi3sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktlygsg%253D%253D&md5=06ee21863b9528fb70211f87827b98ce</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2008.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2008.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DJones%26aufirst%3DC.%2BK.%26atitle%3DActivation%2520of%2520metabotropic%2520glutamate%2520receptors%2520as%2520a%2520novel%2520approach%2520for%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26spage%3D25%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Moghaddam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitt, D.</span><span> </span><span class="NLM_article-title">From Revolution to Evolution: the Glutamate Hypothesis of Schizophrenia and its Implication for Treatment</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1038%2Fnpp.2011.181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=21956446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ejs77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=4-15&author=B.+Moghaddamauthor=D.+Javitt&title=From+Revolution+to+Evolution%3A+the+Glutamate+Hypothesis+of+Schizophrenia+and+its+Implication+for+Treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment</span></div><div class="casAuthors">Moghaddam, Bita; Javitt, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-15</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Glutamate is the primary excitatory neurotransmitter in mammalian brain.  Disturbances in glutamate-mediated neurotransmission have been increasingly documented in a range of neuropsychiatric disorders including schizophrenia, substance abuse, mood disorders, Alzheimer's disease, and autism-spectrum disorders.  Glutamatergic theories of schizophrenia are based on the ability of N-methyl--aspartate receptor (NMDAR) antagonists to induce schizophrenia-like symptoms, as well as emergent literature documenting disturbances of NMDAR-related gene expression and metabolic pathways in schizophrenia.  Research over the past two decades has highlighted promising new targets for drug development based on potential pre- and postsynaptic, and glial mechanisms leading to NMDAR dysfunction.  Reduced NMDAR activity on inhibitory neurons leads to disinhibition of glutamate neurons increasing synaptic activity of glutamate, esp. in the prefrontal cortex.  Based on this mechanism, normalizing excess glutamate levels by metabotropic glutamate group 2/3 receptor agonists has led to potential identification of the first non-monoaminergic target with comparable efficacy as conventional antipsychotic drugs for treating pos. and neg. symptoms of schizophrenia.  In addn., NMDAR has intrinsic modulatory sites that are active targets for drug development, several of which show promise in preclin./early clin. trials targeting both symptoms and cognition.  To date, most studies have been done with orthosteric agonists and/or antagonists at specific sites.  However, allosteric modulators, both pos. and neg., may offer superior efficacy with less danger of downregulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeNMlez-A7MbVg90H21EOLACvtfcHk0lg8a_qGlqi3sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ejs77N&md5=0bf82fc0e3cb5c3ad2bed91414672e6f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2011.181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2011.181%26sid%3Dliteratum%253Aachs%26aulast%3DMoghaddam%26aufirst%3DB.%26aulast%3DJavitt%26aufirst%3DD.%26atitle%3DFrom%2520Revolution%2520to%2520Evolution%253A%2520the%2520Glutamate%2520Hypothesis%2520of%2520Schizophrenia%2520and%2520its%2520Implication%2520for%2520Treatment%26jtitle%3DNeuropsychopharmacology%26date%3D2012%26volume%3D37%26spage%3D4%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Patil, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreev, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avedisova, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardenstein, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurovich, I. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morozova, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosolov, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neznanov, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reznik, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smulevich, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tochilov, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1102</span><span class="NLM_x">–</span> <span class="NLM_lpage">1107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1038%2Fnm1632" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=17767166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVSgtrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1102-1107&author=S.+T.+Patilauthor=L.+Zhangauthor=F.+Martenyiauthor=S.+L.+Loweauthor=K.+A.+Jacksonauthor=B.+V.+Andreevauthor=A.+S.+Avedisovaauthor=L.+M.+Bardensteinauthor=I.+Y.+Gurovichauthor=M.+A.+Morozovaauthor=S.+N.+Mosolovauthor=N.+G.+Neznanovauthor=A.+M.+Reznikauthor=A.+B.+Smulevichauthor=V.+A.+Tochilovauthor=B.+G.+Johnsonauthor=J.+A.+Monnauthor=D.+D.+Schoepp&title=Activation+of+mGlu2%2F3+receptors+as+a+new+approach+to+treat+schizophrenia%3A+a+randomized+Phase+2+clinical+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial</span></div><div class="casAuthors">Patil, Sandeep T.; Zhang, Lu; Martenyi, Ferenc; Lowe, Stephen L.; Jackson, Kimberley A.; Andreev, Boris V.; Avedisova, Alla S.; Bardenstein, Leonid M.; Gurovich, Issak Y.; Morozova, Margarita A.; Mosolov, Sergey N.; Neznanov, Nikolai G.; Reznik, Alexander M.; Smulevich, Anatoly B.; Tochilov, Vladimir A.; Johnson, Bryan G.; Monn, James A.; Schoepp, Darryle D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1102-1107</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Schizophrenia is a chronic, complex and heterogeneous mental disorder, with pathol. features of disrupted neuronal excitability and plasticity within limbic structures of the brain.  These pathol. features manifest behaviorally as pos. symptoms (including hallucinations, delusions and thought disorder), neg. symptoms (such as social withdrawal, apathy and emotional blunting) and other psychopathol. symptoms (such as psychomotor retardation, lack of insight, poor attention and impulse control).  Altered glutamate neurotransmission has for decades been linked to schizophrenia, but all commonly prescribed antipsychotics act on dopamine receptors.  LY404039 is a selective agonist for metabotropic glutamate 2/3 (mGlu2/3) receptors and has shown antipsychotic potential in animal studies.  With data from rodents, we provide new evidence that mGlu2/3 receptor agonists work by a distinct mechanism different from that of olanzapine.  To clin. test this mechanism, an oral prodrug of LY404039 (LY2140023) was evaluated in schizophrenic patients with olanzapine as an active control in a randomized, three-armed, double-blind, placebo-controlled study.  Treatment with LY2140023, like treatment with olanzapine, was safe and well-tolerated; treated patients showed statistically significant improvements in both pos. and neg. symptoms of schizophrenia compared to placebo (P < 0.001 at week 4).  Notably, patients treated with LY2140023 did not differ from placebo-treated patients with respect to prolactin elevation, extrapyramidal symptoms or wt. gain.  These data suggest that mGlu2/3 receptor agonists have antipsychotic properties and may provide a new alternative for the treatment of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYtB0jdSzAQrVg90H21EOLACvtfcHk0lg8a_qGlqi3sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVSgtrvF&md5=afab88e888cba7e72e14c4e949f894d7</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnm1632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1632%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DS.%2BT.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DJackson%26aufirst%3DK.%2BA.%26aulast%3DAndreev%26aufirst%3DB.%2BV.%26aulast%3DAvedisova%26aufirst%3DA.%2BS.%26aulast%3DBardenstein%26aufirst%3DL.%2BM.%26aulast%3DGurovich%26aufirst%3DI.%2BY.%26aulast%3DMorozova%26aufirst%3DM.%2BA.%26aulast%3DMosolov%26aufirst%3DS.%2BN.%26aulast%3DNeznanov%26aufirst%3DN.%2BG.%26aulast%3DReznik%26aufirst%3DA.%2BM.%26aulast%3DSmulevich%26aufirst%3DA.%2BB.%26aulast%3DTochilov%26aufirst%3DV.%2BA.%26aulast%3DJohnson%26aufirst%3DB.%2BG.%26aulast%3DMonn%26aufirst%3DJ.%2BA.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DActivation%2520of%2520mGlu2%252F3%2520receptors%2520as%2520a%2520new%2520approach%2520to%2520treat%2520schizophrenia%253A%2520a%2520randomized%2520Phase%25202%2520clinical%2520trial%26jtitle%3DNat.%2520Med.%26date%3D2007%26volume%3D13%26spage%3D1102%26epage%3D1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">O’Neill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, S. N.</span><span> </span><span class="NLM_article-title">Recent developments in metabotropic glutamate receptors as novel drug targets</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1358%2Fdof.2010.035.04.1487693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslajtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=307-324&author=M.+J.+O%E2%80%99Neillauthor=M.+J.+Fellauthor=K.+A.+Svenssonauthor=J.+M.+Witkinauthor=S.+N.+Mitchell&title=Recent+developments+in+metabotropic+glutamate+receptors+as+novel+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in metabotropic glutamate receptors as novel drug targets</span></div><div class="casAuthors">O'Neill, M. J.; Fell, M. J.; Svensson, K. A.; Witkin, J. M.; Mitchell, S. N.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-324</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system, activating ionotropic (iGlu) and metabotropic (mGlu) glutamate receptors.  Targeting iGlu receptors has proven difficult, as these receptors play such a crit. role in fast synaptic transmission.  In recent years, there has been a switch in the focus of the pharmaceutical industry to target mGlu receptors, as these receptors have a more modulatory role in the brain.  Eight subtypes of the C protein-coupled mGlu receptors have been cloned and classified into three groups according to their second messenger assocn., sequence homol. and agonist selectivity.  Group I (mGlu1 and mGlu5) receptors are pos. coupled to phosphatidylinositol (PI) hydrolysis, while group II (mGlu2 and mGlu3) and group III (mGlu4, mGlu6, mGlu7 and mGlu8) receptors are neg. coupled to adenylate cyclase and thought to act as presynaptic autoreceptors, regulating glutamate transmission.  There has been rapid progress in understanding the biol. of mGlu receptors and their function in the central nervous system (CNS), and the field now has highly potent and selective ligands for many of the mGlu receptor subtypes.  Pharmacol. tools include both orthosteric and allosteric agonists and antagonists.  These mols. have been explored across a range of CNS conditions, the findings of which will be discussed briefly in this review.  Recently, some of the most promising mols. have progressed into clin. trials (mGlu2/3 receptor agonists for the treatment of anxiety and schizophrenia and mGlu5 receptor antagonists for acute migraine and L-DOPA-induced dyskinesia) and achieved proof of concept.  These encouraging results suggest mGlu receptors as novel drug targets with application in a range of psychiatric and neurol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC9EtQj2lZSbVg90H21EOLACvtfcHk0ljhGHwaYDmEZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslajtb4%253D&md5=1b51466a1778a814d0988eab288c623e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1358%2Fdof.2010.035.04.1487693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2010.035.04.1487693%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DM.%2BJ.%26aulast%3DFell%26aufirst%3DM.%2BJ.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26aulast%3DWitkin%26aufirst%3DJ.%2BM.%26aulast%3DMitchell%26aufirst%3DS.%2BN.%26atitle%3DRecent%2520developments%2520in%2520metabotropic%2520glutamate%2520receptors%2520as%2520novel%2520drug%2520targets%26jtitle%3DDrugs%2520Future%26date%3D2010%26volume%3D35%26spage%3D307%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkerton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosford, N. D. P.</span><span> </span><span class="NLM_article-title">Recent progress in the synthesis and characterization of group II metabotropic glutamate receptor allosteric modulators</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">382</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn200008d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksFaqtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=382-393&author=D.+J.+Shefflerauthor=A.+B.+Pinkertonauthor=R.+Dahlauthor=A.+Markouauthor=N.+D.+P.+Cosford&title=Recent+progress+in+the+synthesis+and+characterization+of+group+II+metabotropic+glutamate+receptor+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Progress in the Synthesis and Characterization of Group II Metabotropic Glutamate Receptor Allosteric Modulators</span></div><div class="casAuthors">Sheffler, Douglas J.; Pinkerton, Anthony B.; Dahl, Russell; Markou, Athina; Cosford, Nicholas D. P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">382-393</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Group II metabotropic glutamate (mGlu) receptors consist of the metabotropic glutamate 2 (mGlu2) and metabotropic glutamate 3 (mGlu3) receptor subtypes which modulate glutamate transmission by second messenger activation to neg. regulate the activity of adenylyl cyclase.  Excessive accumulation of glutamate in the perisynaptic extracellular region triggers mGlu2 and mGlu3 receptors to inhibit further release of glutamate.  There is growing evidence that the modulation of glutamatergic neurotransmission by small mol. modulators of Group II mGlu receptors has significant potential for the treatment of several neuropsychiatric and neurodegenerative diseases.  This review provides an overview of recent progress on the synthesis and pharmacol. characterization of pos. and neg. allosteric modulators of the Group II mGlu receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN3kTaVydOYbVg90H21EOLACvtfcHk0ljhGHwaYDmEZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksFaqtbg%253D&md5=98860a15e30c38b831332dcc82425f14</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fcn200008d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200008d%26sid%3Dliteratum%253Aachs%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26aulast%3DDahl%26aufirst%3DR.%26aulast%3DMarkou%26aufirst%3DA.%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26atitle%3DRecent%2520progress%2520in%2520the%2520synthesis%2520and%2520characterization%2520of%2520group%2520II%2520metabotropic%2520glutamate%2520receptor%2520allosteric%2520modulators%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D382%26epage%3D393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Wooley, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pemberton, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bate, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. M.</span><span> </span><span class="NLM_article-title">The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">196</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2008&pages=431-440&author=M.+L.+Wooleyauthor=D.+J.+Pembertonauthor=S.+Bateauthor=C.+Cortiauthor=D.+M.+Jones&title=The+mGlu2+but+not+the+mGlu3+receptor+mediates+the+actions+of+the+mGluR2%2F3+agonist%2C+LY379268%2C+in+mouse+models+predictive+of+antipsychotic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWooley%26aufirst%3DM.%2BL.%26aulast%3DPemberton%26aufirst%3DD.%2BJ.%26aulast%3DBate%26aufirst%3DS.%26aulast%3DCorti%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DD.%2BM.%26atitle%3DThe%2520mGlu2%2520but%2520not%2520the%2520mGlu3%2520receptor%2520mediates%2520the%2520actions%2520of%2520the%2520mGluR2%252F3%2520agonist%252C%2520LY379268%252C%2520in%2520mouse%2520models%2520predictive%2520of%2520antipsychotic%2520activity%26jtitle%3DPsychopharmacology%26date%3D2008%26volume%3D196%26spage%3D431%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Fell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (−)-(1R,4S,5S,6S)-4-Amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic Acid (LY404039)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1124%2Fjpet.108.136861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=18424625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotlyltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2008&pages=209-217&author=M.+J.+Fellauthor=K.+A.+Svenssonauthor=B.+G.+Johnsonauthor=D.+D.+Schoepp&title=Evidence+for+the+role+of+metabotropic+glutamate+%28mGlu%292+not+mGlu3+receptors+in+the+preclinical+antipsychotic+pharmacology+of+the+mGlu2%2F3+receptor+agonist+%28%E2%88%92%29-%281R%2C4S%2C5S%2C6S%29-4-Amino-2-sulfonylbicyclo%5B3.1.0%5Dhexane-4%2C6-dicarboxylic+Acid+%28LY404039%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039)</span></div><div class="casAuthors">Fell, Matthew J.; Svensson, Kjell A.; Johnson, Bryan G.; Schoepp, Darryle D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">209-217</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">(-)-(1R,4S,5S,6S)-4-Amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039) is a potent and selective group II metabotropic glutamate [(mGlu)2 and mGlu3] receptor agonist for which its prodrug LY2140023 [(1R,4S,5S,6S)-2-thiabicyclo[3.1.0]-hexane-4,6-dicarboxylic acid,4-[(2S)-2-amino-4-(methylthio)-1-oxobutyl]amino-, 2,2-dioxide monohydrate] has recently been shown to have efficacy in the treatment of the pos. and neg. symptoms of schizophrenia.  In this article, we use mGlu receptor-deficient mice to investigate the relative contribution of mGlu2 and mGlu3 receptors in mediating the antipsychotic profile of LY404039 in the phencyclidine (PCP) and d-amphetamine (AMP) models of psychosis.  To further explore the mechanism of action of LY404039, we compared the drugs' ability to block PCP-induced hyperlocomotion to that of atypical antipsychotics in wild-type and mice lacking mGlu2/3 receptors.  In wild-type animals, LY404039 (3-30 mg/kg i.p.) significantly reversed AMP (5 mg/kg, i.p.)-induced increases in ambulations, distance traveled, and reduced time spent at rest.  LY404039 reversed PCP (7.5 mg/kg i.p.)-evoked behaviors at 10 mg/kg.  The antipsychotic-like effects of LY404039 (10 mg/kg i.p.) on PCP and AMP-evoked behavioral activation were absent in mGlu2 and mGlu2/3 but not in mGlu3 receptor-deficient mice, indicating that the activation of mGlu2 and not mGlu3 receptors is responsible for the antipsychotic-like effects of the mGlu2/3 receptor agonist LY404039.  In contrast, the atypical antipsychotic drugs clozapine and risperidone inhibited PCP-evoked behaviors in both wild-type and mGlu2/3 receptor-deficient mice.  These data demonstrate that the antipsychotic-like effects of the mGlu2/3 receptor agonist LY404039 in psychostimulant models of psychosis are mechanistically distinct from those of atypical antipsychotic drugs and are dependent on functional mGlu2 and not mGlu3 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQQM2jpXbmkLVg90H21EOLACvtfcHk0ljhGHwaYDmEZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotlyltrw%253D&md5=795527aeddef2ee2829f2ae2c6803b6e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.136861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.136861%26sid%3Dliteratum%253Aachs%26aulast%3DFell%26aufirst%3DM.%2BJ.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26aulast%3DJohnson%26aufirst%3DB.%2BG.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DEvidence%2520for%2520the%2520role%2520of%2520metabotropic%2520glutamate%2520%2528mGlu%25292%2520not%2520mGlu3%2520receptors%2520in%2520the%2520preclinical%2520antipsychotic%2520pharmacology%2520of%2520the%2520mGlu2%252F3%2520receptor%2520agonist%2520%2528%25E2%2588%2592%2529-%25281R%252C4S%252C5S%252C6S%2529-4-Amino-2-sulfonylbicyclo%255B3.1.0%255Dhexane-4%252C6-dicarboxylic%2520Acid%2520%2528LY404039%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D326%26spage%3D209%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Levine, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaydos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goddard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feighner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">The mGlu2/3 receptor agonist, LY354740, reduces panic anxiety induced by a CO<sub>2</sub> challenge in patients diagnosed with panic disorder</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=294-294&author=L.+Levineauthor=B.+Gaydosauthor=D.+Sheehanauthor=A.+Goddardauthor=J.+Feighnerauthor=W.+Potterauthor=D.+D.+Schoepp&title=The+mGlu2%2F3+receptor+agonist%2C+LY354740%2C+reduces+panic+anxiety+induced+by+a+CO2+challenge+in+patients+diagnosed+with+panic+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevine%26aufirst%3DL.%26aulast%3DGaydos%26aufirst%3DB.%26aulast%3DSheehan%26aufirst%3DD.%26aulast%3DGoddard%26aufirst%3DA.%26aulast%3DFeighner%26aufirst%3DJ.%26aulast%3DPotter%26aufirst%3DW.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DThe%2520mGlu2%252F3%2520receptor%2520agonist%252C%2520LY354740%252C%2520reduces%2520panic%2520anxiety%2520induced%2520by%2520a%2520CO2%2520challenge%2520in%2520patients%2520diagnosed%2520with%2520panic%2520disorder%26jtitle%3DNeuropharmacology%26date%3D2002%26volume%3D43%26spage%3D294%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Pin, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prezeau, L.</span><span> </span><span class="NLM_article-title">Positive allosteric modulators for γ-aminobutyric acid<sub>B</sub> receptors open new routes for the development of drugs targeting family 3 G-protein-coupled receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">884</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=881-884&author=J.-P.+Pinauthor=M.-L.+Parmentierauthor=L.+Prezeau&title=Positive+allosteric+modulators+for+%CE%B3-aminobutyric+acidB+receptors+open+new+routes+for+the+development+of+drugs+targeting+family+3+G-protein-coupled+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPin%26aufirst%3DJ.-P.%26aulast%3DParmentier%26aufirst%3DM.-L.%26aulast%3DPrezeau%26aufirst%3DL.%26atitle%3DPositive%2520allosteric%2520modulators%2520for%2520%25CE%25B3-aminobutyric%2520acidB%2520receptors%2520open%2520new%2520routes%2520for%2520the%2520development%2520of%2520drugs%2520targeting%2520family%25203%2520G-protein-coupled%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D60%26spage%3D881%26epage%3D884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Gjoni, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urwyler, S.</span><span> </span><span class="NLM_article-title">Receptor activation involving positive allosteric modulation, unlike full agonism, does not result in GABA<sub>B</sub> receptor desensitization</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1293</span><span class="NLM_x">–</span> <span class="NLM_lpage">1299</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=1293-1299&author=T.+Gjoniauthor=S.+Urwyler&title=Receptor+activation+involving+positive+allosteric+modulation%2C+unlike+full+agonism%2C+does+not+result+in+GABAB+receptor+desensitization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGjoni%26aufirst%3DT.%26aulast%3DUrwyler%26aufirst%3DS.%26atitle%3DReceptor%2520activation%2520involving%2520positive%2520allosteric%2520modulation%252C%2520unlike%2520full%2520agonism%252C%2520does%2520not%2520result%2520in%2520GABAB%2520receptor%2520desensitization%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26spage%3D1293%26epage%3D1299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Melancon, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmitte, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Allosteric modulation of seven transmembrane spanning receptors: Theory, Practice, and opportunities for Central Nervous System Drug Discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1445</span><span class="NLM_x">–</span> <span class="NLM_lpage">1464</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201139r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1SmurnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1445-1464&author=B.+J.+Melanconauthor=C.+R.+Hopkinsauthor=M.+R.+Woodauthor=K.+A.+Emmitteauthor=C.+M.+Niswenderauthor=A.+Christopoulosauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=Allosteric+modulation+of+seven+transmembrane+spanning+receptors%3A+Theory%2C+Practice%2C+and+opportunities+for+Central+Nervous+System+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug Discovery</span></div><div class="casAuthors">Melancon, Bruce J.; Hopkins, Corey R.; Wood, Michael R.; Emmitte, Kyle A.; Niswender, Colleen M.; Christopoulos, Arthur; Conn, P. Jeffrey; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1445-1464</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Allosteric modulation of Seven transmembrane spanning receptors and the opportunities for CNS drug discovery is reviewed here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlr4lj_Wp-O7Vg90H21EOLACvtfcHk0ljGPfAY7Vmu0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1SmurnJ&md5=7c70f066f1581f1ff327c0dce37bb0e1</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm201139r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201139r%26sid%3Dliteratum%253Aachs%26aulast%3DMelancon%26aufirst%3DB.%2BJ.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DAllosteric%2520modulation%2520of%2520seven%2520transmembrane%2520spanning%2520receptors%253A%2520Theory%252C%2520Practice%252C%2520and%2520opportunities%2520for%2520Central%2520Nervous%2520System%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1445%26epage%3D1464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span> </span><span class="NLM_article-title">Progress in the development of positive allosteric modulators of the metabotropic glutamate receptor 2</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.2174%2F092986711793979706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=21110815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslahs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=47-68&author=A.+A.+Trabancoauthor=J.+M.+Cidauthor=H.+Lavreysenauthor=G.+J.+Macdonaldauthor=G.+Tresadern&title=Progress+in+the+development+of+positive+allosteric+modulators+of+the+metabotropic+glutamate+receptor+2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the development of positive allosteric modulators of the metabotropic glutamate receptor 2</span></div><div class="casAuthors">Trabanco, A. A.; Cid, J. M.; Lavreysen, H.; MacDonald, G. J.; Tresadern, G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-68</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The metabotropic glutamate type 2 (mGlu2) receptor is a G-protein coupled receptor (GPCR) expressed on presynaptic nerve terminals where it neg. modulates glutamate and GABA release.  Mixed mGlu2/mGlu3 orthosteric agonists such as LY354740 have shown activity in a range of preclin. animal models of anxiety and schizophrenia.  Clin. work with LY354740 demonstrated activity in a CO2 inhalation study suggesting application in the treatment of anxiety related disorders.  Subsequently, a related prodrug LY2140023 demonstrated improvements in pos. and neg. symptoms in patients suffering from schizophrenia.  These mols. exhibit combined mGlu2/mGlu3 activity although there is evidence from knock-out studies that preclin. anti-psychotic effects may be mediated via the mGlu2 receptor.  An alternative avenue for modulating GPCRs is to act via allosteric mechanisms, binding at a different site from the orthosteric agonist.  Since the first discovery of mGlu2 pos. allosteric modulators (PAMs) such as 2,2,2-TEMPS and BINA, multiple families of mGlu2 modulators have been reported and several have entered into clin. development.  This review focuses on recent advances in the development of novel mGlu2 PAMs by anal. of compds. disclosed in research articles and patent literature between 2007 and 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkHtOXKWJY9rVg90H21EOLACvtfcHk0ljGPfAY7Vmu0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslahs7g%253D&md5=b4059bdfb0001b97cde8ec0e30032a48</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F092986711793979706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711793979706%26sid%3Dliteratum%253Aachs%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DTresadern%26aufirst%3DG.%26atitle%3DProgress%2520in%2520the%2520development%2520of%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25202%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D47%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Passchier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willemsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaalburg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Waarde, A.</span><span> </span><span class="NLM_article-title">Measuring drug-related receptor occupancy with positron emission tomography</span> <span class="citation_source-journal">Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=278-286&author=J.+Passchierauthor=A.+Geeauthor=A.+Willemsenauthor=W.+Vaalburgauthor=A.+van+Waarde&title=Measuring+drug-related+receptor+occupancy+with+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPasschier%26aufirst%3DJ.%26aulast%3DGee%26aufirst%3DA.%26aulast%3DWillemsen%26aufirst%3DA.%26aulast%3DVaalburg%26aufirst%3DW.%26aulast%3Dvan%2BWaarde%26aufirst%3DA.%26atitle%3DMeasuring%2520drug-related%2520receptor%2520occupancy%2520with%2520positron%2520emission%2520tomography%26jtitle%3DMethods%26date%3D2002%26volume%3D27%26spage%3D278%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tauscher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gründer, G.</span><span> </span><span class="NLM_article-title">The role of imaging in proof of concept for CNS drug discovery and development</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1038%2Fnpp.2008.166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=18843264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVyru7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=187-203&author=D.+F.+Wongauthor=J.+Tauscherauthor=G.+Gr%C3%BCnder&title=The+role+of+imaging+in+proof+of+concept+for+CNS+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The Role of Imaging in Proof of Concept for CNS Drug Discovery and Development</span></div><div class="casAuthors">Wong, Dean F.; Tauscher, Johannes; Grunder, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">187-203</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Neuroimaging, particularly that of neuroreceptor radioisotope and functional magnetic resonance imaging (fMRI), has played a fundamental role in neuropharmacol. and neurophysiol.  Because of the unique and pioneering role, esp. of the radiolabeling of central nervous system (CNS) drugs for receptor and neurotransmitter system imaging, there is an increasingly major role to aid in CNS drug development.  One component is providing evidence for proof of concept of the target for which candidate drugs are being tested for receptor occupancy mechanism of action and ultimately rational drug dosing.  There is also a role for other areas of neuroimaging, including fMRI and magnetic resonance spectroscopy in other magnetic resonance-based techniques that, together with radioisotope imaging, represent CNS mol. imaging.  ' The role of these approaches and a review of the recent advances in such neuroimaging for proof-of-concept studies is the subject for this paper.  Moreover, hypothetical examples and possible algorithms for early discovery/phase I development using neuroimaging provide specific working approaches.  In summary, this article reviews the vital biomarker approach of neuroimaging in proof of concept studies.  Neuropsychopharmacol. (2009) 34, 187-203; doi:10.1038/npp.2008.166; published online 8 Oct. 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8I0KCciAqxbVg90H21EOLACvtfcHk0ljK1oJ_FXwxxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVyru7rN&md5=c5c7b9b30303e57ceabf287e7eec35b6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2008.166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2008.166%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DTauscher%26aufirst%3DJ.%26aulast%3DGr%25C3%25BCnder%26aufirst%3DG.%26atitle%3DThe%2520role%2520of%2520imaging%2520in%2520proof%2520of%2520concept%2520for%2520CNS%2520drug%2520discovery%2520and%2520development%26jtitle%3DNeuropsychopharmacology%26date%3D2009%26volume%3D34%26spage%3D187%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Wang, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brownell, A.-L.</span><span> </span><span class="NLM_article-title">Development of metabotropic glutamate receptor ligands for neuroimaging</span> <span class="citation_source-journal">Curr. Med. Imaging Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.2174%2F157340507781387059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFKhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=186-205&author=J.+Q.+Wangauthor=A.-L.+Brownell&title=Development+of+metabotropic+glutamate+receptor+ligands+for+neuroimaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Development of metabotropic glutamate receptor ligands for neuroimaging</span></div><div class="casAuthors">Wang, Ji-Quan; Brownell, Anna-Liisa</div><div class="citationInfo"><span class="NLM_cas:title">Current Medical Imaging Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">186-205</span>CODEN:
                <span class="NLM_cas:coden">CMIRCV</span>;
        ISSN:<span class="NLM_cas:issn">1573-4056</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Metabotropic glutamate receptors (mGluRs) belong to a superfamily of G protein coupled receptors.  In the central nervous system (CNS), mGluRs modulate glutamatergic neurotransmission and are considered to affect also on dopaminergic and adrenergic neurotransmission.  MGluRs have various physiol. functions in CNS and are suggested to be involved in a no. of neurol. disorders.  Receptor ligands binding to mGluRs are also considered as potential therapeutic agents.  Classic competitive ligands, which are amino acid derivs., bind to the orthosteric binding site as endogenous glutamate.  It is believed that developing highly selective competitive agonists and antagonists for specific mGluR subtypes has been exceedingly difficult, because of the high conservation of the glutamate binding site across members of this receptor family and the restricted structural requirements for pharmacophores that occupy the binding pocket.  Another shortcoming of this kind of ligands is that the carboxyl and amino groups make them too polar to penetrate the blood brain barrier.  Although these ligands have had and still have important roles in elucidating physiol. and pathophysiol. properties of mGluRs, their poor selectivity within group presupposes some knowledge of complexity.  In addn., their poor CNS penetration limits their candidacy as promising radiotracers for in vivo imaging of mGluRs.  Over the last decade, a no. of non-competitive mGluR ligands, which are structurally diverse and bind to mGluRs in the allosteric binding sites located in the seven strand transmembrane domain, have been identified.  These include neg., pos. and neutral allosteric modulators.  Modulating mGlu receptor activity through an allosteric binding site is a relatively new strategy with the first example appeared in 1996.  Based on these modulators, a no. of radiotracers useful for imaging specific metabotropic glutamate receptors have been developed and their in vivo biol. properties have been characterized.  We have developed five ligands for PET imaging of metabotropic glutamate subgroup 5 receptors and investigated mGluR functions in animal models of different neurodegenerative disorders.  In this review we evaluate our data in comparison to the theor. and exptl. aspects of developing selective and sensitive imaging ligands for in vivo imaging.  Emphasis will be given to those highly potent and subtype selective allosteric modulators which are good candidates for radiolabeling with fluorine-18 and carbon-11.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroGRnZuSavsLVg90H21EOLACvtfcHk0ljK1oJ_FXwxxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFKhtL8%253D&md5=013394d5d92261cbb092743387a6f6a4</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F157340507781387059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157340507781387059%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%2BQ.%26aulast%3DBrownell%26aufirst%3DA.-L.%26atitle%3DDevelopment%2520of%2520metabotropic%2520glutamate%2520receptor%2520ligands%2520for%2520neuroimaging%26jtitle%3DCurr.%2520Med.%2520Imaging%2520Rev.%26date%3D2007%26volume%3D3%26spage%3D186%26epage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Yu, M.</span><span> </span><span class="NLM_article-title">Recent developments of the PET imaging agents for metabotropic glutamate receptor subtype 5</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1800</span><span class="NLM_x">–</span> <span class="NLM_lpage">1805</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.2174%2F156802607782507394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=17979788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVOrtb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1800-1805&author=M.+Yu&title=Recent+developments+of+the+PET+imaging+agents+for+metabotropic+glutamate+receptor+subtype+5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments of the PET imaging agents for metabotropic glutamate receptor subtype 5</span></div><div class="casAuthors">Yu, Meixiang</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1800-1805</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Glutamate is a major excitatory neurotransmitter in central nervous system (CNS) acting through ionotropic and G-protein coupled metabotropic glutamate receptors.  Metabotropic glutamate receptor 5 (mGluR5), a subtype in the group I mGluRs, presents in high d. in many brain regions (hippocampus, cortex and olfactory system).  Stimulation of mGluR5 leads to the release of calcium from intracellular supplies and protein kinase C activation.  Excessive activation of mGluR5 has been assocd. with psychiatric, neurol. and neurodegenerative diseases, including Parkinson's disease, anxiety, depression, schizophrenia, pain, epilepsy, focal and global ischemia diseases.  2-Methyl-6-(phenylethynyl)pyridine (MPEP) and 2-methyl-4-(pyridin-3-ylethynyl)thiazole (MTEP) are the first generation of non-competitive mGluR5 antagonists with potent, selective and systemically active properties.  They have therapeutic functions in varied diseases.  Investigation of mGluR5 physiol. functions under pathol. conditions in patients will be critically important in mGluR5 antagonist's therapy using noninvasive positron emission tomog. (PET) imaging technique.  There are eleven mGluR5 imaging PET tracers have been tested in animal studies.  This article highlights efforts on the design and development of novel PET tracers for mGluR5 in vivo imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwdizkEifPW7Vg90H21EOLACvtfcHk0ljK1oJ_FXwxxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVOrtb3J&md5=da0bd73681b5b7ed9fe41bb4fc4c3560</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2174%2F156802607782507394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607782507394%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DM.%26atitle%3DRecent%2520developments%2520of%2520the%2520PET%2520imaging%2520agents%2520for%2520metabotropic%2520glutamate%2520receptor%2520subtype%25205%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D1800%26epage%3D1805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Seneca, N.</span><span> </span><span class="NLM_article-title">Recent advances in positron emission tomography imaging of the brain</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">613</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1WgtrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=601-613&author=N.+Seneca&title=Recent+advances+in+positron+emission+tomography+imaging+of+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in positron emission tomography imaging of brain</span></div><div class="casAuthors">Seneca, N.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">601-613</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Positron emission tomog. (PET) has been widely used to non-invasively study various functions of the brain, the pathophysiol. of disease and aid in drug development.  PET and selective radiolabeled mols. allow imaging of certain crit. components of the functioning of healthy and diseased brain.  The shortage of available PET radioligands for studying the functioning of the brain is a major limiting factor for expanding their use in research and implementation in a clin. setting.  Thus, the development of novel PET radioligands for further understanding brain functions is a key factor for advancement in the field.  This article provides an overview of recent developments of novel PET radioligands for imaging various functions of healthy and diseased brain, highlighting the recent development of novel PET radioligands for a monoamine transporter, describing the use of pharmacol. challenges combined with PET imaging to measure neurotransmitter release and potential imaging biomarkers of disease pathol.  In summary, the article reviews recent developments in the field of PET imaging of the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqat_lYq2YPrVg90H21EOLACvtfcHk0lgxcc_TSHhavA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1WgtrbJ&md5=c6763478d90ebe7e4d67661ca337c0b0</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeneca%26aufirst%3DN.%26atitle%3DRecent%2520advances%2520in%2520positron%2520emission%2520tomography%2520imaging%2520of%2520the%2520brain%26jtitle%3DDrugs%2520Future%26date%3D2011%26volume%3D36%26spage%3D601%26epage%3D613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Fujinaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asagawa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nengaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.-R.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of novel radioligands for positron emission tomography imaging of metabotropic glutamate receptor subtype 1 (mGluR1) in rodent brain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2342</span><span class="NLM_x">–</span> <span class="NLM_lpage">2352</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201590g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2342-2352&author=M.+Fujinagaauthor=T.+Yamasakiauthor=J.+Yuiauthor=A.+Hatoriauthor=L.+Xieauthor=K.+Kawamuraauthor=C.+Asagawaauthor=K.+Kumataauthor=Y.+Yoshidaauthor=M.+Ogawaauthor=N.+Nengakiauthor=T.+Fukumuraauthor=M.-R.+Zhang&title=Synthesis+and+evaluation+of+novel+radioligands+for+positron+emission+tomography+imaging+of+metabotropic+glutamate+receptor+subtype+1+%28mGluR1%29+in+rodent+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm201590g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201590g%26sid%3Dliteratum%253Aachs%26aulast%3DFujinaga%26aufirst%3DM.%26aulast%3DYamasaki%26aufirst%3DT.%26aulast%3DYui%26aufirst%3DJ.%26aulast%3DHatori%26aufirst%3DA.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DKawamura%26aufirst%3DK.%26aulast%3DAsagawa%26aufirst%3DC.%26aulast%3DKumata%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DY.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DNengaki%26aufirst%3DN.%26aulast%3DFukumura%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DM.-R.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520novel%2520radioligands%2520for%2520positron%2520emission%2520tomography%2520imaging%2520of%2520metabotropic%2520glutamate%2520receptor%2520subtype%25201%2520%2528mGluR1%2529%2520in%2520rodent%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2342%26epage%3D2352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Wang, J.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuruppu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brownell, A.-L.</span><span> </span><span class="NLM_article-title">Radiosynthesis of PET radiotracer as a prodrug for imaging group II metabotropic glutamate recepotors in vivo</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1958</span><span class="NLM_x">–</span> <span class="NLM_lpage">1962</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1958-1962&author=J.-Q.+Wangauthor=Z.+Zhangauthor=D.+Kuruppuauthor=A.-L.+Brownell&title=Radiosynthesis+of+PET+radiotracer+as+a+prodrug+for+imaging+group+II+metabotropic+glutamate+recepotors+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.-Q.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DKuruppu%26aufirst%3DD.%26aulast%3DBrownell%26aufirst%3DA.-L.%26atitle%3DRadiosynthesis%2520of%2520PET%2520radiotracer%2520as%2520a%2520prodrug%2520for%2520imaging%2520group%2520II%2520metabotropic%2520glutamate%2520recepotors%2520in%2520vivo%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1958%26epage%3D1962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nhem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furnari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluzeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lucas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himogai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlirch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahnaou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drinkenburg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">Discovery of 1,4-disubstituted 3-cyano-2-pyridones: a new class of positive allosteric modulators of the metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2388</span><span class="NLM_x">–</span> <span class="NLM_lpage">2405</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2016864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2388-2405&author=J.+M.+Cidauthor=G.+Duveyauthor=G.+Tresadernauthor=V.+Nhemauthor=R.+Furnariauthor=P.+Cluzeauauthor=J.+A.+Vegaauthor=A.+I.+De+Lucasauthor=E.+Matesanzauthor=J.+M.+Alonsoauthor=M.+L.+Linaresauthor=J.+I.+Andresauthor=S.+M.+Poliauthor=R.+Lutjensauthor=H.+Himogaiauthor=J.-P.+Rocherauthor=G.+J.+Macdonaldauthor=D.+Oehlirchauthor=H.+Lavreysenauthor=A.+Ahnaouauthor=W.+Drinkenburgauthor=C.+Mackieauthor=A.+A.+Trabanco&title=Discovery+of+1%2C4-disubstituted+3-cyano-2-pyridones%3A+a+new+class+of+positive+allosteric+modulators+of+the+metabotropic+glutamate+2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm2016864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2016864%26sid%3Dliteratum%253Aachs%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DDuvey%26aufirst%3DG.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DNhem%26aufirst%3DV.%26aulast%3DFurnari%26aufirst%3DR.%26aulast%3DCluzeau%26aufirst%3DP.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3DDe%2BLucas%26aufirst%3DA.%2BI.%26aulast%3DMatesanz%26aufirst%3DE.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DLinares%26aufirst%3DM.%2BL.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DPoli%26aufirst%3DS.%2BM.%26aulast%3DLutjens%26aufirst%3DR.%26aulast%3DHimogai%26aufirst%3DH.%26aulast%3DRocher%26aufirst%3DJ.-P.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DOehlirch%26aufirst%3DD.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DAhnaou%26aufirst%3DA.%26aulast%3DDrinkenburg%26aufirst%3DW.%26aulast%3DMackie%26aufirst%3DC.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3DDiscovery%2520of%25201%252C4-disubstituted%25203-cyano-2-pyridones%253A%2520a%2520new%2520class%2520of%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2388%26epage%3D2405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Van der Linden, I.; Peeters, L.; Biesmans, I.; Andrés, J. I.; Vliegen, M.; Te Riele, P.; Langlois, X.; Atack, J. R.; Lavreysen, H.</span><span> </span><span class="NLM_article-title">In vitro Characterization of the Binding of the mGlu2 Receptor Positive Allosteric Modulator [<sup>3</sup>H]JNJ-40068782 to Native and Recombinant mGlu2 Receptors</span>. 7th Int. Meeting on Metabotropic Glutamate Receptors<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">, </span>Taormina, Italy.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=I.+Van+der+Linden&author=L.+Peeters&author=I.+Biesmans&author=J.+I.+Andr%C3%A9s&author=M.+Vliegen&author=P.+Te+Riele&author=X.+Langlois&author=J.+R.+Atack&author=H.+Lavreysen&title=In+vitro+Characterization+of+the+Binding+of+the+mGlu2+Receptor+Positive+Allosteric+Modulator+%5B3H%5DJNJ-40068782+to+Native+and+Recombinant+mGlu2+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BLinden%26aufirst%3DI.%26atitle%3DIn%2520vitro%2520Characterization%2520of%2520the%2520Binding%2520of%2520the%2520mGlu2%2520Receptor%2520Positive%2520Allosteric%2520Modulator%2520%255B3H%255DJNJ-40068782%2520to%2520Native%2520and%2520Recombinant%2520mGlu2%2520Receptors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cid-Nuñez, J. M.; Oehlrich, D.; Trabanco-Suárez, A. A.; Tresadern, G. J.; Vega-Ramiro, J. A.; Macdonald, G. J.</span><span> </span><span class="NLM_article-title">1,2,4-Triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders</span>. PCT Int. Appl.WO2010130424, November 18,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+M.+Cid-Nu%C3%B1ez&author=D.+Oehlrich&author=A.+A.+Trabanco-Su%C3%A1rez&author=G.+J.+Tresadern&author=J.+A.+Vega-Ramiro&author=G.+J.+Macdonald&title=1%2C2%2C4-Triazolo%5B4%2C3-a%5Dpyridine+derivatives+and+their+use+for+the+treatment+or+prevention+of+neurological+and+psychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCid-Nu%25C3%25B1ez%26aufirst%3DJ.%2BM.%26atitle%3D1%252C2%252C4-Triazolo%255B4%252C3-a%255Dpyridine%2520derivatives%2520and%2520their%2520use%2520for%2520the%2520treatment%2520or%2520prevention%2520of%2520neurological%2520and%2520psychiatric%2520disorders%26jtitle%3DPCT%2520Int.%2520Appl.%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cid-Nunez, J. M.; De Lucas Olivares, A. I.; Trabanco-Suarez, A. A.; Macdonald, G. J.</span><span> </span><span class="NLM_article-title">7-Aryl-1,2,4-triazolo[4,3-a]pyridine derivatives as positive allosteric modulators of mGluR2 receptors and their preparation, pharmaceutical compositions and use in the treatment of CNS disorders</span>. PCT Int. Appl.WO2010130423, November 18,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+M.+Cid-Nunez&author=A.+I.+De+Lucas+Olivares&author=A.+A.+Trabanco-Suarez&author=G.+J.+Macdonald&title=7-Aryl-1%2C2%2C4-triazolo%5B4%2C3-a%5Dpyridine+derivatives+as+positive+allosteric+modulators+of+mGluR2+receptors+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+CNS+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCid-Nunez%26aufirst%3DJ.%2BM.%26atitle%3D7-Aryl-1%252C2%252C4-triazolo%255B4%252C3-a%255Dpyridine%2520derivatives%2520as%2520positive%2520allosteric%2520modulators%2520of%2520mGluR2%2520receptors%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520CNS%2520disorders%26jtitle%3DPCT%2520Int.%2520Appl.%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cid-Nunez, J. M.; De Lucas Olivares, A. I.; Trabanco-Suarez, A. A.; Macdonald, G. J.</span><span> </span><span class="NLM_article-title">1,2,4-Triazolo[4,3-a]pyridine derivatives as mGluR2 modulators and their preparation and use for the treatment of CNS diseases</span>. PCT Int. Appl.WO2010130422, November 18,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+M.+Cid-Nunez&author=A.+I.+De+Lucas+Olivares&author=A.+A.+Trabanco-Suarez&author=G.+J.+Macdonald&title=1%2C2%2C4-Triazolo%5B4%2C3-a%5Dpyridine+derivatives+as+mGluR2+modulators+and+their+preparation+and+use+for+the+treatment+of+CNS+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCid-Nunez%26aufirst%3DJ.%2BM.%26atitle%3D1%252C2%252C4-Triazolo%255B4%252C3-a%255Dpyridine%2520derivatives%2520as%2520mGluR2%2520modulators%2520and%2520their%2520preparation%2520and%2520use%2520for%2520the%2520treatment%2520of%2520CNS%2520diseases%26jtitle%3DPCT%2520Int.%2520Appl.%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="note"><p class="first last">Manuscripts describing further results of the Medicinal Chemistry exploration around the 1,4-disubstituted-2-pyridones and the 1,2,4-Triazolo[4,3-a]pyridines are in progress and will be reported elsewhere.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topiol, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poda, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasena, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doller, D.</span><span> </span><span class="NLM_article-title">Design and synthesis of 4-arylpiperidinyl amide and <i>N</i>-arylpiperidin-3-yl-cyclopropane carboxamide derivatives as novel melatonin receptor ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1236</span><span class="NLM_x">–</span> <span class="NLM_lpage">1242</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1236-1242&author=G.+Liauthor=H.+Zhouauthor=Y.+Jiangauthor=H.+Keimauthor=S.+W.+Topiolauthor=S.+B.+Podaauthor=Y.+Renauthor=G.+Chandrasenaauthor=D.+Doller&title=Design+and+synthesis+of+4-arylpiperidinyl+amide+and+N-arylpiperidin-3-yl-cyclopropane+carboxamide+derivatives+as+novel+melatonin+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DKeim%26aufirst%3DH.%26aulast%3DTopiol%26aufirst%3DS.%2BW.%26aulast%3DPoda%26aufirst%3DS.%2BB.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DChandrasena%26aufirst%3DG.%26aulast%3DDoller%26aufirst%3DD.%26atitle%3DDesign%2520and%2520synthesis%2520of%25204-arylpiperidinyl%2520amide%2520and%2520N-arylpiperidin-3-yl-cyclopropane%2520carboxamide%2520derivatives%2520as%2520novel%2520melatonin%2520receptor%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D1236%26epage%3D1242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Alcázar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diels, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoentjes, B.</span><span> </span><span class="NLM_article-title">Reproducibility across microwave instruments: First example of genuine parallel scale up of compounds under microwave irradiation</span> <span class="citation_source-journal">QSAR Comb. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">906</span><span class="NLM_x">–</span> <span class="NLM_lpage">910</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=906-910&author=J.+Alc%C3%A1zarauthor=G.+Dielsauthor=B.+Schoentjes&title=Reproducibility+across+microwave+instruments%3A+First+example+of+genuine+parallel+scale+up+of+compounds+under+microwave+irradiation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlc%25C3%25A1zar%26aufirst%3DJ.%26aulast%3DDiels%26aufirst%3DG.%26aulast%3DSchoentjes%26aufirst%3DB.%26atitle%3DReproducibility%2520across%2520microwave%2520instruments%253A%2520First%2520example%2520of%2520genuine%2520parallel%2520scale%2520up%2520of%2520compounds%2520under%2520microwave%2520irradiation%26jtitle%3DQSAR%2520Comb.%2520Sci.%26date%3D2004%26volume%3D23%26spage%3D906%26epage%3D910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="note"><p class="first last">See ref <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">25</a>. CA registry no. 1152617-14-5.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="note"><p class="first last">See ref <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">25</a>. CA registry no. 1254981-17-3.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="note"><p class="first last">See ref <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">25</a>. CA registry no. 1254981-30-0.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Pike, V. W.</span><span> </span><span class="NLM_article-title">PET Radiotracers: Crossing the Blood-Brain Barrier and Surviving Metabolism</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1016%2Fj.tips.2009.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=19616318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1KgsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=431-440&author=V.+W.+Pike&title=PET+Radiotracers%3A+Crossing+the+Blood-Brain+Barrier+and+Surviving+Metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">PET radiotracers: crossing the blood-brain barrier and surviving metabolism</span></div><div class="casAuthors">Pike, Victor W.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">431-440</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Radiotracers for imaging protein targets in the living human brain with positron emission tomog. (PET) are increasingly useful in clin. research and in drug development.  Such radiotracers must fulfill many criteria, among which an ability to enter brain adequately and reversibly without contamination by troublesome radiometabolites is desirable for accurate measurement of the d. of a target protein (e.g. neuroreceptor, transporter, enzyme or plaque).  Candidate radiotracers can fail as a result of poor passive brain entry, rejection from brain by efflux transporters or undesirable metab.  These issues are reviewed.  Emerging PET radiotracers for measuring efflux transporter function and new strategies for ameliorating radiotracer metab. are discussed.  A growing understanding of the mol. features affecting the brain penetration, metab. and efflux transporter sensitivity of prospective radiotracers should ultimately lead to their more rational and efficient design, and also to their greater efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6ftMCpkOSmrVg90H21EOLACvtfcHk0ljU5KZKIDqngQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1KgsLg%253D&md5=97704995fecd968baf1e0892bf70324e</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2009.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2009.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DV.%2BW.%26atitle%3DPET%2520Radiotracers%253A%2520Crossing%2520the%2520Blood-Brain%2520Barrier%2520and%2520Surviving%2520Metabolism%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26spage%3D431%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Laruelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slifstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span> </span><span class="NLM_article-title">Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1016%2Fj.mibio.2003.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=14667491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A280%3ADC%252BD3sroslehtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=363-375&author=M.+Laruelleauthor=M.+Slifsteinauthor=Y.+Huang&title=Relationships+between+radiotracer+properties+and+image+quality+in+molecular+imaging+of+the+brain+with+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography</span></div><div class="casAuthors">Laruelle Marc; Slifstein Mark; Huang Yiyun</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">363-75</span>
        ISSN:<span class="NLM_cas:issn">1536-1632</span>.
    </div><div class="casAbstract">In molecular imaging of the brain, many factors affect the reliability of the quantitative information that can be derived from the imaging process.  This article discusses factors impacting on the imaging quality that are related to the radiotracer per se.  Following a brief summary of key concepts in receptor quantification, a number of these factors are discussed, including selectivity, affinity, delivery, and lipophilicity.  Concepts discussed in the theoretical section are then illustrated, by reviewing a recent comparative evaluation of four agents developed to label the serotonin transporter ([(11)C]ADAM, [(11)C]DASB, [(11)C]DAPA, and [(11)C]AFM).  Specifically, the relationship between affinity and lipophilicity, measured in vitro, and several scanning parameters are investigated.  These include peripherical metabolism, brain uptake, required scanning time, nonspecific binding, and binding potential.  It is shown that, within a given structural family, affinity and lipophilicity are associated with scan outcome in a relatively predictable manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAWgqdOQ2p8o2y4bB4mnvYfW6udTcc2eY3M1YfF5qWjbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3sroslehtg%253D%253D&md5=b38c23d5032e968cc119f5b4197670d1</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.mibio.2003.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mibio.2003.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DLaruelle%26aufirst%3DM.%26aulast%3DSlifstein%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DRelationships%2520between%2520radiotracer%2520properties%2520and%2520image%2520quality%2520in%2520molecular%2520imaging%2520of%2520the%2520brain%2520with%2520positron%2520emission%2520tomography%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2003%26volume%3D5%26spage%3D363%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Waterhouse, R. N.</span><span> </span><span class="NLM_article-title">Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">376</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1016%2Fj.mibio.2003.09.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=14667492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A280%3ADC%252BD3sroslehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=376-389&author=R.+N.+Waterhouse&title=Determination+of+lipophilicity+and+its+use+as+a+predictor+of+blood-brain+barrier+penetration+of+molecular+imaging+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents</span></div><div class="casAuthors">Waterhouse Rikki N</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">376-89</span>
        ISSN:<span class="NLM_cas:issn">1536-1632</span>.
    </div><div class="casAbstract">Compound lipophilicity is a fundamental physicochemical property that plays a pivotal role in the absorption, distribution, metabolism, and elimination (ADME) of therapeutic drugs.  Lipophilicity is expressed in several different ways, including terms such as Log P, clogP, delta Log P, and Log D.  Often a parabolic relationship exists between measured lipophilicity and in vivo brain penetration of drugs, where those moderate in lipophilicity often exhibit highest uptake.  Reduced brain extraction of more lipophilic compounds is associated with increased non-specific binding to plasma proteins.  More lipophilic compounds can also be more vulnerable to P450 metabolism, leading to faster clearance.  Very polar compounds normally exhibit high water solubility, fast clearance through the kidneys, and often contain ionizable functional groups that limit blood-brain barrier (BBB) penetration.  The brain penetration and specific to non-specific binding ratios exhibited in vivo by positron emission tomography (PET) and single photon emission computed tomography (SPECT) radiotracers involves a complex interplay between many critical factors, including lipophilicity, receptor affinity, metabolism, molecular size and shape, ionization potential, and specific binding to BBB efflux pumps or binding sites on albumin or other plasma proteins.  This paper explores situations in which lipophilicity is a good predictor of BBB penetration, as well as those where this correlation is poor.  The more commonly used methods for measuring lipophilicity are presented, and the various terms often found in the literature outlined.  An attempt is made to describe how this information can be used in optimizing the development of PET and SPECT tracers that target the central nervous system (CNS).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAWgqdOQ2p8j0SWnHPWbmmfW6udTcc2eYUuclcWPNmYLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3sroslehtw%253D%253D&md5=cfff94825034cffcce30e56d703745cf</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.mibio.2003.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mibio.2003.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DWaterhouse%26aufirst%3DR.%2BN.%26atitle%3DDetermination%2520of%2520lipophilicity%2520and%2520its%2520use%2520as%2520a%2520predictor%2520of%2520blood-brain%2520barrier%2520penetration%2520of%2520molecular%2520imaging%2520agents%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2003%26volume%3D5%26spage%3D376%26epage%3D389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Celen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koole, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sannen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chitneni, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcazar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dedeurwaerdere, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbruggen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Laere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span> </span><span class="NLM_article-title">Preclinical Evaluation of <sup>18</sup>F-JNJ41510417 as a Radioligand for PET Imaging of Phosphodiesterase-10A in the Brain</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1584</span><span class="NLM_x">–</span> <span class="NLM_lpage">1591</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=1584-1591&author=S.+Celenauthor=M.+Kooleauthor=M.+De+Angelisauthor=I.+Sannenauthor=S.+K.+Chitneniauthor=J.+Alcazarauthor=S.+Dedeurwaerdereauthor=D.+Moecharsauthor=M.+Schmidtauthor=A.+Verbruggenauthor=X.+Langloisauthor=K.+Van+Laereauthor=J.+I.+Andr%C3%A9sauthor=G.+Bormans&title=Preclinical+Evaluation+of+18F-JNJ41510417+as+a+Radioligand+for+PET+Imaging+of+Phosphodiesterase-10A+in+the+Brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DKoole%26aufirst%3DM.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DSannen%26aufirst%3DI.%26aulast%3DChitneni%26aufirst%3DS.%2BK.%26aulast%3DAlcazar%26aufirst%3DJ.%26aulast%3DDedeurwaerdere%26aufirst%3DS.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DVerbruggen%26aufirst%3DA.%26aulast%3DLanglois%26aufirst%3DX.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.%2BI.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DPreclinical%2520Evaluation%2520of%252018F-JNJ41510417%2520as%2520a%2520Radioligand%2520for%2520PET%2520Imaging%2520of%2520Phosphodiesterase-10A%2520in%2520the%2520Brain%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2010%26volume%3D51%26spage%3D1584%26epage%3D1591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Andrés, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcazar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iturrino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dedeurwaerdere, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenaerts, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanhoof, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span> </span><span class="NLM_article-title">Synthesis, <i>In Vivo</i> Occupancy and Radiolabeling of Potent Phosphodiesterase Subtype-10 Inhibitors as candidates for Positron Emission Tomography Imaging</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5820</span><span class="NLM_x">–</span> <span class="NLM_lpage">5835</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200536d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5820-5835&author=J.+I.+Andr%C3%A9sauthor=M.+De+Angelisauthor=J.+Alcazarauthor=L.+Iturrinoauthor=X.+Langloisauthor=S.+Dedeurwaerdereauthor=I.+Lenaertsauthor=G.+Vanhoofauthor=S.+Celenauthor=G.+Bormans&title=Synthesis%2C+In+Vivo+Occupancy+and+Radiolabeling+of+Potent+Phosphodiesterase+Subtype-10+Inhibitors+as+candidates+for+Positron+Emission+Tomography+Imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm200536d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200536d%26sid%3Dliteratum%253Aachs%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.%2BI.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DAlcazar%26aufirst%3DJ.%26aulast%3DIturrino%26aufirst%3DL.%26aulast%3DLanglois%26aufirst%3DX.%26aulast%3DDedeurwaerdere%26aufirst%3DS.%26aulast%3DLenaerts%26aufirst%3DI.%26aulast%3DVanhoof%26aufirst%3DG.%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DSynthesis%252C%2520In%2520Vivo%2520Occupancy%2520and%2520Radiolabeling%2520of%2520Potent%2520Phosphodiesterase%2520Subtype-10%2520Inhibitors%2520as%2520candidates%2520for%2520Positron%2520Emission%2520Tomography%2520Imaging%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5820%26epage%3D5835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="note"><p class="first last">Method for identification of main metabolites: the test compounds were incubated with human and rat liver microsomes, at 0.4% final solvent concentration (0.16% DMSO and 0.24% MeCN). The study was conducted to identify the main metabolites formed after 0 min (control) and 60 min incubation time in the presence of the NADPH generating system at 37 °C. The test concentration of the compound was 5 μM. Samples were compared to the control incubations, in which compound was added at termination. Data were acquired on a Waters UPLC/QToF Premier mass spectrometer using a 10 min generic UPLC method and a generic MSe method. Complementary MS/MS experiments were performed when necessary. An Acquity UPLC C18 (2.1 mm × 100 mm, 1.8 μm) column was used. Interpretation of data was performed with Waters Metabolynx software.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="note"><p class="first last">The CEREP selectivity screen was performed on the following targets: 5HT<sub>1A</sub>, 5HT<sub>2A</sub>, 5HT<sub>3</sub>, 5HT<sub>5A</sub>, 5HT<sub>6</sub>, 5HT<sub>7</sub>, A<sub>1</sub>, A<sub>2A</sub>, A<sub>3</sub>, AT<sub>1</sub>, Beta<sub>1</sub>, BK<sub>2</sub>, CCKA, CCR<sub>1</sub>, D<sub>1</sub>, D<sub>2</sub>, DAT, ETA, GAL<sub>2</sub>, H<sub>1</sub>, H<sub>2</sub>, IL<sub>8B</sub>, CXCR<sub>2</sub>, M<sub>1</sub>, M<sub>2</sub>, M<sub>3</sub>, MC<sub>4</sub>, ML<sub>1</sub>, NET, NK<sub>2</sub>, NK<sub>3</sub>, NPY<sub>1</sub>, NPY<sub>2</sub>, NT<sub>1</sub>, OP<sub>1</sub>, OP<sub>3</sub>, ORL<sub>1</sub>, V<sub>1</sub>A, VIP, SST, 5HT<sub>1B</sub>, α<sub>1</sub>, α<sub>2</sub>, BZD, CaCH, CICH, GABA, KCH, NaCH, SKCaCH.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ohishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, N.</span><span> </span><span class="NLM_article-title">Distribution of a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat and mouse: an immunohistochemical study with a monoclonal antibody</span> <span class="citation_source-journal">Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1016%2FS0168-0102%2897%2900120-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=9572581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADyaK1cXhtVWrs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1998&pages=65-82&author=H.+Ohishiauthor=A.+Nekiauthor=N.+Mizuno&title=Distribution+of+a+metabotropic+glutamate+receptor%2C+mGluR2%2C+in+the+central+nervous+system+of+the+rat+and+mouse%3A+an+immunohistochemical+study+with+a+monoclonal+antibody"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39aR"><div class="casContent"><span class="casTitleNuber">39a</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution of a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat and mouse: an immunohistochemical study with a monoclonal antibody</span></div><div class="casAuthors">Ohishi, Hitoshi; Neki, Akio; Mizuno, Noboru</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Research (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-82</span>CODEN:
                <span class="NLM_cas:coden">NERADN</span>;
        ISSN:<span class="NLM_cas:issn">0168-0102</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">The distribution of a metabotropic glutamate receptor mGluR2 in the central nervous system was immunohistochem. examd. in the rat and mouse with a monoclonal antibody raised against an N-terminal sequence of rat mGluR2 (amino acid residues 87-134).  Neuronal cell bodies with mGluR2-like immunoreactivity (mGluR2-LI) were clearly shown in the horizontal cells of Cajal in the cerebral cortex, neurons in the triangular septal nucleus and medial mammillary nucleus, Golgi cells and the unipolar brush cells in the cerebellar cortex, and Golgi-like and unipolar brush-like cells in the cochlear nucleus.  Neuropil was intensely immunostained in the accessory olfactory bulb, bed nucleus of the accessory olfactory tract, neocortex, cingulate cortex, retrosplenial cortex, subicular and entorhinal cortices, stratum lacunosum-moleculare of CA1 and CA3, mol. layer of the dentate gyrus, periamygdaloid cortex, basolateral amygdaloid nucleus, bed nucleus of the anterior commissure, caudate-putamen, accumbens nucleus, thalamic reticular nucleus, anteroventral and paraventricular thalamic nuclei, granular layer of the cerebellar cortex, anterior and ventral tegmental nuclei, granular layer of the cochlear nucleus, and parvicellular part of the lateral reticular nucleus.  Many axons in the white matter and fiber bundles were also immunostained.  No glial cells with mGluR2-LI were found.  No particular species differences were found in the distribution pattern of mGluR2-LI between the rat and mouse.  The results indicate that mGluR2 is expressed not only in somato-dendritic domain, but also in axonal domain of excitatory and inhibitory neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoltow_VoMzdLVg90H21EOLACvtfcHk0ljG2buSQu9g2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtVWrs7k%253D&md5=64d4794a23898739f08ef586d9106c69</span></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=10.1016%2FS0168-0102%2897%2900120-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0168-0102%252897%252900120-X%26sid%3Dliteratum%253Aachs%26aulast%3DOhishi%26aufirst%3DH.%26aulast%3DNeki%26aufirst%3DA.%26aulast%3DMizuno%26aufirst%3DN.%26atitle%3DDistribution%2520of%2520a%2520metabotropic%2520glutamate%2520receptor%252C%2520mGluR2%252C%2520in%2520the%2520central%2520nervous%2520system%2520of%2520the%2520rat%2520and%2520mouse%253A%2520an%2520immunohistochemical%2520study%2520with%2520a%2520monoclonal%2520antibody%26jtitle%3DNeurosci.%2520Res.%26date%3D1998%26volume%3D30%26spage%3D65%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit39b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Richards, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malherbe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brockhaus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutel, V.</span><span> </span><span class="NLM_article-title">Distribution and abundance of metabotropic glutamate receptor subtype 2 in rat brain revealed by [<sup>3</sup>H]LY354740 binding in vitro and quantitative radioautography: correlation with the sites of synthesis, expression, and agonist stimulation of [<sup>35</sup>S]GTPgammaS binding</span> <span class="citation_source-journal">J. Comp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">487</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=16&amp;doi=10.1021%2Fjm300912k&amp;key=10.1002%2Fcne.20538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=8&amp;doi=10.1021%2Fjm300912k&amp;key=15861463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=32&amp;doi=10.1021%2Fjm300912k&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvVGhs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=487&publication_year=2005&pages=15-27&author=G.+Richardsauthor=J.+Messerauthor=P.+Malherbeauthor=R.+Pinkauthor=M.+Brockhausauthor=H.+Stadlerauthor=J.+Wichmannauthor=H.+Schaffhauserauthor=V.+Mutel&title=Distribution+and+abundance+of+metabotropic+glutamate+receptor+subtype+2+in+rat+brain+revealed+by+%5B3H%5DLY354740+binding+in+vitro+and+quantitative+radioautography%3A+correlation+with+the+sites+of+synthesis%2C+expression%2C+and+agonist+stimulation+of+%5B35S%5DGTPgammaS+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39bR"><div class="casContent"><span class="casTitleNuber">39b</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution and abundance of metabotropic glutamate receptor subtype 2 in rat brain revealed by [3H]LY354740 binding in vitro and quantitative radioautography: Correlation with the sites of synthesis, expression, and agonist stimulation of [35S]GTPγS binding</span></div><div class="casAuthors">Richards, Grayson; Messer, Juerg; Malherbe, Pari; Pink, Richard; Brockhaus, Manfred; Stadler, Heinz; Wichmann, Juergen; Schaffhauser, Herve; Mutel, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Comparative Neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">487</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-27</span>CODEN:
                <span class="NLM_cas:coden">JCNEAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9967</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Until recently, there was a lack of selective radioligands for the subtypes of metabotropic glutamate (mGlu) receptors.  [3H]LY 354740 ((+)-2-aminobicyclo[3,1,0]hexane-2,6-dicarboxylic acid), a selective agonist for group II receptors (mGlu2 and -3, which are neg. coupled to cAMP prodn.), has now been used to map their brain distribution and abundance by in vitro binding and quant. radioautog.  The selective cation dependence of its binding allowed the discrimination between mGlu2 and mGlu3 receptor labeling.  Thus, in the presence of Ca2+ and Mg2+ ions, the agonist bound selectively to mGlu2 receptors as evidenced by: (1) the correlative distribution and abundance of binding sites (highest in the lacunosum moleculare of the hippocampus and lowest in white matter) with mGlu2 receptor mRNA and protein revealed by in situ hybridization histochem. and immunohistochem., resp.; (2) its selective pharmacol.; and (3) the distribution of LY 354740-stimulated [35S]GTPγS binding (25-97% above basal, according to the brain region), revealing G protein-coupled receptor coupling to Gi proteins.  Nonspecific binding (in the presence of 10 μM DCG-IV, a group II-selective, mGlu2-preferring, receptor agonist) was <10% of total.  In adjacent sections, the distribution of binding sites for [3H]DCG-IV was very similar.  This extensive study paves the way for investigations of the regional expression and regulation of mGlu2 receptors in human CNS diseases, such as Alzheimer's disease, which may reveal their functional roles and identify potential therapeutic drug targets.  Indeed, it has recently been demonstrated (Higgins et al. [2004]) that pharmacol. manipulation of mGlu2 receptors influences cognitive performance in the rodent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV2ub35EbJUbVg90H21EOLACvtfcHk0liurvTNpop48A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvVGhs7k%253D&md5=711b9b109da0ea76161bbe8a629b1336</span></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=10.1002%2Fcne.20538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcne.20538%26sid%3Dliteratum%253Aachs%26aulast%3DRichards%26aufirst%3DG.%26aulast%3DMesser%26aufirst%3DJ.%26aulast%3DMalherbe%26aufirst%3DP.%26aulast%3DPink%26aufirst%3DR.%26aulast%3DBrockhaus%26aufirst%3DM.%26aulast%3DStadler%26aufirst%3DH.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DSchaffhauser%26aufirst%3DH.%26aulast%3DMutel%26aufirst%3DV.%26atitle%3DDistribution%2520and%2520abundance%2520of%2520metabotropic%2520glutamate%2520receptor%2520subtype%25202%2520in%2520rat%2520brain%2520revealed%2520by%2520%255B3H%255DLY354740%2520binding%2520in%2520vitro%2520and%2520quantitative%2520radioautography%253A%2520correlation%2520with%2520the%2520sites%2520of%2520synthesis%252C%2520expression%252C%2520and%2520agonist%2520stimulation%2520of%2520%255B35S%255DGTPgammaS%2520binding%26jtitle%3DJ.%2520Comp.%2520Neurol.%26date%3D2005%26volume%3D487%26spage%3D15%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Cid, J. M.; Tresadern, G.; Vega, J. A.; De Lucas, A. I.; Matesanz, E.; Iturrino, L.; Linares, M. L.; Garcia, A.; Andrés, J. I.; Macdonald, G. J.; Oehlrich, D.; Lavreysen, H.; Megens, A.; Ahnaou, A.; Drinkenburg, W.; Mackie, C.; Pype, S.; Gallacher, D.; Trabanco, A. A.</span><span> </span><span class="NLM_article-title">Discovery of 3-Cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-a]pyridine (JNJ-42153605): A Positive Allosteric Modulator of the Metabotropic Glutamate 2 Receptor.</span> <span class="citation_source-journal">J. Med. Chem. </span>[Online early access]. DOI: http://dx.doi.org/10.1021/jm3010724</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Cid%2C+J.+M.%3B+Tresadern%2C+G.%3B+Vega%2C+J.+A.%3B+De+Lucas%2C+A.+I.%3B+Matesanz%2C+E.%3B+Iturrino%2C+L.%3B+Linares%2C+M.+L.%3B+Garcia%2C+A.%3B+Andr%C3%A9s%2C+J.+I.%3B+Macdonald%2C+G.+J.%3B+Oehlrich%2C+D.%3B+Lavreysen%2C+H.%3B+Megens%2C+A.%3B+Ahnaou%2C+A.%3B+Drinkenburg%2C+W.%3B+Mackie%2C+C.%3B+Pype%2C+S.%3B+Gallacher%2C+D.%3B+Trabanco%2C+A.+A.+Discovery+of+3-Cyclopropylmethyl-7-%284-phenylpiperidin-1-yl%29-8-trifluoromethyl%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyridine+%28JNJ-42153605%29%3A+A+Positive+Allosteric+Modulator+of+the+Metabotropic+Glutamate+2+Receptor.J.+Med.+Chem.+%5BOnline+early+access%5D.+DOI%3A+http%3A%2F%2Fdx.doi.org%2F10.1021%2Fjm3010724"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCid%26aufirst%3DJ.%2BM.%26atitle%3DDiscovery%2520of%25203-Cyclopropylmethyl-7-%25284-phenylpiperidin-1-yl%2529-8-trifluoromethyl%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyridine%2520%2528JNJ-42153605%2529%253A%2520A%2520Positive%2520Allosteric%2520Modulator%2520of%2520the%2520Metabotropic%2520Glutamate%25202%2520Receptor.%26jtitle%3DJ.%2520Med.%2520Chem.%2520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i65"><a href="/doi/suppl/10.1021/jm300912k">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_54060"></div></div></div></div></div><hr /></hr><p class="last">The different methods used for the LCMS and GCMS characterization of the compounds described in this manuscript; the biodistribution of [<sup>11</sup>C]<b>20f</b> in normal rats at 2, 30, and 60 min post-tracer-injection; the reconstructed radiochromatogram corresponding to a rat plasma analysis at 30 min postinjection of [<sup>11</sup>C]<b>20f</b>; and reconstructed radiochromatograms corresponding to a rat perfused cerebrum and cerebellum analysis at 30 min postinjection of [<sup>11</sup>C]<b>20f</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300912k/suppl_file/jm300912k_si_001.pdf">jm300912k_si_001.pdf (400.99 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm300912k&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-20%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm300912k" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm300912k" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991ef1ef05197f","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
